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RNA Polymerase II (Pol II) transcription is a highly regulated process.  Many factors associate 
with Pol II to ensure that transcription occurs as efficiently as possible.  One of these factors is 
the Paf1 complex, which consists of the subunits Paf1, Ctr9, Rtf1, Cdc73, and Leo1.  This 
complex has been shown to be important for the regulation of chromatin modifications that 
promote active transcription.  Rkr1 was identified in a genetic screen to uncover factors that 
function in parallel with the Paf1 subunit Rtf1.  My work has focused on characterizing a role for 
Rkr1 in transcription and chromatin function.  I have shown that strains lacking RKR1 have 
transcription-related phenotypes.  Genetic analysis has shown that Rkr1 functions in parallel with 
Rtf1-dependent histone modifications, particularly histone H2B ubiquitylation and histone H3 
lysine 4 methylation.  Strains lacking RKR1 have telomeric silencing defects, further connecting 
Rkr1 to chromatin function.  Rkr1 is a nuclear protein that contains a RING domain at its 
extreme carboxy terminus.  RING domain proteins often act as ubiquitin-protein ligases, which 
determine substrate specificity in the ubiquitylation pathway.  Subsequent analyses have shown 
that Rkr1 does possess ubiquitin ligase activity in vitro, and mutational analysis shows that the 
RING domain of Rkr1 is required for in vivo activity.  In an attempt to identify a functional 
process for Rkr1, a yeast two-hybrid screen was performed using an amino-terminal fragment of 
Rkr1 as bait.  Twenty proteins were identified to interact with this region of Rkr1, many of 
which are functionally connected to transcription and chromatin.  Microarray analysis shows that 
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 v 
Rkr1 is required for proper expression of a subset of genes in yeast.  Taken together, my work 
has identified a new ubiquitylation pathway within the nucleus that acts to regulate transcription 
and chromatin function.   
 
 
 vi 
TABLE OF CONTENTS 
1.0 INTRODUCTION........................................................................................................ 1 
1.1 TRANSCRIPTION OCCURS IN THE CONTEXT OF NUCLEOSOMES.. 1 
1.1.1 Nucleosome structure is dynamic and regulated at many levels .............. 6 
1.1.2 The histones are post-translationally modified ........................................ 11 
1.1.2.1 Histone acetylation.............................................................................. 14 
1.1.2.2 Histone methylation ............................................................................ 14 
1.1.3 Histone variants lead to changes in chromatin structure and function. 19 
1.1.4 Chromatin remodelers restructure and reposition nucleosomes ........... 21 
1.1.4.1 The RSC complex................................................................................ 22 
1.1.4.2 Chd1 ..................................................................................................... 24 
1.2 TRANSCRIPTION BY RNA POLYMERASE II IS A HIGHLY 
REGULATED PROCESS ................................................................................................. 25 
1.2.1 RNA Pol II is a conserved, multi-subunit enzyme complex.................... 25 
1.2.2 The modification state of the CTD of RNA Pol II changes during the 
transcription cycle...................................................................................................... 29 
1.2.2.1 CTD kinases......................................................................................... 30 
1.2.2.2 CTD phosphatases............................................................................... 31 
1.2.3 Transcription initiation .............................................................................. 32 
 vii 
1.2.3.1 Promoter elements regulate transcription initiation ....................... 32 
1.2.3.2 Transcriptional activators and repressors bind to DNA elements 
and recruit coactivators and corepressors ...................................................... 35 
1.2.3.3 Transcription coactivators mediate interactions between activators 
and the general transcription factors............................................................... 39 
1.2.3.4 The general transcription machinery coordinately regulates 
transcription initiation ...................................................................................... 48 
1.2.4 Transcription elongation is facilitated by many proteins that associate 
with Pol II ................................................................................................................... 52 
1.2.4.1 The Paf1 complex ................................................................................ 52 
1.2.4.2 Spt4/5, Spt6, and yeast FACT modulate chromatin structure during 
transcription....................................................................................................... 59 
1.2.4.3 TFIIS .................................................................................................... 61 
1.2.5 Transcription termination and 3’-end formation of the mRNA ............ 62 
1.3 TRANSCRIPTIONAL SILENCING MECHANISMS IN YEAST.............. 63 
1.3.1 What is silencing? ....................................................................................... 63 
1.3.2 The Sir proteins are required to establish and maintain silencing ........ 64 
1.3.3 The histone modification state in silenced regions differs from the 
modification state in actively transcribed regions................................................... 67 
1.3.4 Three regions of the S. cerevisiae genome are subjected to silencing..... 67 
1.3.4.1 Telomeric silencing ............................................................................. 68 
1.3.4.2 Silencing of the mating type cassettes ............................................... 70 
1.3.4.3 rDNA silencing .................................................................................... 71 
 viii 
1.4 THE UBIQUITIN-PROTEASOME PATHWAY IS CONNECTED TO RNA 
POL II TRANSCRIPTION ............................................................................................... 73 
1.4.1 What is ubiquitylation? .............................................................................. 76 
1.4.2 Components of the ubiquitylation pathway ............................................. 76 
1.4.2.1 Ubiquitin-activating enzymes............................................................. 80 
1.4.2.2 Ubiquitin-conjugating enzymes ......................................................... 80 
1.4.2.3 Ubiquitin-protein ligases .................................................................... 81 
1.4.2.4 Deubiquitylating enzymes .................................................................. 85 
1.4.3 The proteasome degrades ubiquitylated proteins.................................... 86 
1.4.3.1 How do ubiquitylated proteins get to the proteasome?................... 86 
1.4.3.2 The 26S proteasome selectively degrades ubiquitylated proteins .. 87 
1.4.4 The ubiquitin-proteasome machinery functions within the nucleus...... 94 
1.4.4.1 Proteolytic and nonproteolytic activities of the proteasome regulate 
many nuclear events .......................................................................................... 94 
1.4.4.2 Nuclear ubiquitin-protein ligases ...................................................... 97 
1.5 THESIS AIMS ................................................................................................... 99 
2.0 GENETIC ANALYSIS TO INVESTIGATE A FUNCTION FOR RKR1......... 101 
2.1 INTRODUCTION ........................................................................................... 101 
2.2 METHODS....................................................................................................... 102 
2.2.1 Genetic methods ........................................................................................ 102 
2.2.2 Plasmids ..................................................................................................... 107 
2.2.3 Media.......................................................................................................... 108 
2.2.4 Growth assays............................................................................................ 108 
 ix 
2.2.5 Sporulation efficiency assay ..................................................................... 108 
2.2.6 Indirect immunofluorescence .................................................................. 109 
2.2.7 Northern analysis ...................................................................................... 109 
2.2.8 Chromatin immunoprecipitation (ChIP) analysis ................................. 110 
2.3 RESULTS ......................................................................................................... 113 
2.3.1 rtf1Δ is synthetically lethal with rkr1Δ .................................................... 113 
2.3.2 RKR1 is not synthetically lethal with other members of the Paf1 complex 
or other transcription elongation factors............................................................... 126 
2.3.3 Strains lacking RKR1 have phenotypes that suggest a role for Rkr1 in 
transcription and sporulation ................................................................................. 128 
2.3.4 Rkr1 is a nuclear protein.......................................................................... 134 
2.3.5 RKR1 genetically interacts with factors involved in chromatin 
modification .............................................................................................................. 137 
2.3.6 Strains lacking RKR1 have defects in telomeric silencing..................... 144 
2.3.6.1 Histone deposition at telomeres is not affected in rkr1Δ strains ... 147 
2.3.6.2 Telomeric histone H4 acetylation is not affected by the loss of 
RKR1…. ............................................................................................................ 150 
2.3.7 RKR1 genetically interacts with other factors involved in 
transcription…. ........................................................................................................ 153 
2.3.7.1 Deletion of RKR1 is synthetically lethal with a deletion of SPT10, a 
gene encoding a potential histone acetyltransferase..................................... 153 
2.3.7.2 RKR1 shows genetic interactions with other transcription factors 
that were identified in the synthetic lethal screen with rtf1Δ....................... 158 
 x 
2.4 CONCLUSIONS.............................................................................................. 163 
3.0 FUNCTIONAL ANALYSIS OF RKR1 USING DATABASE ANALYSIS AND 
IN VITRO ASSAYS................................................................................................................... 167 
3.1 INTRODUCTION ........................................................................................... 167 
3.2 METHODS....................................................................................................... 168 
3.2.1 Plasmids ..................................................................................................... 168 
3.2.2 Media.......................................................................................................... 168 
3.2.3 Sequence analysis. ..................................................................................... 169 
3.2.4 Growth assays............................................................................................ 169 
3.2.5 Immunoblotting analysis. ......................................................................... 170 
3.2.6 Purification of recombinant proteins. ..................................................... 170 
3.2.7 In vitro ubiquitylation assays ................................................................... 171 
3.3 RESULTS ......................................................................................................... 172 
3.3.1 Database analyses reveal that Rkr1 contains a RING domain at its 
extreme carboxy terminus....................................................................................... 172 
3.3.2 Mutational analysis shows that the RING domain of Rkr1 is required 
for in vivo function ................................................................................................... 178 
3.3.3 The RING domain of Rkr1 possesses ubiquitin-protein ligase activity in 
vitro…… .................................................................................................................... 181 
3.4 CONCLUSIONS.............................................................................................. 184 
4.0 IDENTIFICATION OF PROTEINS THAT PHYSICALLY INTERACT WITH 
RKR1…...................................................................................................................................... 187 
4.1 INTRODUCTION ........................................................................................... 187 
 xi 
4.2 METHODS....................................................................................................... 191 
4.2.1 Plasmids ..................................................................................................... 191 
4.2.2 Yeast Strains and Media .......................................................................... 192 
4.2.3 Coimmunoprecipitation experiments ..................................................... 194 
4.2.4 Immunoblot analysis................................................................................. 194 
4.2.5 Cycloheximide-chase experiments........................................................... 195 
4.2.6 Modified TAP purification....................................................................... 195 
4.2.7 Silver staining SDS-PAGE gels................................................................ 197 
4.3 RESULTS ......................................................................................................... 197 
4.3.1 A yeast two-hybrid screen shows that Rkr1 physically interacts with 
proteins involved in chromatin function, transcription, and ubiquitylation...... 197 
4.3.1.1 Dsk2 physically interacts with Rkr1................................................ 202 
4.3.1.2 The global levels of proteins identified in the two-hybrid screen are 
not significantly affected by the loss of Rkr1 in rich medium ..................... 205 
4.3.1.3 Rsc8 and Gzf3 are not degraded in a Rkr1-dependent manner in 
rich medium ..................................................................................................... 208 
4.3.2 Modified TAP purification....................................................................... 212 
4.4 CONCLUSIONS.............................................................................................. 215 
5.0 IDENTIFICATION OF YEAST GENES REGULATED BY RKR1 USING 
MICROARRAY ANALYSIS................................................................................................... 217 
5.1 INTRODUCTION ........................................................................................... 217 
5.2 METHODS....................................................................................................... 218 
5.2.1 Strains and media ..................................................................................... 218 
 xii 
5.2.2 RNA isolation, cDNA and cRNA synthesis for microarrays................. 220 
5.2.3 Data analysis for microarrays.................................................................. 220 
5.2.4 Significance analysis of microarray (SAM)............................................ 221 
5.2.5 Real-time PCR analysis ............................................................................ 221 
5.3 RESULTS ......................................................................................................... 224 
5.3.1 Microarray analysis shows that Rkr1 affects the expression of a subset 
of genes in yeast ........................................................................................................ 224 
5.3.2 SAM analysis suggests that Rkr1 significantly affects the expression of 
73 genes in yeast ....................................................................................................... 231 
5.3.3 Real-time PCR confirms that several genes are affected by the loss of 
RKR1…...................................................................................................................... 232 
5.3.4 Some yeast genes appear to be oppositely affected by the loss of Rkr1 
and Rtf1 ………………………………………………………………………….237 
5.3.5 Information obtained in the yeast two-hybrid screen overlaps with 
information obtained in microarray experiments................................................. 239 
5.4 CONCLUSIONS.............................................................................................. 241 
6.0 DISCUSSION ........................................................................................................... 242 
6.1 SUMMARY OF RESULTS ............................................................................ 242 
6.2 GENETIC ANALYSIS SUGGESTS THAT RKR1 IS FUNCTIONALLY 
CONNECTED TO CHROMATIN MODIFICATIONS THAT MARK ACTIVE 
TRANSCRIPTION........................................................................................................... 245 
6.2.1 How can we interpret the synthetic lethality observed in rkr1Δ rtf1Δ 
strains? ………………………………………………………………………….245 
 xiii 
6.2.2 Why is telomeric silencing disrupted in rkr1Δ strains?......................... 247 
6.2.3 What do the genetic interactions between RKR1 and factors involved in 
chromatin modification tell us? .............................................................................. 249 
6.2.3.1 Does Rkr1 function to regulate histone modification(s)? .............. 250 
6.2.4 What do the phenotypes that are observed in rkr1Δ strains mean? .... 251 
6.2.5 How can we explain the genetic interactions between RKR1 and 
transcription factors? .............................................................................................. 252 
6.2.5.1 Why are rkr1Δ spt10Δ strains inviable? .......................................... 252 
6.2.5.2 Why are rkr1Δ srb5Δ strains inviable?............................................ 253 
6.2.5.3 Why do rkr1Δ ctk1Δ strains grow poorly?...................................... 254 
6.3 RKR1 IS A NUCLEAR, RING DOMAIN CONTAINING PROTEIN...... 255 
6.3.1 Rkr1 contains a functionally important RING domain ........................ 255 
6.3.2 The RING domain of Rkr1 possesses ubiquitin ligase activity............. 256 
6.3.2.1 What type(s) of ubiquitylation does Rkr1 catalyze?...................... 256 
6.3.2.2 What are the targets of Rkr1’s ubiquitin ligase activity? ............. 257 
6.3.2.3 Could Rkr1 act as a ligase for ubiquitin-like modifications?........ 258 
6.4 RKR1 PHYSICALLY INTERACTS WITH PROTEINS INVOLVED IN 
UBIQUITYLATION, TRANSCRIPTION AND CHROMATIN FUNCTION.......... 259 
6.4.1 Are any of the proteins that interact with Rkr1 targets of its ubiquitin 
ligase activity? .......................................................................................................... 259 
6.4.2 Physical connections between Rkr1 and the proteasome support a role 
for Rkr1 in ubiquitylation in vivo. .......................................................................... 260 
6.5 RKR1 IS IMPORTANT FOR THE PROPER EXPRESSION OF A 
 xiv 
SUBSET OF GENES IN YEAST.................................................................................... 261 
6.5.1 How does Rkr1 affect gene expression in yeast?.................................... 261 
6.5.2 Is Rkr1 directly involved in regulating any of the genes identified by 
microarray? .............................................................................................................. 263 
6.6 OVERALL MODEL FOR RKR1 ACTIVITY ............................................. 264 
BIBLIOGRAPHY..................................................................................................................... 267 
 xv 
 LIST OF TABLES 
Table 1. RNA Polymerase II transcription and chromatin factors.................................................. 2 
Table 2. Ubiquitin related factors. ................................................................................................ 74 
Table 3. Strains used in Chapter 2. ............................................................................................. 104 
Table 4. Primers used in Chapter 2 studies................................................................................. 112 
Table 5. Genetic interactions suggest that Rkr1 does not primarily function to promote 
elongation.................................................................................................................................... 127 
Table 6. Strains lacking RKR1 do not sporulate. ........................................................................ 133 
Table 7. Genetic interactions between RKR1 and genes encoding proteins involved in chromatin 
modification. ............................................................................................................................... 138 
Table 8. List of genes that are synthetically lethal with rtf1Δ. ................................................... 160 
Table 9. Table of Strains for Chapter 4....................................................................................... 193 
Table 10. Proteins that physically interact with the amino terminus of Rkr1, as determined by a 
two-hybrid screen........................................................................................................................ 199 
Table 11. Table of strains used in Chapter 5. ............................................................................. 219 
Table 12. Table of primers used for real time PCR. ................................................................... 223 
Table 13. . List of genes that require Rkr1 for full expression. .................................................. 228 
Table 14. List of genes that require Rkr1 for their repression. ................................................... 229 
Table 15.  Confirmation of microarray results with realtime PCR............................................. 236 
 xvi 
Table 16. Real-time PCR shows that Rkr1, Rtf1 and Ctr9 regulate an overlapping set of genes in 
minimal medium. ........................................................................................................................ 238 
Table 17.  An overlap in the microarray and yeast-two hybrid screen datasets. ........................ 240 
Table 18. Summary of evidence that suggests a role for Rkr1 in regulating chromatin function.
..................................................................................................................................................... 244 
Table 19.  High-Copy-Number suppressors of rtf1Δ/rkr1Δ synthetic lethality. ......................... 266 
 xvii 
LIST OF FIGURES 
Figure 1. The structure of the nucleosome...................................................................................... 9 
Figure 2. The histones are post-translationally modified.............................................................. 12 
Figure 3. Histone acetylation and methylation are most often marks of active transcription. ..... 17 
Figure 4.  Structure of RNA Pol II................................................................................................ 27 
Figure 5. Gal4 recruits coactivators to activated promoters. ........................................................ 37 
Figure 6. The SAGA complex. ..................................................................................................... 42 
Figure 7. The Mediator complex. ................................................................................................. 46 
Figure 8. Recruitment of the general transcription machinery is highly ordered. ........................ 50 
Figure 9.  Many transcription elongation factors regulate chromatin structure............................ 57 
Figure 10. Three regions of the genome are subjected to silencing.............................................. 65 
Figure 11. The ubiquitylation pathway......................................................................................... 78 
Figure 12.  RING domain architecture. ........................................................................................ 83 
Figure 13. The proteasome structure. ........................................................................................... 88 
Figure 14.  The 20S proteasome structure. ................................................................................... 92 
Figure 15. Strains lacking RTF1 and RKR1 are inviable. ........................................................... 114 
Figure 16. Specific regions of Rtf1 are required when Rkr1 is absent. ...................................... 117 
Figure 17. Genetic interactions suggest that Rkr1 functions in parallel with Rtf1 dependent 
histone modifications. ................................................................................................................. 121 
 xviii 
Figure 18. Genetic interactions suggest that Rkr1 functions in parallel with Chd1. .................. 124 
Figure 19. Strains lacking RKR1 grow poorly on medium lacking inositol. .............................. 130 
Figure 20. Rkr1 is a nuclear protein............................................................................................ 135 
Figure 21. Genetic interactions between RKR1 and genes that encode proteins that affect histone 
H2B ubiquitylation and histone H3 K4 methylation. ................................................................. 139 
Figure 22. Rtf1-dependent histone modifications are not dirupted in rkr1Δ strains................... 142 
Figure 23. Strains lacking RKR1 have telomeric silencing defects. ........................................... 145 
Figure 24.  Histone deposition at telomere VI is not affected by the loss of Rkr1..................... 148 
Figure 25. Histone H4 acetylation at telomere VI is not affected by the loss of Rkr1. .............. 151 
Figure 26.  rkr1Δ is synthetically lethal with spt10Δ.................................................................. 156 
Figure 27. rkr1Δ is synthetically lethal with srb5Δ and rkr1Δ ctk1Δ strains grow very poorly . 161 
Figure 28. Model for Rkr1 function based on genetic interactions. ........................................... 165 
Figure 29. Rkr1 protein sequence is conserved among eukaryotes. ........................................... 174 
Figure 30. The RING domain of Rkr1 is highly conserved........................................................ 176 
Figure 31. The RING domain of Rkr1 is required for in vivo function. ..................................... 179 
Figure 32. The RING domain of Rkr1 possesses ubiquitin protein ligase activity in vitro........ 182 
Figure 33.  Model for Rkr1 activity in vivo. ............................................................................... 185 
Figure 34. Coimmunoprecipitation experiments do not detect a physical interaction between 
Rkr1 and Rtf1.............................................................................................................................. 189 
Figure 35. Network of physical and genetic interactions among the proteins identified in the 
yeast two-hybrid screen with Rkr1. ............................................................................................ 200 
Figure 36. Rkr1 physically interacts with Dsk2.......................................................................... 203 
Figure 37. The levels of proteins that physically interact with Rkr1 are not significantly affected 
 xix 
by the loss of Rkr1. ..................................................................................................................... 206 
Figure 38. Rsc8 and Gzf3 protein levels are not affected by the loss of Rkr1 in rich medium.. 210 
Figure 39. Purification of Rkr1................................................................................................... 213 
Figure 40. Rkr1 affects the expression of a subset of yeast genes when strains are grown in 
minimal medium. ........................................................................................................................ 226 
Figure 41. The NAD biosynthesis pathway in yeast................................................................... 234 
 xx 
PREFACE 
 
First, I must thank Karen Arndt.  Karen, you have been an amazing advisor, mentor and 
role model through the last 6 years.  I want to thank you for taking me into your lab and teaching 
me how to be the best scientist I can be.  Thank you for pushing me to speak at scientific 
meetings and for supporting me and my career choices.  Rkr1 rocks! 
I also need to thank my committee members, Jeff Brodsky, Jeffrey Lawrence, Valerie 
Oke, and John Woolford.  Thank you for all of your insight and advice regarding my project.  
Thanks to Jeff Brodsky and his lab for allowing me to borrow equipment and reagents, and for 
helpful advice about the ubiquitin related experiments.  Thanks to Jeffrey Lawrence for all of 
your advice throughout graduate school.  You’re musical talents are incredible, I will miss 
listening to you and Heather perform.  Thanks to Valerie for being a great teacher; I learned a lot 
while we taught that first Genetics class.  Thank you for providing many delicious baked goods 
throughout the years.  Thanks to John for all of your help in troubleshooting the TAP 
purifications, and for your advice and support during my postdoc search. 
I also need to thank many people who offered much appreciated advice, reagents and 
techniques that greatly advanced our progress with Rkr1.  Thanks to Joe Martens for all of your 
advice at lab meetings, and especially for your help with the real time PCR.  Thanks to Richard 
Gardner for many emails with support and advice regarding the ubiquitin ligase experiments and 
 xxi 
helping us to identify substrates for Rkr1.  Thanks to Greg Prelich for advice and for entertaining 
discussions at Yeast Meetings.  Thanks to Fred Winston for sharing unpublished results, for 
supplying us with reagents and strains.  Thank you for all of your support and encouragment 
with my postdoc search.  I really appreciate all of your help! 
I want to thank the current and past members of the Arndt lab for creating the BEST 
environment for me to enjoy showing up to work everyday.  Thanks to Peggy Shirra for all of 
her help in introducing me to the research in the lab and how to critically think about controls for 
experiments, and for hosting many great Superbowl parties through the years.  Thanks to our 
former technician Rajna Simic for her competitive spirit during ultimate frisbee games.  Many 
thanks to Roxanne Scarano for being a great friend and confidant throughout grad school.  I need 
to thank your family as well, for making sure I survived comps and for taking care of Mike and I 
while we were neighbors.  Thanks to Dan Sheidy for your friendship and for taking time to 
explain hockey to me.  I also wish to thank all of the rotation and undergrad students who have 
been in the lab, especially those who have advanced our understanding of Rkr1, including Becky 
Gonda, Ping Zhang, Ruta Sahasrabudhe, Kristin Klucevsek, Allie Carulli, Jessica Heck, and 
Nathan Schaffer.   
I especially need to thank the graduate students who have been a part of the Arndt lab 
during the last 5 years: Kathryn Sheldon, Marcie Warner and Elia Crisucci.  Thanks to all of you 
for keeping me sane!  Thanks to “Katie Shoulders-Sheldon-Kumer” and her husband Pablo for 
hosting the “Reno 911” and New Year’s parties.  Thanks to Marcie “Jo” for always keeping a 
level head and helping me to see the positive side of every situation.  Thanks to Elia for advice 
on life, science, fashion, and for making me work out when I didn’t want to.  I also want to thank 
Alycia “P.B.” Bittner, who we always considered to be a member of the Arndt lab, for her 
 xxii 
friendship and for positively representing the prokaryotic world even in the face of adversity.  
Thanks to Kathryn, Marcie and Alycia for all of the memories of the trips to Fort Lauderdale and 
Las Vegas—alligator farms, monkey squirrels, death-trap roller coaster rides, crazy circus shows 
and all.  Thanks to all of you for your friendship through the years.  I will miss you all so much, 
and I promise to visit as often as I can. 
I also need to thank many other grad students in our department for helping me through 
the last 6 years.  Thanks to all of the members of our class for your camaraderie and support, 
especially through our first year and through our comprehensive exams.  I especially need to 
thank some of you for so much more.  Thanks to Lisa Sproul, for being a great friend that I’ve 
known since the 6th grade—can you believe we’ve been in school this long?  Sproulio, you never 
cease to amaze me with your poise through any situation, and your never-ending supply of 
enthusiasm about life and science.  Here’s to the “mountain girls”!  I want to thank her fiancé, 
Jason Hoverman, for being a great friend as well.  Thanks to Heather Hendrickson for your 
friendship, for sharing your musical talents, and especially for the discussions over the last few 
months in deciding what we want to do with our lives.  Thanks to Laura Marinelli for your 
friendship and for always helping me to remember that “it’s going to be ok”.  Go Penguins! 
Thanks to Steve Hancock for your friendship, your passion for ultimate frisbee, Pittsburgh sports 
and The Clarks.  Even though I lost the bet, thanks for not being scared to wear a rockin’ mullet 
to a Pirates’ game!  Thanks to Team Dalzell for throwing many memorable parties, including the 
infamous “JELLO” parties.  Thanks to all of you for attending MANY Clarks’ shows with me 
through the years.  I will miss you all and I promise to keep in touch. 
I need to thank all of the members of the main and fiscal offices, especially Cathy Barr.  
Cathy, your attention and care for every grad student in the department is amazing, and I know 
 xxiii 
that I would have missed many important deadlines without your help.  Thanks to Natalie 
Marinzel for providing an endless supply of candy and for the entertaining discussions about 
Penn State.  Thanks to Pat Dean for helping me with last minute or lost orders, and for all of your 
advice on life outside of the CLC complex.   
I need to thank so many more people for making my time in graduate school so 
memorable.  Thanks to Lori Bibb, Julia Van Kessel, Matt Bochman, and Justin Pruneski for your 
friendship and for so many memories, especially “fourties at four” and our New York City trip.    
Most importantly, I want to thank my family for their constant support.  I need to thank 
my parents, Clyde and Cynthia Braun.  I also need to thank the rest of my family: my sister Staci 
and her husband Rich, my brother Joe, his wife Gretchen and their daughter Lyla, and my sister 
Stevie.  Thank you for fostering my interest in science and for supporting and encouraging my 
decision to build a career in science.  Thank you for asking questions about work and for 
distracting me when I needed it.  Thank you to Mike Quigney for being the best friend I’ve ever 
had.  Thank you for your support and advice about life and science.  Thank you for challenging 
me to be a better person.  I love you all! 
 
 1 
1.0  INTRODUCTION 
1.1 TRANSCRIPTION OCCURS IN THE CONTEXT OF NUCLEOSOMES 
A regulated pattern of DNA/histone interactions (chromatin) condenses the DNA and helps to 
regulate the binding of non-histone proteins to the DNA.  The access of these proteins, including 
DNA replication and repair factors, recombination and transcription factors, needs to be highly 
regulated to ensure the integrity of the genome.  The state of the chromatin template can prove to 
be an obstacle to transcription, and many factors associate with RNA polymerase II and assist it 
in navigating through the nucleosomal template during transcription.  This section will describe 
the nucleosome structure and post-translational modifications of histone proteins.   
 2 
Table 1. RNA Polymerase II transcription and chromatin factors. 
Factor Characteristics 
Asf1 Nucleosome assembly and disassembly 
factor; Overexpression causes derepression 
of silenced loci 
Bre1 RING finger protein; recruits Rad6 to 
chromatin to catalyze the ubiquitylation of 
histone H2B at lysine 123; Ubiquitin 
protein ligase (E3) 
Bur1/Bur2 Cyclin dependent kinase/cyclin pair; 
phosphorylates the CTD of RNA Pol II in 
vitro; Bur2 is required to recruit the Paf1 
complex to chromatin 
CAF1 complex (Cac1, Cac2 and Msi1) Chromatin assembly complex; Incorporates 
newly synthesized histones into chromatin 
Ccr-Not4 complex Regulates transcription initiation, 
elongation and mRNA degradation; E3 
activity in Not4 subunit 
Chd1 Chromatin remodeling activity; Physically 
interacts with the Rtf1 subunit of the Paf1 
complex; Physically associated with 
actively transcribed genes 
COMPASS complex Histone H3 K4 methyltransferase complex; 
Set1 is the catalytic subunit 
CPF Cleavage and polyadenylation factor; 
Involved in RNA Pol II transcription 
termination 
CTD C-terminal domain of the largest subunit of 
RNA Pol II; Subject to phosphorylation 
pattern changes during transcription 
Ctk1 Phosphorylates the CTD of RNA Pol II at 
serine 2 at the 3’ ends of genes 
Dot1 Methyltransferase that targets histone H3 at 
lysine 79 
DSIF complex Mammalian transcription elongation 
complex that is homologous to yeast 
Spt4/Spt5 proteins 
Esa1 Catalytic subunit of the NuA4 histone 
acetyltransferase complex; Acetylates 
several lysine residues of histone H4 
FACT complex (Spt16, Pob3, Nhp6) Transcription elongation complex; 
Important for maintaining proper 
chromatin structure during elongation 
Fcp1 Phosphatase that targets the CTD of RNA 
Pol II 
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Gal4 Transcriptional activator of the GAL genes 
HAT Histone acetyltransferase 
HDAC Histone deacetylase 
HHF1 and HHF2 Genes that encode histone H4 proteins 
HHT1 and HHT2 Genes that encode histone H3 proteins 
Hir proteins (Hir1, Hir2, Hir3, Hir4) Family of proteins that are important for 
proper expression of the histone genes and 
proper incorporation of histones into 
chromatin 
HTA1 and HTA2 Genes that encode histone H2A proteins 
HTB1 and HTB2 Genes that encode histone H2B proteins 
Htz1 Histone H2A variant in yeast; Homologous 
to mammalian variant H2A.Z 
Kin28 Subunit of TFIIH; Phosphorylates the CTD 
of RNA Pol II at serine 5 during the 
transition from initiation to elongation 
Lge1 RING domain protein; Associates with 
Bre1 to catalyze the ubiquitylation of 
histone H2B at lysine 123 
Mediator complex Transcriptional coactivator complex that 
interacts with both transcription activators 
and RNA Pol II to promote transcription 
Nhp6 Subunit of FACT transcription elongation 
complex 
NuA4 Histone acetyltransferase complex; 
Acetylates histones H2A and H4 at several 
lysine residues 
Paf1 complex (Paf1, Ctr9, Rtf1, Cdc73, 
Leo1) 
Transcription elongation complex; 
Subunits are required for post-translational 
histone modifications 
Pob3 Subunit of FACT transcription elongation 
complex 
P-TEFb Mammalian CTD kinase; phosphorylates 
serine 2 
Rad6 Ubiquitin-conjugating enzyme (E2); 
Ubiquitylates many proteins in yeast, 
including histone H2B at lysine 123 
Rap1 DNA binding protein; Important for 
establishing telomeric silencing 
Rpd3-Sin3 Histone deacetylase complex that regulates 
transcription and silencing; Recruited to 
actively transcribed genes by histone H3 
lysine 36 methylation 
RSC Chromatin remodeling complex 
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SAGA Transcription coactivator complex; 
Catalytic subunits Gcn5 and Ubp8 
acetylate and deubiquitylate histones, 
respectively 
Set1 Methyltransferase that targets histone H3 at 
lysine 4 
Set2 Methyltransferase that targets histone H3 at 
lysine 36 
Sir proteins (Sir1, Sir2, Sir3, Sir4) Family of proteins that establish and 
maintain heterochromatin-like 
transcriptionally silenced regions of the 
yeast genome; Sir2 is a histone deacetylase 
Spt10 Required for histone gene expression; 
Forms a heterodimer with Spt21; Contains 
a putative acetyltransferase domain 
Spt21 Required for histone gene expression; 
Forms a heterodimer with Spt10 
Spt16 Subunit of FACT; Required for proper 
chromatin structure during transcription 
elongation 
Spt4/Spt5 Transcription elongation factors that are 
required for proper chromatin structure 
during elongation; Required for Paf1 
complex association with actively 
transcribed genes 
Spt6 Transcription elongation factor that is 
required for proper chromatin structure 
during elongation 
Ssu72 CTD phosphatase in vitro; Targets serine 5 
phosphorylation 
SWI/SNF complex ATP-dependent chromatin remodeling 
complex; Swi2/Snf2 is the catalytic 
ATPase subunit 
SWR1 ATP-dependent chromatin remodeling 
complex; Exchanges Htz1 for H2A at 
euchromatic boundaries 
TFIIA (2 subunits) Transcription initiation factor; Coactivator 
TFIIB (3 subunits) Transcription initiation factor; Stabilizes 
TBP-TFIIA interaction 
TFIID (TBP and TAFs; 15 subunits) Transcription initiation factor; Binds to the 
TATA box within a promoter 
TFIIE (2 subunits) Transcription initiation factor; Stimulates 
TFIIH kinase activity 
TFIIF (3 subunits) Transcription initiation factor; Stimulates 
elongation 
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TFIIH (11 subunits) Transcription initiation factor; Kin28 
subunit phosphorylates the CTD of RNA 
Pol II 
TFIIS Transcription elongation factor; Stimulates 
RNA Pol II ribonuclease activity 
Ume6 Transcriptional repressor; Recruits factors 
to create a chromatin state that is repressive 
to transcription 
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1.1.1 Nucleosome structure is dynamic and regulated at many levels 
Amazingly, a eukaryotic cell facilitates the incorporation of two meters of DNA in a small 
nuclear space, without tangling or physically damaging the DNA.  Cells condense DNA by 
wrapping it around histone proteins to form nucleosomes, which are further compacted in higher 
order structures to allow all of the DNA to fit into the nucleus in an ordered fashion.  A 
nucleosome contains an octamer of histone proteins surrounded by 147 bp of DNA (WHITE et al. 
2001).  Most often, a histone octamer consists of two molecules each of histones H2A, H2B, H3 
and H4 (WHITE et al. 2001).  Histone H1 acts as a linker histone that helps to further condense 
chromatin by contacting DNA in between nucleosomes (WHITE et al. 2001).  The histone 
octamer is thought to be formed in a stepwise fashion where a tetramer of H3/H4 molecules are 
incorporated, and then two separate H2A/H2B dimers are added to complete the nucleosome 
assembly process (reviewed in POLO and ALMOUZNI 2006).   
The octamer is dynamic, and the histone proteins are incorporated into and dissociated 
from nucleosomes with the help of many factors, including chromatin remodeling factors 
(discussed in section 1.1.4) and histone chaperone proteins like Asf1 (TYLER et al. 1999), the 
histone regulatory (Hir) proteins (SHARP et al. 2001), and the heterotrimeric chromatin assembly 
factor-1 (CAF1) complex (SMITH and STILLMAN 1989).  The histone chaperones are important 
for promoting proper nucleosomal interactions and preventing DNA and proteins from 
interacting with the histones prior to their incorporation into nucleosomes (reviewed in PARK and 
LUGER 2006).  For example, Asf1 binds to H3/H4 dimers at the carboxy terminus of histone H3 
to prevent histone H3 dimerization prior to nucleosome formation (POLO and ALMOUZNI 2006).  
These factors act to regulate histone deposition during DNA replication, but more recent data 
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suggest that they also act during DNA repair (EMILI et al. 2001) and transcription (JAMAI et al. 
2007) to return the chromatin template to its original structure after these processes have been 
performed.   
Expression of the histone genes in humans and yeast is regulated by similar mechanisms, 
although the proteins that regulate this process are not conserved.  Human histones are encoded 
by many genes, including several variants of the four core histones that are dispersed throughout 
the genome (reviewed in GOVIN et al. 2005). Many of the histone variants are expressed in 
specific tissues, like H3t, which is thought to be expressed only in the testes (GOVIN et al. 2005).  
Yeast histones are encoded by two loci each, H2A (HTA1 and HTA2), H2B (HTB1 and HTB2), 
H3 (HHT1 and HHT2) and H4 (HHF1 and HHF2).  These loci are found in divergently 
transcribed pairs, H2A and H2B are paired (HTA1 and HTB1), as well as H3 and H4 (HHT1 and 
HHF1).  Histone gene expression peaks during S-phase.  Spt10 and Spt21 are important for 
proper expression of a subset of the histone genes in yeast (DOLLARD et al. 1994; ERIKSSON et 
al. 2005; HESS et al. 2004; XU et al. 2005), and bind to specific DNA sequences within the 
promoters to promote transcription activation (ERIKSSON et al. 2005).   
In all eukaryotes, the histone proteins fold in a distinct manner to create a globular central 
region that forms the core of the nucleosome, with the amino- and carboxy-terminal tails of the 
histones protruding from the core to surround the DNA (Figure 1).  The core domain is 
structured into a three alpha helix domain called a “histone fold” (LUGER et al. 1997).  The 
amino-terminal tails are unstructured and highly post-translationally modified, and more recently 
several modifications have been identified within the globular region of the histones (reviewed in 
SHILATIFARD 2006).  Proteins involved in transcription, recombination, DNA repair and 
replication can gain access to the DNA via histone modification and chromatin remodeling 
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strategies.  These processes will be described in more detail in the next few sections.   
 9 
 Figure 1. The structure of the nucleosome.  
The left side of the figure illustratesthe nucleosomal structure.  146 basepairs of DNA is shown 
wrapped around an octamer of histones containing two molecules each of of histones H2A 
(yellow), H2B (red), H3 (blue) and H4 (green).   The right side of the figure illustrates the 
nucleosomal structure that has been turned 90 degrees to the left.  From Luger, K. et al. (1997) 
Nature. 389:251-260.   
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1.1.2 The histones are post-translationally modified 
Each of the histones is subject to a variety of post-translational modifications, including 
acetylation, methylation, phosphorylation, ubiquitylation and sumoylation (reviewed in 
PETERSON and LANIEL 2004) (Figure 2).  All of these modifications are reversible, adding 
another level of regulation to chromatin function.  Histone modifications can affect chromatin 
structure and function in a variety of ways (reviewed in LUGER 2006).  Specifically, histone 
modifications can affect the recruitment of proteins that bind to specific histone modifications.  
Bromodomain containing proteins bind to acetylated histones (DHALLUIN et al. 1999; ZENG and 
ZHOU 2002).  Analysis of eukaryotic proteins that contain chromodomains, WD40 domains, PhD 
domains and Tudor domains show that these proteins recognize specific methylated residues 
within the histones (HUYEN et al. 2004; KIM et al. 2006; LACHNER et al. 2001; WYSOCKA et al. 
2005).  Histone modifications can also alter histone-DNA interactions and histone-histone 
interactions to affect the localized chromatin structure (reviewed in LUGER 2006).  The 
arrangements of particular sets of histone modifications is thought to form a readable “histone 
code”, which acts to regulate chromatin structure at a given area in the genome (STRAHL and 
ALLIS 2000).  In general, acetylation and methylation of histones is associated with active 
transcription, and hypo-methylated and hypo-acetylated histones are found in repressed and 
silenced genomic regions.  However, histone methylation can have both positive and negative 
effects on transcription.  In the next few sections, I will describe chromatin modifications that are 
associated with active transcription and how these modifications can be reversed.   
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Figure 2. The histones are post-translationally modified. 
The primary amino acid sequences of the four core histones and Htz1 in S. cerevisiae are shown.  
The sites and types of post-translational modifications are shown.  Blue marks represent sites 
that are acetylated, yellow marks represent phosphorylation sites, green marks represent 
ubiquitylation sites, and red marks represent methylation sites.  From Abcam’s website: 
(http://www.abcam.com/assets/pdf/chromatin/histone_modification_map_yeast.pdf). 
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1.1.2.1 Histone acetylation 
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) regulate histone 
acetylation patterns.  In general, HATs can catalyze acetylation of many lysine residues within 
the histones.  Gcn5, the catalytic component of the Spt-Ada-Gcn5-acetyltransferase (SAGA) 
complex, is recruited to promoters by transcriptional activators (BHAUMIK et al. 2004; LEROY et 
al. 2006; UTLEY et al. 1998) and acetylates histones in this region to promote transcription 
(IMOBERDORF et al. 2006).  In yeast, Gcn5 acetylates several lysines residues of different 
histones, including lysines 9, 14, 18, 23 and 27 of histone H3 and lysines 11 and 16 of histone 
H2B (reviewed in MILLAR and GRUNSTEIN 2006).  Esa1 is the catalytic subunit of the NuA4 
complex (ALLARD et al. 1999; SMITH et al. 1998).  Esa1 acetylates histone H2A at lysine 7, and 
lysines 5, 8, 12, and 16 of histone H4, and lysine 14 of histone variant Htz1 (reviewed in MILLAR 
and GRUNSTEIN 2006).  These modifications are also associated with actively transcribed genes 
(POKHOLOK et al. 2005).  Rpd3 is one of the major HDACs in yeast, and acts to reverse the 
activities of Gcn5 and Esa1 (except histone H4 K16 acetylation) (reviewed in MILLAR and 
GRUNSTEIN 2006).   Not surprisingly, Rpd3 activity is associated with transcriptional repression 
both in transcription initiation and transcription elongation.  During elongation, Rpd3 (as part of 
the Rpd3S complex) is recruited to actively transcribing genes by histone H3 K36 tri-
methylation, where it deacetylates histones to restore a repressed chromatin structure in the wake 
of RNA Pol II passage (CARROZZA et al. 2005; KEOGH et al. 2005).   
1.1.2.2 Histone methylation 
Lysine residues within the histones are also subject to methylation.  Unlike HATs, 
histone methyltransferases (HMTs) in yeast only regulate the methylation of single residues 
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within the histones.  Some methylation events cannot occur without prior addition of ubiquitin (a 
76 amino acid moiety added as a post-translational modification) to histone H2B at lysine 123 
(K123).  Rad6, the ubiquitin-conjugating enzyme, is recruited to histone H2B at activated 
promoters by the ubiquitin-protein ligases Bre1 and Lge1 (HWANG et al. 2003; WOOD et al. 
2003a).  These proteins act together to catalyze the transfer of ubiquitin from Rad6 to histone 
H2B at lysine 123 (WOOD et al. 2003a).  Histone H2B ubiquitylation at active genes is transient, 
and the ubiquitin protease Ubp8 (a component of SAGA) cleaves the ubiquitin moiety from 
K123 almost as quickly as the mark is added (DANIEL et al. 2004; HENRY et al. 2003).  
Ubiquitylation of histone H2B at lysine 123 is required for subsequent methylation of histone H3 
at lysines 4 (K4) and 79 (K79) (SUN and ALLIS 2002).  Although the functional purpose of this 
relationship is not well understood, the proteasome appears to be important for connecting these 
modifications.  The proteasomal ATPases Rpt4 and Rpt6 are recruited to chromatin by histone 
H2B K123 ubiquitylation (EZHKOVA and TANSEY 2004).  In the absence of Rpt4 and Rpt6, 
histone H3 methylation at K4 and K79 is lost, but histone H2B ubiquitylation remains intact 
(EZHKOVA and TANSEY 2004).  Very recently, Tanny and colleagues showed that histone H2B 
ubiquitylation affects transcription and chromatin structure independently of its role in 
promoting histone H3 methylation in S. pombe (TANNY et al. 2007).  H2B monoubiquitylation is 
required for proper transcription throughout the genome, and strains lacking H2B ubiquitylation 
have defects in cell growth and septation, while strains lacking histone H3 methylation did not 
exhibit these phenotypes (TANNY et al. 2007).  This suggests that H2B ubiquitylation is not 
simply a mark that promotes H3 methylation, but instead is important for promoting transcription 
independent of its role in H3 methylation.  Genome-wide studies have recently shown that 
histone H2B ubiquitylation is important for the proper expression of approximately 75 genes in 
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yeast (MUTIU et al. 2007).  Many of these changes occur at genes within ten kilobases of a 
telomere and are thought to be the result of indirect effects on telomeric silencing (MUTIU et al. 
2007).  Interestingly, histone H2B ubiquitylation is important for the repression and activation of 
genes in yeast, and this modification has effects on the expression of a subset of genes 
independent of its role in promoting downstream methylation events on histone H3 (MUTIU et al. 
2007).   
Set1 (COMPASS subunit) and Dot1 catalyze the methylation of histone H3 at lysine 4 
(K4) and 79 (K79), respectively (FENG et al. 2002; SANTOS-ROSA et al. 2002).  Both of these 
modifications require the mono-ubiquitylation of histone H2B at K123 by Rad6, Bre1 and Lge1 
(SUN and ALLIS 2002).  Lysines can be mono-, di- or tri-methylated, with each of these 
modifications occurring in unique patterns within an actively transcribing gene (POKHOLOK et al. 
2005) (Figure 3).  Interestingly, K4 mono- and di-methylation are found throughout the genome 
(POKHOLOK et al. 2005).  However, Set1 and K4 tri-methylation peaks at the 5’ end of actively 
transcribed genes (BERNSTEIN et al. 2002; BRIGGS et al. 2001; KROGAN et al. 2003b; NG et al. 
2003b; POKHOLOK et al. 2005; SANTOS-ROSA et al. 2002) (Figure 3).  Dot1 and histone H3 K79 
tri-methylation are also localized at actively transcribed genes (POKHOLOK et al. 2005). Recently, 
histone demethylases have been identified, consisting of a conserved family of proteins that 
contain JmjC domains.  The yeast protein Jhd2 demethylates histone H3 that is tri-methylated at 
K4 (LIANG et al. 2007a; LIANG et al. 2007b).  The demethylation process appears to be a slow 
one, as methylated histones have a half life of several hours, and are thought to provide a record 
of recent transcription (NG et al. 2003b). 
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Figure 3. Histone acetylation and methylation are most often marks of active transcription.   
A) Covalent attachment of acetyl or methyl groups to lysine residues within histone proteins. 
From www.benbest.com/health/cancer.html.  B) Lysines can be mono-, di-, or trimethylated.  
From Shilatifard A. (2006) Annu. Rev. Biochem. 75:243-69. C) Chromatin immunoprecipitation 
experiments show that the pattern of chromatin modifications changes over an open reading 
frame.  From Li, B. et al. (2007). Cell. 128:707-719. 
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 Another HMT, Set2, is required for histone H3 lysine 36 (K36) methylation events 
(STRAHL et al. 2002).  Similar to K4 and K79 methylation, histone H3 K36 mono- and di-
methylation is found throughout the genome (POKHOLOK et al. 2005).  K36 tri-methylation is 
associated with actively transcribed genes and is skewed towards the 3’ end of genes (POKHOLOK 
et al. 2005; STRAHL et al. 2002).  Very recently, evidence of K36 demethylating enzymes in 
yeast has been reported.  Jhd1, a JmjC domain containing protein, has been shown to 
demethylate K36 mono- and di-methylation (TU et al. 2007).  Rph1 (also a JmjC domain 
containing protein) demethylates K36 that is di- and tri-methylated (KLOSE et al. 2007).   
1.1.3 Histone variants lead to changes in chromatin structure and function 
In addition to post-translational modification of histones, variants of the core histones can be 
incorporated into nucleosomes to impact chromatin structure and function.  Eukaryotic 
organisms encode non-allelic histone proteins that are similar in sequence to the core histones.  
Humans encode variants of histones H3 and H2A, including H3.3 and H2A.X (reviewed in 
LUGER 2003).  Histone H3.3 is incorporated into nucleosomes in a replication-independent 
manner (AHMAD and HENIKOFF 2002).  H2A.X is enriched in germline cells, and found in 
somatic cells of the thymus and spleen (MEISTRICH et al. 1985; NAGATA et al. 1991).  H2A.X 
phosphorylation is associated with double-stranded break formation in mammalian cells 
(ROGAKOU et al. 1998).  Interestingly, the yeast versions of the core histones H3 and H2A are 
more similar to the human histones H3.3 and H2A.X than the human core histone proteins 
(reviewed in LUGER 2003).  This may be due to the fact that the majority of the yeast genome is 
transcriptionally active in rich medium, as opposed to the human genome which is highly 
repressed.   
 20 
Eukaryotes also encode for a histone variant of H2A termed H2A.Z in mice and humans 
and Htz1 in yeast.  Approximately 4% of all nucleosomes in mouse cells contain H2A.Z (WEST 
and BONNER 1980).  Incorporation of this histone has been shown to alter the nucleosomal 
structure, and may have larger effects on intra- and inter-nucleosomal contacts (LUGER 2003).  
Specifically, nucleosomes containing H2A.Z have a more compact structure than nucleosomes 
containing H2A, however, these nucleosomes have decreased inter-nucleosomal interactions 
(LUGER 2003).  Htz1 is exchanged with core H2A by the ATP-dependent activity of the SWR1 
complex (MIZUGUCHI et al. 2004).  Many studies in yeast have uncovered multiple functions for 
Htz1.  Htz1 incorporation is enriched in euchromatin and has been shown to enhance the activity 
of boundary elements to prevent the spreading of silencing factors into euchromatic regions of 
the genome (MENEGHINI et al. 2003).    Genome-wide experiments that combine chromatin 
immunoprecipitation and microarray techniques (ChIP-chip) have shown that two Htz1 
containing nucleosomes are preferentially found flanking a nucleosome-free region within the 
promoters of transcriptionally silent genes (GUILLEMETTE et al. 2005; LI et al. 2005; RAISNER et 
al. 2005; ZHANG et al. 2005a).  These promoters exhibit reduced levels of Htz1-containing 
nucleosomes upon transcription activation (GUILLEMETTE et al. 2005; LI et al. 2005; RAISNER et 
al. 2005; ZHANG et al. 2005a).  Interestingly, Htz1 is acetylated at lysine 14 in the remaining 
nucleosomes within the promoters of active genes (MILLAR et al. 2006).  The purpose of this 
acetylation event is not well understood, but may lead to removal of Htz1-containing 
nucleosomes, or act to promote transcription activation in another manner (BABIARZ et al. 2006; 
KEOGH et al. 2006; MILLAR et al. 2006).   
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1.1.4 Chromatin remodelers restructure and reposition nucleosomes 
Many chromatin associated factors, including transcription, DNA replication and repair, and 
recombination factors require access to DNA sequences to accomplish their mission.  Chromatin 
remodeling factors rearrange the nucleosome structure to allow or restrict access to the DNA.  
There are several classes of chromatin remodelers, and these complexes are recruited to 
chromatin through interactions with transcriptional activator proteins and specific post-
translational modifications on the histones.  Both chromatin remodeler and modifier complexes 
interact with RNA and DNA polymerases, defining chromatin structure as a critical component 
for proper modulation of many essential nuclear processes (reviewed in VAN VUGT et al. 2007). 
Chromatin remodelers can restructure or reposition chromatin using ATPase subunits to 
insert histone variants into nucleosomes or to slide or eject nucleosomes (reviewed in VAN VUGT 
et al. 2007).  The ATP-dependent chromatin remodeling complexes in S. cerevisiae, including 
SWI/SNF, RSC, ISW1, and INO80 complexes and Chd1, contain motifs that facilitate 
interactions with specific chromatin modifications.  SWI/SNF and RSC complex subunits 
contain bromodomains, which bind to acetylated lysines (reviewed in HASSAN et al. 2002; 
WINSTON and ALLIS 1999).  The ISW1 complex contains SANT and SLIDE domains that bind 
histone tails and linker DNA, respectively (reviewed in GRUNE et al. 2003).  Chd1 contains a 
chromodomain, which recognizes methylated lysine residues (BANNISTER et al. 2001), and 
INO80 complex subunits contain DBINO domains that are predicted to interact with DNA 
(BAKSHI et al. 2004).   
In yeast, DNA sequences position approximately 50% of the nucleosomes throughout the 
genome (SEGAL et al. 2006).  Chromatin remodelers are used to reposition nucleosomes to allow 
or prevent access to the DNA (reviewed in VAN VUGT et al. 2007).  Specifically, SWI/SNF 
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moves nucleosomes to allow the transcription machinery to access binding sites in the DNA 
(SCHNITZLER et al. 2001).  Conversely, ISW1 spaces the nucleosomes relative to each other to 
promote a tightly packed chromatin structure that prevents non-histone protein-DNA interactions 
(BLANK and BECKER 1996; WHITEHOUSE and TSUKIYAMA 2006).   
In the next two sections I will discuss two chromatin remodelers, the RSC complex and 
Chd1.  These represent the only essential chromatin remodeling complex and the only single 
subunit chromatin remodeler, respectively, in yeast. 
1.1.4.1 The RSC complex 
SWI/SNF was the first ATP-dependent chromatin remodeling complex to be identified in yeast 
(PETERSON et al. 1994; PETERSON and HERSKOWITZ 1992).  This 12 subunit complex is found at 
approximately 100-200 copies per cell, and is not essential for viability (CAIRNS et al. 1996; 
GHAEMMAGHAMI et al. 2003).  Microarray analysis of strains grown in rich medium suggests 
that SWI/SNF is responsible for the proper expression of approximately 5% of the yeast genome 
(HOLSTEGE et al. 1998; SUDARSANAM et al. 2000).   
The RSC (remodels the structure of chromatin) complex was identified based on 
sequence similarity to the SWI/SNF complex (CAIRNS et al. 1996).  RSC is 10 times more 
abundant than SWI/SNF (CAIRNS et al. 1996), and contains 17 subunits, ten of which are 
essential for viability.  Five subunits are paralogous with SWI/SNF subunits and three subunits 
are shared with SWI/SNF (CAIRNS et al. 1996; and reviewed in VAN VUGT et al. 2007).  The 
catalytic subunit of RSC, Sth1, is similar in sequence to Snf2 of SWI/SNF, however Sth1 is 
essential (DU et al. 1998).  In vitro experiments show that purified RSC complex exhibits DNA-
dependent ATPase activity, as well as the ability to transfer histones onto a naked DNA template 
and remodel nucleosomes (KORNBERG and LORCH 1999; SAHA et al. 2002).  Swi2 and Sth1 have 
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been shown to disrupt histone-DNA contacts within nucleosomal arrays, seen as altered 
sensitivity to DNase I (CAIRNS et al. 1996).  Rsc1, Rsc2, Rsc4, and Sth1 contain bromodomains 
(Sth1 is the only of these proteins that contains a single bromodomain), and these proteins 
contain seven of the 15 bromodomains found in the yeast proteome (reviewed in VAN VUGT et al. 
2007).   
Two isoforms of RSC have been identified, one contains Rsc1 and the other contains 
Rsc2 (CAIRNS et al. 1999; NG et al. 2002b).  Both Rsc1 and Rsc2 contain bromodomains, a 
bromo-associated homology domain and an AT hook domain (CAIRNS et al. 1999).  A complete 
understanding of the functional significance of these two sub-complexes has yet to be elucidated.  
However, both rsc1Δ and rsc2Δ strains have reduced sporulation efficiency, but only rsc1Δ 
strains have defects in tetrad formation during sporulation (YUKAWA et al. 2002).  Furthermore, 
overexpression of RSC1 in a rsc2Δ/rsc2Δ mutant strain does not suppress the sporulation defect, 
and vice versa (BUNGARD et al. 2004; YUKAWA et al. 2002), further suggesting that these 
proteins differentially regulate the function of their respective RSC complexes.   
Identification of human homologs of the SWI/SNF and RSC complexes has been 
complicated by the high levels of similarity shared by the subunits of these complexes 
(MUCHARDT and YANIV 2001).  The mammalian homolog of Snf2 is Brg (MOHRMANN et al. 
2004; WANG et al. 1996), and purification of Brg shows that it is found in two complexes, 
SWI/SNF-A (also known as BAF) and SWI/SNF-B (also known as PBAF) (MOHRMANN et al. 
2004).  PBAF contains Polybromo, a protein that contains six bromodomains and is similar in 
sequence with yeast Rsc1, Rsc2 and Rsc4 (MOHRMANN et al. 2004).  Further work is needed to 
identify all components of the human RSC complex and characterize its functional role in 
chromatin structure.   
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1.1.4.2 Chd1 
Chd1 (Chromodomain-ATPase/helicase-DNA binding protein 1) is a conserved ATP-dependent 
chromatin remodeling enzyme (FLAUS et al. 2006) that acts alone in Drosophila and yeast to 
remodel chromatin (LUSSER et al. 2005; TRAN et al. 2000).  In S. cerevisiae, Chd1 is found at 
approximately 1600 proteins per cell (GHAEMMAGHAMI et al. 2003), and localizes to chromatin 
throughout the genome (TRAN et al. 2000).  Chd1 is thought to interact with DNA in linker 
regions between nucleosomes (STOCKDALE et al. 2006) and reposition nucleosomes in an ATP 
dependent manner (TRAN et al. 2000).  Strains lacking CHD1 and genes encoding subunits of 
SWI/SNF are inviable (TRAN et al. 2000), suggesting that these two complexes functionally 
overlap in vivo.  Like the SWI/SNF and RSC complexes, Chd1 can alter histone-DNA contacts, 
seen as altered DNase I sensitive sites (TRAN et al. 2000).  However, the DNase I patterns of 
nucleosome arrays treated with SWI/SNF and Chd1 differ, suggesting that these enzymes 
function independently to create distinct changes in nucleosome position in vivo (TRAN et al. 
2000).   
Human and S. cerevisiae Chd1 contain two tandem chromodomains that have been 
shown to interact with Paf1 complex-dependent histone H3 K4 trimethylation through these 
domains (OKUDA et al. 2007; PRAY-GRANT et al. 2005; SIMS et al. 2005).  However, the 
existence of this interaction in yeast is a topic of debate (PRAY-GRANT et al. 2005; SIMS et al. 
2005).  NMR structural studies and sequence alignments suggest that yeast Chd1 lacks several 
key residues found in the human Chd1 that are important for recognizing trimethylated lysine 
residues (OKUDA et al. 2007).  Importantly, yeast Chd1 interacts with several transcription 
elongation factors, including the Paf1 complex, FACT and Spt4/5 (see section 1.2.4 for more 
details) (SIMIC et al. 2003), which may mediate its association with actively transcribed regions.   
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1.2 TRANSCRIPTION BY RNA POLYMERASE II IS A HIGHLY REGULATED 
PROCESS 
1.2.1 RNA Pol II is a conserved, multi-subunit enzyme complex 
S. cerevisiae contains approximately 6000 protein coding genes (GOFFEAU et al. 1996), as well 
as genes that encode many untranslated RNAs.  RNA polymerase II (Pol II) transcribes these 
protein coding genes (mRNAs), as well as small nuclear RNAs (snRNAs) and small nucleolar 
RNAs (snoRNAs).  RNA Pol II in yeast is a twelve subunit complex (Rpb1-12) with a molecular 
mass of approximately 0.5 megadaltons (reviewed in CRAMER 2004).  RNA Pol II subunits 
Rpb5, Rpb6, Rpb8, Rpb10 and Rpb12 are shared among all three nuclear RNA polymerases (Pol 
I, II, and III) in eukaryotes (reviewed in MARTINEZ 2002).  The subunits of RNA Pol II are 
highly conserved in eukaryotes, and studies of the RNA Pol II from S. cerevisiae have pioneered 
a structural understanding of the mechanism of transcription in eukaryotes (Figure 4).  Rpb1 and 
Rpb2 are the largest subunits of Pol II, that together form the “clamp” and active site portions of 
the polymerase (CRAMER et al. 2000; CRAMER et al. 2001).  The structure of RNA Pol II without 
Rpb4 and Rpb7 shows that the active site of the enzyme provides the foundation for a nine 
basepair DNA/RNA hybrid (GNATT et al. 2001).  Rpb1 contains an unstructured C-terminal 
domain (CTD) that was not visible in the X-ray structures of RNA Pol II.  I will discuss the CTD 
in more detail in section 1.2.2.  Importantly, RNA Pol II has a multi-faceted surface that interacts 
with the DNA template and supplies a foundation for many interacting proteins that are 
important for regulating transcription (KETTENBERGER et al. 2004).  
The subunits of eukaryotic RNA Pol II are somewhat conserved in archaea and 
prokaryotes (reviewed in GOEDE et al. 2006).  However, archaeal RNA polymerase is more 
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similar to eukaryotic RNA Pol II than to the four subunit bacterial core RNA polymerase 
(GOEDE et al. 2006).  Subcomplexes of the polymerases show similar interactions in archaeal and 
eukaryotic polymerases.  Archaeal polymerase subunits E and F are homologous to eukaryotic 
Pol II subunits Rpb4 and Rpb7, which form a subcomplex that is not stably associated with the 
core polymerase (reviewed in GOEDE et al. 2006; TODONE et al. 2001).  Interestingly, archaeal 
subunits E and F also form a complex, and archaeal F interacted with human Rpb7 to form a 
hybrid complex (WERNER et al. 2000).  Archaeal D, N, L and P form a subcomplex as well, 
similar to RNA Pol II subcomplex made up of Rpb3, Rpb10, Rpb11, and Rpb12 (CRAMER et al. 
2001; WERNER et al. 2000).   
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Figure 4.  Structure of RNA Pol II.  
RNA Polymerase II structure shown from the front (a) and top (b).  Subunits are colored 
according to small scale in the middle of the figure.  From Cramer, P. (2004) Curr. Opin. Gen. 
Dev. 14:218-226. 
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Despite the structural complexity of RNA Pol II, this enzyme cannot function alone in the 
transcription process.  RNA Pol II transcription has three main stages: 1) initiation, where the 
polymerase is recruited to an activated gene through physical interactions with many proteins, 2) 
elongation, where the nascent RNA chain grows as nucleotides are incorporated, and 3) 
termination, where the RNA is released, the polymerase dissociates from the DNA template, and 
the polymerase can be recycled at another promoter.  Many factors, including promoter DNA 
sequences, activator and repressor proteins, the general transcription machinery, and association 
of accessory factors, are all important for regulating the individual steps of the transcription 
cycle.  The next few sections will discuss what is currently known about how these factors 
coordinately regulate the transcription cycle. 
1.2.2 The modification state of the CTD of RNA Pol II changes during the transcription 
cycle 
Many proteins dynamically associate with RNA Pol II throughout the transcription cycle.  It has 
become clear that many of these associations are regulated by the carboxy-terminal domain 
(CTD) of the largest subunit of RNA Pol II (Rpb1).  The CTD is composed of a heptapeptide 
repeat (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), and the number of repeats within the CTD increases 
with the complexity of the organism.  The CTD of S. cerevisiae is made up of 26 or 27 repeats, 
C. elegans 34 repeats, Drosophila 42 repeats, and mice and humans 52 repeats (reviewed in 
HAMPSEY 1998).  Only 8 repeats are required for viability in yeast (NONET et al. 1987; WEST and 
CORDEN 1995).   
Many RNA processing factors bind to the CTD in vitro, and the CTD is required for 
efficient capping, splicing and polyadenylation in vivo (HIROSE and MANLEY 1998; HIROSE and 
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MANLEY 2000; MCCRACKEN et al. 1997; PROUDFOOT et al. 2002).  These factors recognize 
specific phosphorylation patterns within the CTD (DAHMUS 1995; MANIATIS and REED 2002; 
PALANCADE and BENSAUDE 2003; reviewed in PROUDFOOT 2004; SIMS et al. 2004; ZORIO and 
BENTLEY 2004).  RNA Pol II that contains a hypo-phosphorylated CTD is recruited to promoters 
through an interaction with the Mediator complex (described in more detail in section 1.2.3.3) 
(reviewed in BJORKLUND and GUSTAFSSON 2004; MALIK and ROEDER 2000; MYERS and 
KORNBERG 2000).  The CTD is phosphorylated at position 5 in a TFIIH-dependent manner 
shortly after initiating transcription (KOMARNITSKY et al. 2000).  As the polymerase moves along 
the open reading frame, serine 5 phosphorylation decreases and Ctk1-dependent serine 2 
phosphorylation increases at the 3’ end of the gene (KOMARNITSKY et al. 2000; MORRIS et al. 
2005).  These changes in the modification state of the polymerase are controlled by several 
kinases and phosphatases.     
1.2.2.1 CTD kinases 
CTD phosphorylation occurs through the action of cyclin dependent kinases (CDKs) 
(reviewed in MEINHART et al. 2005).  CDK7/cyclin H (Kin28 is the CDK in yeast) is a 
component of TFIIH that phosphorylates serine 5 of the CTD during transcription initiation 
(COIN and EGLY 1998; HENGARTNER et al. 1998; KOMARNITSKY et al. 2000).  This activity is 
enhanced by the Mediator complex during initiation and promotes transcription elongation 
(GUIDI et al. 2004).  CDK8/cyclin C (Srb10/11 in yeast) are components of a subset of Mediator 
complexes that phosphorylate serine 5 of the CTD (BORGGREFE et al. 2002; BOUBE et al. 2002; 
HENGARTNER et al. 1998; LIU et al. 2001) in order to repress transcription by preventing 
initiation complex formation (HENGARTNER et al. 1998).   
CDK9/cyclin T are the core components of the positive transcription elongation factor-b 
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(P-TEFb) (PRICE 2000).  P-TEFb was originally isolated though its ability to facilitate 
transcription of stalled elongating Pol II complexes in a CTD dependent manner (MARSHALL et 
al. 1996; MARSHALL and PRICE 1995).  P-TEFb phosphorylates serine 2 of the CTD to promote 
transcription elongation (PRICE 2000; YAMAGUCHI et al. 2002; YAMAGUCHI et al. 1999).  P-
TEFb also phosphorylates human Spt5 to counteract the negative elongation function of this 
factor (WADA et al. 1998; YAMAGUCHI et al. 1998).  Significantly, P-TEFb and Spt5 are required 
for Tat-mediated stimulation of HIV transcription in vitro (IVANOV et al. 2000; PRICE 2000; 
WADA et al. 1998; WU-BAER et al. 1998).  The proposed homologs of P-TEFb in S. cerevisiae 
are Ctk1 and Bur1 (GUO and STILLER 2004; MURRAY et al. 2001; PRELICH 2002; PRELICH and 
WINSTON 1993).  Keogh and colleagues propose that these proteins act separately to facilitate P-
TEFb-like activity, where Ctk1 is the primary kinase for the CTD, and Bur1 may be the kinase 
for Spt5 (KEOGH et al. 2003).  Interestingly, Ctk1 appears to affect transcription by regulating 
histone H3 K4 and K36 methylation (WOOD et al. 2007; XIAO et al. 2007).  Specifically, strains 
lacking CTK1 have increased levels of H3 K4 trimethylation in chromatin, while histone H2B 
ubiquitylation levels are unchanged (WOOD et al. 2007; XIAO et al. 2007).  Ctk1 appears to 
regulate chromatin structure during transcription elongation by promoting histone H3 K36 
methylation and preventing histone H3 K4 trimethylation (XIAO et al. 2007).   
1.2.2.2 CTD phosphatases 
There are two known CTD phosphatases, Fcp1 and Ssu72 (reviewed in MEINHART et al. 
2005).  Fcp1 is a conserved, essential phosphatase that targets the CTD of both free and actively 
transcribing Pol II (ARCHAMBAULT et al. 1997; ARCHAMBAULT et al. 1998; CHAMBERS and 
DAHMUS 1994; CHAMBERS and KANE 1996; CHAMBERS et al. 1995; KONG et al. 2005; LEHMAN 
and DAHMUS 2000).  Fcp1 physically interacts with RNA Pol II subunits Rpb4/7 (CHAMBERS et 
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al. 1995; KAMENSKI et al. 2004; KIMURA et al. 2002), the phosphorylated CTD (YU et al. 2003), 
and TFIIF, which stimulates Fcp1 activity (ARCHAMBAULT et al. 1998; CHAMBERS et al. 1995; 
KAMADA et al. 2003; NGUYEN et al. 2003).  Ssu72 is also a conserved and essential phosphatase 
that is believed to target the CTD of RNA Pol II in vivo (KRISHNAMURTHY et al. 2004).  In vitro 
experiments show that Ssu72 can dephosphorylate recombinant CTD that is phosphorylated at 
serine 5, and serine 5 phosphorylation levels are increased in strains that are depleted of Ssu72 
(KRISHNAMURTHY et al. 2004).  Ssu72 activity is dependent on Pta1, and both proteins are 
subunits of the RNA cleavage and polyadenylation factor (CPF) (KRISHNAMURTHY et al. 2004; 
STEINMETZ and BROW 2003).  Mammalian Ssu72 has been shown to bind the Pta1 homolog and 
Pol II (ST-PIERRE et al. 2005).   
1.2.3 Transcription initiation 
Transcription initiation requires that the RNA Pol II general transcription factors correctly 
recognize DNA elements within the promoter of a gene, and the assembly of these general 
transcription factors with RNA Pol II into a preinitiation complex.  Initiation needs to be highly 
regulated to ensure that the cell reacts to its environment appropriately and in a timely fashion.  
This section will provide an overview of what regulates initiation, including promoter DNA 
sequences, activator and repressor proteins, and chromatin structure.  
1.2.3.1 Promoter elements regulate transcription initiation 
The promoter region of a gene contains core DNA sequences which are recognized by the 
RNA Pol II general transcription factors, as well as sequences that are recognized by gene 
specific activators and repressors (reviewed in SMALE and KADONAGA 2003).  The core 
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promoter region consists of approximately 35 basepairs of DNA upstream and downstream of 
the transcription initiation site.  This region contains binding sites for the general transcription 
factors (GTFs) and RNA Pol II.  The TATA box, named for the conserved sequence of 
TATAAA that is found approximately 25-30 basepairs upstream of the transcription start site, is 
found at many metazoan gene promoters (reviewed in BREATHNACH and CHAMBON 1981).  The 
TATA box is found approximately 40-120 basepairs from the transcription start site in 20% of 
promoters in S. cerevisiae (BASEHOAR et al. 2004; STRUHL 1989).  The other 80% of the genome 
contains TATA-less promoters (BASEHOAR et al. 2004).  The TATA-containing genes are most 
commonly regulated by stress and the expression of these genes is tightly controlled (BASEHOAR 
et al. 2004).  The conserved initiator (Inr) element found in eukaryotes contains the DNA 
sequence in which transcription initiates (CORDEN et al. 1980; JAVAHERY et al. 1994; SMALE and 
BALTIMORE 1989; SMALE et al. 1990).  This sequence consists of an adenosine at the 
transcription start site, a cytosine at the -1 position, and a few pyrimidines surrounding these 
nucleotides (reviewed in SMALE and KADONAGA 2003).  This sequence is less conserved in 
yeast, but mutations around the transcription start site have been shown to result in the use of 
alternate transcription initiation sites (CHEN and STRUHL 1985; HAHN et al. 1985; MCNEIL and 
SMITH 1985; NAGAWA and FINK 1985).  When the TATA box is located within 25-30 basepairs 
of the Inr element, these sequences synergistically activate transcription, but act independently if 
they are located more than 20 basepairs apart (O'SHEA-GREENFIELD and SMALE 1992).  The 
TATA box and Inr coordinately direct the polarity of transcription (EMAMI et al. 1997; SMALE et 
al. 1990).  
Another promoter element, the downstream promoter element (DPE), is important for 
TFIID binding at TATA-less promoters (reviewed in SMALE and KADONAGA 2003).  This 
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element is conserved in metazoans, the core sequence is found downstream relative to the Inr 
element at basepairs +28-32 (KUTACH and KADONAGA 2000).  The DPE and Inr work together to 
recruit TFIID to TATA-less promoters (KUTACH and KADONAGA 2000).  One element found in 
promoters is not recognized by TFIID, but instead interacts with TFIIB (reviewed in SMALE and 
KADONAGA 2003).   The TFIIB recognition element (BRE), is found immediately upstream of 
the TATA box in some promoters of both archaea and eukaryotes (LAGRANGE et al. 1998; 
QURESHI and JACKSON 1998).  The consensus sequence G/C-G/C-G/A-C-G-C-C is found in 
human promoters (LAGRANGE et al. 1998).  The carboxy-terminus of TFIIB interacts with this 
sequence, but yeast and plant homologs of TFIIB do not contain this region, suggesting the BRE 
element may not be important for initiation in these organisms (LAGRANGE et al. 1998; NIKOLOV 
et al. 1995; TSAI and SIGLER 2000).  Various combinations of these promoter elements are found 
at promoters in vivo (reviewed in SMALE and KADONAGA 2003).  
There are also DNA sequence elements that act at a distance from the site of transcription 
initiation (reviewed in SMALE and KADONAGA 2003).  One class of these elements consists of the 
upstream activating and repressor sequences (UAS and URS, respectively).  These sequences are 
bound by gene specific activator and repressor proteins that regulate recruitment of the general 
transcription machinery (described in section 1.2.3.2).  Another DNA sequence that influences 
transcription initiation is known as an enhancer element.  These sequences can be found 
kilobases upstream or downstream of the core promoter yet remain important for the regulation 
of transcription initiation.  Interactions between factors bound at UAS/URS or enhancer 
sequences and the GTFs and Pol II act coordinately to control transcription initiation.   
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1.2.3.2 Transcriptional activators and repressors bind to DNA elements and recruit 
coactivators and corepressors 
Transcriptional activators and repressors bind to upstream activating sequences (UAS) or 
upstream repressing sequences (URS), respectively, within the promoters of genes, often in 
response to environmental stimuli.  Activator proteins recruit coactivator complexes (described 
in the section 1.2.3.3), chromatin remodeling complexes (discussed in section 1.1.4), and the 
general transcription machinery (discussed in section 1.2.3.4).  Repressor proteins often recruit 
histone deacetylases and chromatin remodeling factors to create a chromatin structure that is 
repressive to transcription.  There are many well characterized gene specific activators and 
repressors, which regulate a subset of genes in response to nutrient conditions or carbon sources.  
In this section, I will describe the modes of action for the model activator protein Gal4 and the 
model repressor protein Ume6. 
 Gal4 is an 881 amino acid protein that folds in such a way as to create two functional 
domains: a DNA-binding domain and an activation domain (reviewed in TRAVEN et al. 2006).  
Gal4 dimerizes, and together the DNA-binding domains recognize a 17 basepair sequence within 
a GAL promoter (MARMORSTEIN et al. 1992).  The GAL genes encode for proteins that are 
required for galactose utilization, including membrane transporters and glycolytic enzymes.  
Therefore, these genes are repressed when yeast cells are grown in non-galactose conditions and 
activated when galactose is the primary carbon source.  Under non-inducing conditions, Gal4 is 
bound to GAL promoters, but transcription activation is prevented by the binding of Gal80 to 
Gal4 (reviewed in TRAVEN et al. 2006).  Gal80 prevents recruitment of TBP and TFIIB in vitro 
(WU et al. 1996), and SAGA recruitment in vivo (CARROZZA et al. 2002).  Although the exact 
mechanism of disruption is unknown, under inducing conditions the cytoplasmic protein Gal3 is 
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recruited to the nucleus where Gal3 interacts with Gal80 and disrupts the Gal4-Gal80 complex 
(and reviewed in TRAVEN et al. 2006; ZENKE et al. 1996).  Once Gal80 is removed, Gal4 can 
physically interact with TBP (MELCHER and JOHNSTON 1995; WU et al. 1996), TFIIB (WU et al. 
1996), Mediator (ANSARI et al. 2002; JEONG et al. 2001; KOH et al. 1998), SAGA (BHAUMIK et 
al. 2004; BROWN et al. 2001), the chromatin remodeler SWI/SNF (YUDKOVSKY et al. 1999), and 
components of the proteasome (CHANG et al. 2001; GONZALEZ et al. 2002) (Figure 5).  SAGA 
recruitment to the promoter is facilitated by a direct interaction with the SAGA subunit Tra1 
with Gal4 bound to a promoter (BHAUMIK et al. 2004).  Order of recruitment studies show that 
SAGA binds to promoters prior to the general transcription machinery, suggesting that a scaffold 
is created to facilitate transcription initiation (BHAUMIK and GREEN 2001; BRYANT and PTASHNE 
2003).  Mediator is also recruited to promoters by Gal4, but there is debate over whether or not 
Mediator recruitment depends on SAGA (BHAUMIK et al. 2004; BRYANT and PTASHNE 2003; 
KURAS et al. 2003; LARSCHAN and WINSTON 2005; LEMIEUX and GAUDREAU 2004).  
Recruitment of TBP and the general transcription machinery to GAL genes requires Gal4, SAGA 
and Mediator (BHAUMIK and GREEN 2001; BHAUMIK and GREEN 2002; DUDLEY et al. 1999; 
LARSCHAN and WINSTON 2001; LARSCHAN and WINSTON 2005).  Interestingly, phosphorylation 
of Gal4 may regulate its interaction with Gal80, and ubiquitylation of Gal4 appears to be 
important for regulating transcription activation (reviewed in TRAVEN et al. 2006).  The role of 
activator turnover in transcription activation will be discussed in section 14.4.1.   
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 Figure 5. Gal4 recruits coactivators to activated promoters. 
Mechanism of Gal4 activity in non-inducing and inducing conditions.  Under non-inducing 
conditions, Gal80 interacts with Gal4 to prevent transcription coactivator recruitment by Gal4.  
Under inducing conditions (addition of galactose), Gal80 is released from Gal4 and Gal4 then 
recruits coactivators to promote transcription.  See text for more information.  From Traven, A. 
et al. (2006) EMBO Reports. 7:496-499. 
 38 
 
 
 
 
 
 
 
 39 
 Many transcriptional repressors control transcription by recruiting factors that condense 
the chromatin structure within bound promoters (reviewed in HAMPSEY 1998).  Other repressors 
act to disrupt pre-initiation complex formation, but for simplicity I will only discuss the function 
of chromatin related repressors like Ume6.  Ume6 binds to the URS1 sequence within the 
promoters of meiosis specific genes during mitosis (reviewed in MITCHELL 1994).  Ume6 
recruits the histone deacetylase complex Sin3-Rpd3 (KADOSH and STRUHL 1997; KADOSH and 
STRUHL 1998a) which deacetylates two nucleosomes within the promoter (DECKERT and STRUHL 
2001; KADOSH and STRUHL 1998b; RUNDLETT et al. 1998; SUKA et al. 2001).  Ume6 also 
recruits the ISW2 chromatin remodeling complex which results in the formation of a nuclease-
resistant chromatin structure within Ume6-bound promoters (GOLDMARK et al. 2000; KENT et al. 
2001).  Both Sin3-Rpd3 and ISW2 are required for Ume6-mediated repression, suggesting that 
the overall chromatin structure within the promoter controls transcription regulation (FAZZIO et 
al. 2001; GOLDMARK et al. 2000; KENT et al. 2001).   
1.2.3.3 Transcription coactivators mediate interactions between activators and the general 
transcription factors 
Coactivators are factors that mediate interactions between proteins bound at the UAS 
sequences upstream of a core promoter and the general transcription machinery.  There are 
several well characterized coactivator complexes in yeast, including SAGA (Spt-Ada-Gcn5-
acetyltransferase) Mediator, TFIIA, TBP-associated factors (TAFs), SWI/SNF, and ISW1 
complexes.   I will focus on the functions of SAGA and Mediator, and how each complex 
utilizes a unique mechanism to activate transcription.   
SAGA contains 16-20 different proteins that form a complex with an approximate 
molecular mass of 1.8 megaDaltons (reviewed in TIMMERS and TORA 2005).  There are three 
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distinct subsets of proteins that make up the majority of the SAGA complex: 1) the Ada proteins 
(Ada1, Ada2, Ada3, Ada4 (Gcn5), and Ada5) which were identified in a genetic screen for 
proteins that interact with transcription activators Gcn4 and VP16 (BERGER et al. 1992; PINA et 
al. 1993), 2) the Spt proteins (Spt3, Spt7, Spt8, and Spt20) which were originally identified as 
suppressors of altered transcription initiation from Ty transposable elements within promoters 
(WINSTON et al. 1984), and 3) some of the TBP-associated factors (TAFs), (Taf5, Taf6, Taf9, 
Taf10, and Taf12), which are also subunits of TFIID (GRANT et al. 1998).  SAGA also contains 
several other proteins, including the ataxia telangiectasia mutated (ATM)-related protein, Tra1 
(GRANT et al. 1998; SALEH et al. 1998), the H2B-K123-ubiquitin protease Ubp8 (HENRY et al. 
2003), Sgf11, which anchors Ubp8 to the SAGA complex (LEE et al. 2005b), Sgf29 and Sgf73 
(unknown functions) (SANDERS et al. 2002; SHUKLA et al. 2006), and Sus1, a component of the 
mRNA export nuclear pore complex (RODRIGUEZ-NAVARRO et al. 2004).  An alternative SAGA 
complex known as SLIK (SAGA-like) or SALSA contains Rtg2 and a truncated Spt7 protein but 
lacks Spt8 (PRAY-GRANT et al. 2002; STERNER et al. 2002; WU and WINSTON 2002).   
SAGA acts as a coactivator by interacting with DNA-bound activators at promoters, 
modifying the chromatin structure, and recruiting the general transcription machinery (reviewed 
in MARTINEZ 2002) (Figure 6).  Ada1, Spt7 and Spt20 are required for structural integrity of the 
complex (GRANT et al. 1998; STERNER et al. 1999; WU and WINSTON 2002) and Gcn5 and Ubp8 
are the catalytic subunits, possessing histone acetyltransferase (HAT) activity (RUIZ-GARCIA et 
al. 1997) and ubiquitin protease activity (HENRY et al. 2003), respectively.  Consistent with this, 
microarray experiments have shown that Gcn5 and Spt3 are required for the expression of 4% 
and 3% of yeast genes, but Spt20 is required for the expression of 10% of genes (LEE et al. 
2000).  While SAGA was initially identified as a histone acetyltransferase (GRANT et al. 1997), 
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which are characteristically associated with transcription activation, microarray analysis suggests 
that Gcn5 activity is important for the repression of a subset of yeast genes (HOLSTEGE et al. 
1998).   
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Figure 6. The SAGA complex. 
Ths SAGA complex contains several modules that interact with many other factors at the 
promoter of an activated gene.  Arrows are color coordinated with SAGA subunits to represent 
interactions with factors at promoters.  (*) represent subunits that are required for structural 
integrity of the complex.  See text for additional information.  Adapted from Martinez, E. (2002) 
Plant Mol. Biol. 50:925-947.
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Mediator acts as a transcriptional coactivator by interacting with DNA-bound activators 
and recruiting RNA Pol II to activated genes (reviewed in KORNBERG 2005).  Experiments for 
factors that stimulated in vitro RNA Pol II transcription demonstrated that Mediator contains 
approximately 20 proteins that fold together to form a complex with a total molecular mass of 
about 1 megaDalton (KIM et al. 1994) (Figure 7).  Many of the subunits of Mediator were 
identified in genetic screens for factors involved in transcriptional regulation, including the Srb 
(suppressors of RNA polymerase B) proteins.  Other components were identified by intensive 
biochemical purification and termed the Med (Mediator) proteins (MYERS et al. 1998).  Mediator 
components are conserved throughout eukaryotes (BOUBE et al. 2002; BOURBON et al. 2004).  
Mediator is a modulated complex that consists of the “head”, “middle”, “tail”, and Cdk8 (Srb8-
11) subcomplexes (GUGLIELMI et al. 2004).  This modular architecture is conserved from yeast 
to humans (GUGLIELMI et al. 2004).  The head and middle modules contact RNA Pol II (DAVIS 
et al. 2002).  The tail module physically contacts transcriptional activators (HAN et al. 1999; 
PARK et al. 2000).  The Cdk8 subcomplex represses transcription by phosphorylating various 
gene-specific regulatory proteins (HIRST et al. 1999; NELSON et al. 2003) and the CTD of RNA 
Pol II (HOLSTEGE et al. 1998; LIAO et al. 1995).   
Srb4 and Srb6 are “core” subunits of Mediator, and microarray analysis using a 
temperature-sensitive Srb4 mutant shows that over 5000 genes depend on Mediator for 
transcription (yeast contain approximately 6000 genes), and expression changes were similar to 
those seen in strains containing a temperature sensitive allele of RPB1, which encdes the largest 
subunit of RNA Pol II (HOLSTEGE et al. 1998; THOMPSON and YOUNG 1995).  However, 
mutations in SRB5 and MED6 only affect expression of 16% and 10% of genes in yeast 
(HOLSTEGE et al. 1998).  Consistent with a role for Mediator in regulating transcription initiation, 
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ChIP-chip analysis shows that Mediator is found at promoters and is associated throughout an 
actively transcribing gene (ZHU et al. 2006) as well as at the promoters of inactive genes 
(ANDRAU et al. 2006).    
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Figure 7. The Mediator complex. 
The modular architecture of the Mediator complex.  Head (blue), middle (green), tail (yellow), 
and Cdk8 (red) suncomplexes are shown.  From Guglielmi et al. (2004) NAR 32(18):5379-5391. 
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1.2.3.4 The general transcription machinery coordinately regulates transcription initiation  
In vitro order of recruitment experiments have shown that members of the general 
transcription machinery can be recruited to an activated gene in a specific order (BURATOWSKI et 
al. 1989; FANG and BURTON 1996; HA et al. 1993) (Figure 8).  The general transcription factors 
(GTFs) are the minimal components that are required for RNA Pol II transcription.  The first step 
in preinitiation complex (PIC) formation involves the binding of the TATA-binding protein 
(TBP) to the TATA element within a promoter.  Interestingly, TBP is also used to recruit RNA 
Pol I and Pol III to their respective promoters (KIM and ROEDER 1994).  TBP associates with 14 
other conserved proteins (TBP-associated factors, or TAFs) to compose TFIID (reviewed in 
BURLEY and ROEDER 1996; GREEN 2000).  TBP binds the minor groove of the TATA box and 
induces an 80 degree bend in the DNA (LEE et al. 1991; WU et al. 2001b).  The TAFs interact 
with the Inr and DPE elements around the TATA box (BURKE and KADONAGA 1997; and 
reviewed in BURLEY and ROEDER 1996; CHALKLEY and VERRIJZER 1999; OELGESCHLAGER et al. 
1996; VERRIJZER and TJIAN 1996; WU et al. 2001a).  TFIIA is recruited to TBP-DNA complexes 
(BISWAS et al. 2004).  TFIIA was originally identified as a GTF (MATSUI et al. 1980; REINBERG 
and ROEDER 1987), but more recent evidence suggests that TFIIA is best described as a 
coactivator that directly contacts TBP (BISWAS et al. 2004).  TFIIB is recruited to form a DNA-
TBP-IIA-IIB ternary complex (BURATOWSKI et al. 1989), which then recruits TFIIF bound to 
RNA Pol II (FLORES et al. 1989).  TFIIF is thought to interact with Pol II prior to PIC formation 
to prevent nonspecific binding of the polymerase to DNA and this interaction stabilizes the PIC 
once it is recruited to a promoter (reviewed in CONAWAY and CONAWAY 1993; GREENBLATT 
1991).  TFIIE enters the PIC after Pol II, but before TFIIH (BURATOWSKI et al. 1989; FLORES et 
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al. 1989).  TFIIE physically interacts with unphosphorylated Pol II, TFIIF, and TFIIH (FLORES 
et al. 1989; MAXON and TJIAN 1994).  TFIIH is the only GTF with known enzymatic activities, 
which include DNA-dependent ATPase (CONAWAY and CONAWAY 1989; ROY et al. 1994), 
ATP-dependent DNA helicase (SCHAEFFER et al. 1993; SERIZAWA et al. 1993), and CTD kinase 
activities (FEAVER et al. 1991; LU et al. 1992; SERIZAWA et al. 1992).   
Once the PIC is assembled, RNA Pol II separates the strands of the DNA duplex, and 
begins transcription (reviewed in MARTINEZ 2002).  Promoter clearance occurs after TFIIH-
dependent CTD phosphorylation, at which point TFIIB, IIE and IIH contacts are disrupted, and 
the polymerase enters the open reading frame.  TFIID and TFIIA remain bound to the promoter, 
and TFIIF remains bound to the polymerase.  The polymerase then enters the elongation stage of 
transcription, which will be described in the next section.  A study in yeast showed that Mediator 
components, TFIIA, IID, IIE and IIH are stabilized at the promoter through interactions with 
activators, suggesting that only TFIIB, IIF and a dephosphorylated Pol II are required for 
subsequent rounds of transcription at an activated promoter (YUDKOVSKY et al. 2000).   
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Figure 8. Recruitment of the general transcription machinery is highly ordered. 
In vitro experiments defined the order of recruitment if the general transcription machinery.  See 
text for additional information.  Adapted from Martinez, E. (2002) Plant Mol. Biol. 50:925-947.
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1.2.4 Transcription elongation is facilitated by many proteins that associate with Pol II 
Transcription elongation occurs as the polymerase incorporates nucleotides into a growing 
nascent RNA chain.  RNA Pol II transcription of protein coding genes is coupled to mRNA 
processing, including capping, splicing, and polyadenylation of the transcript.  Therefore, there is 
a dynamic association of many factors with the polymerase during the transcription cycle; 
different factors are required at the beginning of transcription as compared to the termination of 
transcription.    
Both eukaryotic and bacterial transcription complexes can form stalled elongation 
complexes in vitro (LANDICK 1997; MOTE and REINES 1998; NUDLER et al. 1994), suggesting 
that there are factors that assist the polymerase in overcoming obstacles to transcription 
elongation in vivo.   Many “elongation factors” have been characterized in eukaryotes and 
archaea.  Interestingly, increasing information suggests that many eukaryotic elongation factors 
function to regulate chromatin modifications associated with active transcription (Figure 9).  In 
the next few sections, I will describe the best characterized elongation factors in yeast and 
relevant disease connections in humans.   
1.2.4.1 The Paf1 complex 
The Paf1 complex is a nuclear complex, approximately 670 kiloDaltons in size, and 
minimally composed of 5 subunits, Paf1, Ctr9, Rtf1, Cdc73, and Leo1 (KROGAN et al. 2002; 
MUELLER and JAEHNING 2002; SQUAZZO et al. 2002).  The members of this complex are 
conserved from S. cerevisiae to humans (ROZENBLATT-ROSEN et al. 2005; YART et al. 2005).  
Paf1 and Cdc73 were originally connected to transcription by purification of RNA Pol II 
transcription complexes that lacked the Mediator complex (SHI et al. 1997).  The results of this 
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purification were confirmed by coimmunoprecipitation analysis that showed that the Paf1 
complex members physically interact with RNA Pol II associated factors, including Spt4-5, yeast 
FACT and Chd1 (KROGAN et al. 2002; SIMIC et al. 2003; SQUAZZO et al. 2002).  Genetic 
analysis also suggested that these proteins all worked in parallel to affect transcription (KROGAN 
et al. 2002; MUELLER and JAEHNING 2002; SIMIC et al. 2003; SQUAZZO et al. 2002).  
Quantitative Western blots show that the members of the Paf1 complex are found in equal 
amounts with RNA Pol II subunits, which led to the suggestion that there is one Paf1 complex 
associated with each transcribing Pol II complex (MUELLER et al. 2004). Subsequent analysis 
showed that the Paf1 complex is associated with all actively transcribed genes tested (MUELLER 
et al. 2004; SHELDON et al. 2005; SIMIC et al. 2003). Loss of individual Paf1 complex members 
leads to the altered expression of a subset of genes in yeast (PORTER et al. 2005; SHELDON 2005).  
Whereas the subunits of the Paf1 complex are found together on actively transcribed genes, the 
complex members do not act coordinately to affect transcription in the same manner, and data 
that I will discuss in the next few paragraphs show that the subunits have unique roles in 
promoting transcription.   
Paf1 and Ctr9 are considered the integral subunits of the complex; loss of these factors 
leads to more severe phenotypes as compared to the loss of other subunits.  Strains lacking PAF1 
or CTR9 grow poorly, even on rich medium (BETZ et al. 2002). Strains lacking RTF1, CDC73 or 
LEO1 exhibit growth defects on medium containing 6-azauracil (6AU), although these strains  
grow slightly better on this medium compared to paf1Δ or ctr9Δ strains (BETZ et al. 2002; 
SQUAZZO et al. 2002).  Strains that grow poorly on 6AU medium often have defects in 
transcription elongation because 6AU reduces nucleotide levels in vivo, increasing the need for 
transcription elongation factors that assist stalled elongation complexes (EXINGER and LACROUTE 
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1992).  Strains lacking PAF1, CTR9, and to a lesser extent RTF1, have growth defects on 
medium lacking inositol (BETZ et al. 2002).  The Ino- phenotype is associated with general 
transcription defects (HAMPSEY 1997).  Strains lacking all Paf1 complex members exhibit an Spt- 
phenotype, which connects these factors to the regulation of transcription initiation (SQUAZZO et 
al. 2002).  This phenotype is observed in mutant strains that restore transcription initiation to the 
proper TATA box in promoters that contain a competing TATA box within a Ty transposable 
element (WINSTON et al. 1984).  Genetic interactions are seen in strains lacking members of the 
Paf1 complex and other transcription elongation factors, including Spt4, Spt5, and Spt16 
(SQUAZZO et al. 2002).   
Rtf1 was originally identified as a suppressor of a mutation in TBP that had altered DNA 
binding specificity (STOLINSKI et al. 1997).  The graduate work of Patrick Costa (of the Arndt 
lab) showed that a rtf1Δ mutation was synthetically lethal with mutations in POB3, FCP1, and 
CTK1, which encode for a member of the FACT transcription elongation complex, an RNA Pol 
II CTD phosphatase, and an RNA Pol II CTD kinase, respectively (COSTA and ARNDT 2000).  
These results suggested that Rtf1 was important for regulating the transition from transcription 
initiation to elongation.  The graduate work of Kathryn Sheldon of the Arndt lab showed that 
overexpression of NAB3, an essential factor involved in 3’-end formation of non-polyadenylated 
RNA Pol II transcripts, suppresses a conditional phenotype of rtf1 mutant strains (SHELDON et al. 
2005).  Subsequent experiments showed that loss of Paf1 complex members results in 
transcription readthrough at the 3’-end of non-polyadenylated RNA Pol II transcripts, and paf1Δ 
strains have reduced amounts of Nab3 at actively transcribed genes (SHELDON et al. 2005).  
Work from the Jaehning lab showed that Paf1 is also important for 3’-end formation of RNA Pol 
II poly-adenylated transcripts (PENHEITER et al. 2005).   
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Interestingly, the Paf1 complex seems to ensure proper transcription by regulating the 
recruitment and activity of several histone modifying enzymes whose activity is associated with 
active transcription (Figure 9).  Rtf1, Paf1 and Ctr9 are required for the recruitment and activity 
of Rad6 and Bre1, the ubiquitin-conjugating enzyme and ubiquitin-protein ligase that mono-
ubiquitylate histone H2B at lysine 123 (K123) (NG et al. 2003b; WOOD et al. 2003b; XIAO et al. 
2005).  Because this ubiquitylation event is required for subsequent methylation of histone H3 at 
lysines 4 and 79, Paf1 complex members are also required for these methylation events (WOOD 
et al. 2003b).  However, Paf1 and Ctr9 strains have decreased Rtf1 protein levels (MUELLER et 
al. 2004; SQUAZZO et al. 2002), which suggests that Rtf1 may be the primary factor that is 
responsible for the recruitment of the H2B ubiquitylation machinery.   
Paf1 and Ctr9 are also required for tri-methylation of histone H3 at lysine 36 (Y. Chu, R. 
Simic, M. Warner, K. Arndt and G. Prelich, submitted for publication).  Other members of the 
Paf1 complex have no effect on K36 methylation.  Specifically, Paf1 and Ctr9 are important for 
the recruitment of Set2, the enzyme that methylates histone H3 at K36.  This result is interesting 
because mono-, di-, and tri-methylation of K36 are all performed by Set2, but loss of Paf1 or 
Ctr9 only affects the tri-methylation event at actively transcribing genes.  Further analysis will be 
needed to fully understand this interesting result.  
The Paf1 complex is conserved in eukaryotes.  Cdc73 is 32% identical in sequence with 
the human tumor suppressor protein, parafibromin (ROZENBLATT-ROSEN et al. 2005).  Mutations 
in this protein are associated with hyperparathyroidism-jaw tumor syndrome (CARPTEN et al. 
2002; SHATTUCK et al. 2003).  Immunoprecipitations show that parafibromin associates with the 
human homologs of Paf1, Ctr9 and Leo1, suggesting it is a member of the human Paf1 complex 
(ROZENBLATT-ROSEN et al. 2005; YART et al. 2005).   In contrast to the Paf1 complex in yeast, 
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the human homolog of Rtf1 did not interact with parafibromin, suggesting that human Rtf1 may 
regulate transcription in a Paf1-independent manner in humans.  However, similar to yeast, the 
human Paf1 complex physically associates with Rbbp5 and Ash2L, components of the human 
histone H3 K4 methyltransferase complex (ROZENBLATT-ROSEN et al. 2005).  These results 
suggest that Rtf1 function may not be conserved through eukaryotes, or that human Rtf1 does not 
need to stably interact with the Paf1 complex to affect transcription. 
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Figure 9.  Many transcription elongation factors regulate chromatin structure. 
A) The state of the chromatin template during transcription elongation is regulated by factors that 
associate with RNA Pol II.  The Paf1 complex associates with RNA Pol II that is phosphorylated 
at serine 5.  This complex regulates the association of Rad6/Bre1, COMPASS, and FACT with 
chromatin, leading to an increase in H2B ubiquitylation and histone H3 K4 methylation at the 5’-
end of ORFs.  Set2 interacts with RNA Pol II that is phosphorylated within the CTD at serine 2.  
This leads to histone H3 K36 methylation at the 3’-ends of ORFs.  Chromatin remodeling (eg. 
Chd1) and chromatin modifying (eg. Rpd3S) complexes are recruited to actively transcribed 
ORFs by the post-translational histone modifications mentioned above.   B)  Nucleosomal 
stability is highly regulated during transcription.  Once the transcription complex has moved into 
the body of a gene where activator-dependent HATs no longer operate, other HATs are recruited 
to facilitate transcription through a chromatin template.  The passage of the polymerase causes 
histone displacement.  These histones are redeposited onto the DNA behind Pol II by histone 
chaperones and elongation factors, including FACT and Spt6.  Alternatively, “new” histones in 
the nucleus are also available for nucleosome deposition.  These newly deposited histones are 
hyperacetylated and are immediately methylated at histone H3 K36 by Set2.  This modification 
recruits the Rpd3S deacetylase complex.  Rpd3S HDAC activity results in the stabilization of the 
nucleosome.  Methylation of H3K36 is eventually eliminated by a histone demethylases when 
the gene turns off.  From Li, B. et al. (2007) Cell. 128:707-719. 
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1.2.4.2 Spt4/5, Spt6, and yeast FACT modulate chromatin structure during transcription 
The SPT (suppressors of Ty) genes were identified in genetic screens to identify factors 
that suppressed initiation from an alternate TATA element within the promoters of yeast genes 
(WINSTON et al. 1984).  Mutations in the SPT genes group into two classes; 1) those that cause 
phenotypes similar to mutations in SPT15 (encodes TBP), and 2) those that cause phenotypes 
similar to histone gene mutations (the histone genes were identified in this screen as well).  
Several of the genes in the second class of factors are important for regulating chromatin 
modifications and structure during transcription, including Spt4, Spt5, Spt6 and Spt16.  
Spt6 is a conserved elongation factor that is important for maintaining chromatin 
structure.  Yeast Spt6 has been shown to physically interact with histones, and can assemble 
nucleosomes on plasmid DNA in vitro (BORTVIN and WINSTON 1996).  Micrococcal nuclease 
assays show that spt6 strains have genome-wide changes in chromatin structure (BORTVIN and 
WINSTON 1996).  Strains expressing temperature sensitive alleles of SPT6 have increased levels 
of transcription from cryptic TATA elements that are found within open reading frames, 
suggesting that Spt6 is important for reassembling nucleosomes that are displaced during 
transcription (KAPLAN et al. 2003) (Figure 9).  Spt6 has been shown to physically interact with 
RNA Pol II, Spt5, and a novel protein Iws1 (interacts with Spt6) (KROGAN et al. 2002).  
Chromatin immunoprecipitation experiments have shown that Drosophila Spt6 colocalizes at 
genes with RNA Pol II upon induction of transcription (ANDRULIS et al. 2000; KAPLAN et al. 
2000).   
Spt4 and Spt5 form a tightly associated complex in yeast (KROGAN et al. 2002; SWANSON 
and WINSTON 1992) that is functionally connected to the regulation of transcription elongation 
(HARTZOG et al. 1998).  Spt5 has also been shown to associate with RNA Pol II, transcription 
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initiation factors, RNA processing factors, and several transcription elongation factors, including 
Spt4, Pob3, TFIIS, and Spt6 (KROGAN et al. 2002; LINDSTROM et al. 2003).  Spt4 physically 
interacts with RNA Pol II and Spt5 (KROGAN et al. 2002).  Interestingly, Spt4 and Spt5 copurify 
with RNA Pol I and are important for proper expression of rRNA (SCHNEIDER et al. 2006a).  
Importantly, Spt4 (and possibly Spt5) is important for Paf1 complex recruitment to RNA Pol II 
after promoter clearance (QIU et al. 2006).  Spt4 and Spt5 are conserved proteins, and the human 
homologs of these factors comprise the DSIF complex (WADA et al. 1998).  This complex was 
identified as an inhibitor of transcription of elongation in cells exposed to the nucleoside analog 
5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) (WADA et al. 1998).  In vitro 
experiments suggest that both the human (DSIF) and yeast (Spt4/5) proteins act to positively and 
negatively regulate transcription elongation (HARTZOG et al. 1998; WADA et al. 1998).  
Consistent with a positive role in transcription elongation, yeast and Drosophila Spt4 and Spt5 
are localized at actively transcribed genes (ANDRULIS et al. 2000; KAPLAN et al. 2000; 
POKHOLOK et al. 2002).  Genetic interactions with CTD truncations and CTD kinases and 
phosphatases suggest that Spt4 and Spt5 regulate elongation events that are controlled by 
physical interactions with the CTD of RNA Pol II (LINDSTROM and HARTZOG 2001; MURRAY et 
al. 2001). 
Spt16 physically interacts with Pob3 and Nhp6 to form the yeast homolog of the human 
FACT (facilitates chromatin transcription) complex (ORPHANIDES et al. 1998).  The human 
FACT complex contains Spt16 and SSRP1, which is similar in sequence to yeast proteins Pob3 
and Nhp6 (BREWSTER et al. 2001).  Spt16 physically interacts with RNA Pol II and transcription 
elongation factors, including the Paf1 complex and Spt4/5 (KROGAN et al. 2002).  Chromatin 
immunoprecipitation experiments in yeast (MASON and STRUHL 2003) and Arabidopsis 
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(DUROUX et al. 2004) and immunofluorescence experiments in Drosophila (SAUNDERS et al. 
2003) have shown that FACT is associated with actively transcribed genes.  Interestingly, human 
FACT physically associates with the chromatin remodeling enzyme Chd1 (KELLEY et al. 1999) 
bound to histone H3 that is tri-methylated at K4 (reviewed in REINBERG and SIMS 2006), and 
knockdown of Chd1 protein levels in Drosophila reduces FACT recruitment to active genes 
(ADELMAN et al. 2006).  FACT facilitates the removal of an H2A/H2B dimer during 
transcription (BELOTSERKOVSKAYA et al. 2003) (Figure 9), and strains containing mutations in 
FACT subunits exhibit aberrant initiation from cryptic TATA elements (KAPLAN et al. 2003), 
suggesting that FACT is important for maintaining proper chromatin structure during 
transcription (reviewed in REINBERG and SIMS 2006)).  Interestingly, yeast FACT interacts with 
DNA polymerase α (SCHLESINGER and FORMOSA 2000; WITTMEYER and FORMOSA 1997; 
WITTMEYER et al. 1999), suggesting that FACT may modulate chromatin structure during many 
nuclear events, including transcription and DNA replication.   
1.2.4.3 TFIIS 
TFIIS, encoded by the gene DST1 (also known as PPR2), is a 35 kiloDalton protein that 
stimulates transcription elongation in vitro and in vivo (KULISH and STRUHL 2001; SEKIMIZU et 
al. 1976).  TFIIS is conserved throughout eukaryotes, and physically interacts with RNA Pol II 
(AGARWAL et al. 1991; HIRASHIMA et al. 1988; RAPPAPORT et al. 1988; REINBERG and ROEDER 
1987; SHIMOARAISO et al. 1997).  TFIIS is also homologous to GreA and GreB in bacteria 
(BORUKHOV et al. 1993).  TFIIS and its bacterial homologs facilitate movement of the 
polymerase through an arrest site by stimulating the intrinsic RNA cleavage activity of RNA Pol 
II (KETTENBERGER et al. 2003; RUDD et al. 1994; WEILBAECHER et al. 2003).  After cleavage, 
the transcript remains associated with RNA Pol II, and is realigned within the active site, where 
 62 
the polymerase attempts elongation again (GU et al. 1993; KIREEVA et al. 2000; KOMISSAROVA 
and KASHLEV 1997).  Strong synthetic phenotypes are observed in strains containing mutations 
in DST1 and mutations in other elongation factors, including CTK1 (JONA et al. 2001), RTF1 
(COSTA and ARNDT 2000), SPT4, SPT5, SPT6 (HARTZOG et al. 1998), and SPT16 (ORPHANIDES 
et al. 1999), suggesting that all of these factors functionally overlap to promote transcription 
elongation.   
1.2.5 Transcription termination and 3’-end formation of the mRNA 
Transcription termination occurs when the RNA polymerase releases the nascent RNA and 
dissociates from the DNA template (reviewed in ROSONINA et al. 2006).  This process allows the 
polymerase to be recycled at another promoter, and prevents aberrant transcription of 
downstream genes.  DNA or RNA elements at specific positions downstream of eukaryotic genes 
are recognized by eukaryotic RNA Pol I and Pol III and prokaryotic RNA polymerases and act to 
directly or indirectly disrupt the polymerase-DNA-RNA complex to terminate transcription 
(reviewed in HENKIN 2000; PAULE and WHITE 2000).  Eukaryotic RNA Pol II transcription 
termination occurs stochastically and appears to be independent of cis-acting sequences 
(reviewed in ROSONINA et al. 2006).  A full understanding of RNA Pol II termination is lacking, 
but it is known that termination is functionally connected to the 3’ end formation of the nascent 
transcript.  Transcription of the poly(A) sequence prompts the endonucleolytic cleavage of the 
transcript, which is released to be polyadenylated and translated, and the polymerase continues 
transcribing downstream of the poly(A) site, creating another uncapped transcript (reviewed in 
COLGAN and MANLEY 1997; ZHAO et al. 1999).  This new transcript is targeted for degradation 
by Rat1/Xrn2 exonuclease, which promotes transcription termination (KIM et al. 2004b; WEST et 
 63 
al. 2004).  Rosonina and colleagues propose that after the poly(A) site the polymerase pauses, 
possibly due to conformational changes in accessory factors, which results in the recruitment of 
unknown termination factors that disrupt the polymerase-DNA-RNA interaction, leading to 
transcription termination (ROSONINA et al. 2006).   
1.3 TRANSCRIPTIONAL SILENCING MECHANISMS IN YEAST 
1.3.1 What is silencing? 
Silenced chromatin has been characterized as a repressive chromatin structure that is established 
and maintained through physical interactions between non-histone proteins and histone proteins 
(reviewed in VAN LEEUWEN and GOTTSCHLING 2002).  The chromatin structure within silenced 
regions in yeast is similar to that found in heterochromatin in humans and Drosophila (reviewed 
in RUSCHE et al. 2003).  Specifically, the silenced regions in yeast are highly condensed 
throughout the cell cycle, associated with the nuclear periphery, and these regions have very little 
to no gene expression (VAN LEEUWEN and GOTTSCHLING 2002).  Therefore, silencing 
mechanisms in yeast have been used as a model to understand heterochromatin function in 
higher eukaryotes.  Although silencing is characterized by the loss of gene expression, factors 
involved in other processes related to chromatin, including DNA repair and replication are also 
excluded from silenced regions (GOTTSCHLING 1992; LOO and RINE 1994; SINGH and KLAR 
1992).  The amino-terminal tails of histones H3 and H4 within nucleosomes at silenced regions 
are hypo-methylated and hypo-acetylated (BRAUNSTEIN et al. 1993; SUKA et al. 2001).  As one 
might expect, silenced chromatin contains highly ordered nucleosomes that are arranged in a 
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regularly spaced manner (RAVINDRA et al. 1999; WEISS and SIMPSON 1998).   
1.3.2 The Sir proteins are required to establish and maintain silencing 
There are three regions of the yeast genome that utilize silencing mechanisms, and while the 
exact mechanism of silencing differs in all three regions, the proteins that establish and maintain 
silencing are common (Figure 10).  The silent information regulator (Sir) proteins, Sir1-4, are 
required for silencing, although not all Sir proteins act at all three silenced regions (to be 
discussed further in subsequent sections).  Sequence specific DNA binding proteins bind to 
silencer sequences at each silenced region and act to recruit the Sir proteins to a “starting” point 
for silencing.  Sir1 is not required for silencing, but helps to assemble the other Sir proteins at 
silenced regions (PILLUS and RINE 1989; RUSCHE et al. 2002; ZHANG et al. 2002).  Sir2 is an 
NAD+-dependent histone deacetylase (IMAI et al. 2000) and is recruited to all of the silenced 
regions through physical interactions with sequence specific DNA-binding proteins (reviewed in 
RUSCHE et al. 2003).  Sir3 and Sir4 require physical interactions with each other and hypo-
acetylated histones to maintain silencing at telomeres and the silent mating loci (HECHT et al. 
1995).  Silencing is thought to spread from the silencing origin using a mechanism in which Sir2 
deacetylates histone tails, creating a binding substrate for Sir3 and Sir4.  As Sir2 continues to 
deacetylate histone tails in sequential nucleosomes as it moves away from the silencing origin, 
and Sir3 and Sir4 spread by binding these tails (reviewed in RUSCHE et al. 2003).  Sir2 and Sir3 
are found in limited concentrations in vivo, and silencing is affected by subtle changes in the 
protein levels of either factor.  For example, overexpression of Sir3 enhances telomeric silencing 
(RENAULD et al. 1993).  However, deletion of Sir4 decreases telomeric silencing (COCKELL et al. 
1995), because Sir4 is required for Sir3 binding to this region.    
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Figure 10. Three regions of the genome are subjected to silencing. 
Telomeres, mating loci and rDNA are subjected to silencing mechanisms in yeast.  See text for 
additional details.  Adapted from Van Leeuwen and Gottschling (2002) Methods Enz. 350:165-
186.   
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1.3.3 The histone modification state in silenced regions differs from the modification state 
in actively transcribed regions 
Post-translational modifications of histones play an important role in gene expression as well as 
transcriptional silencing.  As described in section 1.1.2, histone acetylation and Rtf1-dependent 
histone modifications, specifically histone H3 K4 and K79 trimethylation, are found in 
euchromatic regions of the genome (POKHOLOK et al. 2005).  Conversely, chromatin in silenced 
regions is hypo-acetylated and hypo-methylated.  Interestingly, histone H3 lysine 9 (K9) 
methylation is characteristic of transcriptionally silenced regions in higher eukaryotes, but this 
modification is not found in S. cerevisiae.  However, silencing defects appear in strains lacking 
certain factors required for global histone modifications, specifically Rad6 (SUN and ALLIS 
2002), Set1 (BRYK et al. 2002; LAIBLE et al. 1997; NISLOW et al. 1997), Dot1 (NG et al. 2002a; 
SINGER et al. 1998; VAN LEEUWEN et al. 2002), or members of the Paf1 complex required for the 
activity of these enzymes (KROGAN et al. 2003a; NG et al. 2003a; WOOD et al. 2003b).  
Chromatin immunoprecipitation experiments in these strains show that the Sir proteins are 
diluted away from the normally silenced regions, due to the fact that the entire genome is hypo-
methylated in these strains (NG et al. 2003a).   
1.3.4 Three regions of the S. cerevisiae genome are subjected to silencing 
In S. cerevisiae, telomeres, the silent mating loci, and rDNA repeats are subjected to 
silencing mechanisms.  Each region uses distinct mechanisms to establish and maintain 
silencing, and I will describe these mechanisms in the next few sections. 
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1.3.4.1 Telomeric silencing 
Telomeres are a specialized structure found on the ends of linear chromosomes.  The 
purpose of this specialized structure is to maintain genomic integrity by protecting the ends of 
the chromosome from degradation or improper DNA fusions.  Yeast telomeres are maintained in 
a mechanism that is similar, but not identical, to those used in higher eukaryotes.  Unlike the rest 
of the genome, the DNA at the ends of the chromosome is not found in nucleosomes.  The DNA 
sequence at the ends of the chromosome is made up of 350 +/- 75 basepairs of repetitive 
sequence (5’-TG1-3-3’) (WRIGHT et al. 1992). These repeats are bound by non-histone proteins, 
including Rap1 (CONRAD et al. 1990; GILSON et al. 1993; WRIGHT and ZAKIAN 1995), Cdc13 
(BOURNS et al. 1998; TSUKAMOTO et al. 2001) and Hdf1 and Hdf2 (yeast Ku complex) (GRAVEL 
et al. 1998; MARTIN et al. 1999), resulting in the end of the chromosome folding back on itself, 
thereby protecting the end from exonucleases and illegitimate DNA fusions (DE BRUIN et al. 
2000; STRAHL-BOLSINGER et al. 1997).  This complex is structurally different from those found 
in higher eukaryotes because it does not include a DNA-strand invasion mechanism (DE BRUIN et 
al. 2000).   
S. cerevisiae contain other repetitive DNA sequences that are found adjacent to the 
telomeric repeats described above, known as Y’ and X (reviewed in THAM and ZAKIAN 2002).  
The DNA sequences adjacent to these telomeric repeats are found in nucleosomes (WRIGHT et al. 
1992).  Genes located in this region are subject to reversible transcriptional repression that is 
position and chromatin dependent, a consequence known as telomere position effect (TPE) 
(GOTTSCHLING et al. 1990).  Transcriptional silencing in this region depends on many proteins, 
including those mentioned above and the four Sir proteins (Sir1-4) (HECHT et al. 1996; STRAHL-
BOLSINGER et al. 1997) (Figure 10).  Rap1 and the Ku complex bind to the telomeric repeats 
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(TG1-3) and are thought to recruit Sir4 (HOPPE et al. 2002; LUO et al. 2002; MARTIN et al. 1999).  
Telomeric silencing is thought to spread as Sir2 deacetylates histone H3 and H4 tails, which 
provides high affinity binding sites for Sir3 and Sir4  (reviewed in RUSCHE et al. 2003; THAM 
and ZAKIAN 2002).  Repetition of this deacetylation/tail-binding cycle results in a highly 
compact chromatin structure that excludes many DNA binding proteins, including endonucleases 
and transcriptional activators and repressors.   
While the actual mechanism of silencing differs between budding yeast, fission yeast and 
humans, there are some generalizations that can be made about the silencing processes among 
these organisms.  The mechanism of silencing is poorly characterized in humans (BAUR et al. 
2001; KOERING et al. 2002).  The telomeric DNA in all organisms is TG-rich and is bound by 
sequence-specific DNA binding proteins (reviewed in PERROD and GASSER 2003).  
Heterochromatin formation in higher eukaryotes is associated with histone H3 K9 methylation 
by Su(var)3-9 (MIAO and NATARAJAN 2005; SCHOTTA et al. 2002; STEWART et al. 2005).  
Reminiscent of S. cerevisiae Sir complex function, hypoacetylated histones with H3 K9 
methylation are bound by HP1 in heterochromatic regions, which maintains the silenced state 
(JACOBS et al. 2001; SCHOTTA et al. 2002).  Fission yeast contain histone H3 K9 methylation, an 
HP1 homolog known as Swi6, and use a telomeric silencing mechanism similar to humans 
(NAKAYAMA et al. 2001).   
Telomeric silencing is more easily perturbed than mating loci silencing due to the fact 
that the HM genes have weak promoters that are more easily silenced (reviewed in VAN 
LEEUWEN and GOTTSCHLING 2002).   Overexpression and loss of function mutations in many 
genes have been shown to disrupt telomeric silencing.  Not surprisingly, strains that contain 
mutations that disrupt the cellular levels of the Sir proteins (APARICIO et al. 1991) or contain 
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mutations in the region of Rap1 that is important for interacting with Sir4 (KYRION et al. 1993; 
MORETTI and SHORE 2001) lose telomeric silencing.  Overexpression or deletion of Dot1, the 
histone H3 K79 methyltranferase, or Set1, the histone H3 K4 methyltransferase, results in the 
loss of telomeric silencing (SINGER et al. 1998).  These methylation events depend on the Paf1 
complex member Rtf1, and not-suprisingly, strains lacking RTF1 also lose telomeric silencing 
(NG et al. 2003a).  These effects have been attributed to the redistribution of the Sir proteins 
from the telomeres to the rest of the genome, which is hypomethylated in the absence of these 
factors, much like the telomeric regions in wild type strains (NG et al. 2003a).   
1.3.4.2 Silencing of the mating type cassettes 
Haploid S. cerevisiae strains are either a or α mating types.  Yeast secrete phereomones 
that correspond to their mating type in order to mate with cells of the opposite mating type.  The 
mating type of a given strain is determined by the MAT locus, which can be either MATa or 
MATα.  The MAT loci encode master transcriptional regulators which control the expression of a 
large number of genes.  Yeast contain unexpressed versions of the a or α information at the 
silenced HMR and HML loci.  Some yeast strains can switch mating types using a mechanism 
similar to gene conversion to enchange the gene found at the MAT locus with the gene found at 
either of the HM loci (reviewed in RUSCHE et al. 2003).  This process utilizes the HO 
endonuclease.  However, most laboratory yeast strains do not encode an active HO enzyme but 
the strains still maintain the silenced mating loci.   
The cis-acting DNA sequences called the E and I silencers flank the HML and HMR loci, 
and are required for establishing and maintaining silencing in these regions (BRAND et al. 1985; 
FELDMAN et al. 1984; MAHONEY and BROACH 1989).  Origin recognition complex (ORC) 
subunits, Abf1 and Rap1 bind to silencer sequences and recruit the Sir proteins to establish 
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silencing at these loci (BRAND et al. 1985; BUCHMAN et al. 1988; MAHONEY and BROACH 1989; 
MAHONEY et al. 1991; SHORE and NASMYTH 1987; SHORE et al. 1987) (Figure 10).   All four Sir 
proteins (Sir1-4) are required for silencing at the HML and HMR loci (HABER and GEORGE 1979; 
HOPPER and HALL 1975; IVY et al. 1985; IVY et al. 1986; KLAR et al. 1979; RINE et al. 1979) 
and are recruited to these regions through physical interactions with the DNA binding proteins 
(RUSCHE et al. 2002; TRIOLO and STERNGLANZ 1996).  Strains that lose silencing in this region 
express both mating pheromones and the haploid strain acts like a diploid (reviewed in 
LAURENSON and RINE 1992).  Specifically, these cells do not mate with cells of the opposite 
mating type and do not respond to the mating pheromones. 
Loss of function mutations have been shown to disrupt silencing of the mating loci.  As 
stated above, the Sir proteins are required for establishing and maintaining silencing at the 
mating loci (HABER and GEORGE 1979; HOPPER and HALL 1975; IVY et al. 1985; IVY et al. 1986; 
KLAR et al. 1979; RINE et al. 1979).  Mutations within MCM10, which encodes a DNA binding 
protein that is important for the initiation of DNA replication, have been shown to disrupt 
silencing of the mating loci (DOUGLAS et al. 2005).  This is thought to be the result of the loss of 
a physical interaction between Sir2, Sir3 and Mcm10, which may be important for recruiting the 
Sir proteins to silenced region (DOUGLAS et al. 2005).  Strains that contain mutations in the 
genes encoding Sas2, the catalytic subunit of the SAS histone acetyltransferase complex, or 
Asf1, a histone chaperone protein, exhibit defects in silencing of the mating loci (OSADA et al. 
2005).  While a mechanistic understanding of this observation is lacking, this suggests that SAS 
activity and Asf1 function are required for HM silencing (OSADA et al. 2005).   
1.3.4.3 rDNA silencing 
The ribosomal DNA (rDNA), found on chromosome XII in yeast, consists of 100-200 tandem 
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copies of 9.1 kb units that encode for ribosomal RNAs (reviewed in SMITH and BOEKE 1997).  
Each repeat encodes a copy of the 5S rRNA gene that is transcribed by RNA Pol III, and a copy 
of a 35S pre-rRNA gene that is transcribed by RNA Pol I (reviewed in SMITH and BOEKE 1997).  
The 35S pre-rRNA is ultimately processed into the 5.8S, 25S, and 18S rRNAs (reviewed in 
ZANCHIN and GOLDFARB 1999).  These two genes are separated by non-transcribed spacer (NTS) 
regions (Figure 10).  Because of the repetitive nature of this large genomic region, silencing 
mechanisms exist to prevent aberrant recombination of these essential genes.  Interestingly, RNA 
Pol II transcribed genes are expressed when relocated to the rDNA repeats, suggesting that the 
rDNA is not completely repressed (KEIL and MCWILLIAMS 1993; SZOSTAK and WU 1980).   
There appear to be inactive regions within the rDNA repeats that are associated with 
nucleosomes, and the actively transcribed repeats remain nucleosome-free (DAMMANN et al. 
1993).  Sir2 is the only Sir protein required for rDNA silencing (GOTTLIEB and ESPOSITO 1989), 
and strains lacking SIR2 exhibit increased expression of rDNA repeats (SMITH and BOEKE 1997).  
Interestingly, while Sir3 and Sir4 are not involved in the spreading of silencing at rDNA, RNA 
Pol I has been shown to propagate Sir2 association within the rDNA in the direction of 
transcription (BUCK et al. 2002).   
Several loss of function mutations have been shown to disrupt rDNA silencing.  As stated 
above, strains lacking SIR2 have rDNA silencing defects (GOTTLIEB and ESPOSITO 1989; SMITH 
and BOEKE 1997).  Strains containing mutations in COMPASS subunits (histone H3 K4 
methyltransferase complex) have been shown to disrupt rDNA silencing (MUELLER et al. 2006).  
Also, because the Paf1 complex is required for histone H3 K4 methylation by the COMPASS 
complex, strains that lack members of the Paf1 complex also have rDNA silencing defects 
(MUELLER et al. 2006).  Mutations in the gene that encodes Ubp10, a histone H2B 
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deubiquitylating enzyme, also disrupt rDNA silencing (CALZARI et al. 2006).  This silencing 
defect is the result of the loss of Sir2 association with the rDNA repeats (CALZARI et al. 2006).   
1.4 THE UBIQUITIN-PROTEASOME PATHWAY IS CONNECTED TO RNA POL 
II TRANSCRIPTION 
Surprisingly, components of the cellular machinery that are important for tagging and degrading 
aberrant proteins are functionally connected to the regulation of transcription.  This section will 
discuss the components of the degradation machinery and how these factors are known to impact 
transcription at many levels. 
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Table 2. Ubiquitin related factors. 
Factor Characteristic 
19S proteasome “Cap” subcomplex of the 26S proteasome; 
Acts to specify which proteins are 
degraded; Unfolds proteins prior to entry 
into the 20S core 
20S proteasome Catalytic “core” subcomplex of the 26S 
proteasome; Three proteases degrade 
proteins within the central cavity of this 
complex 
26S proteasome Protein complex that selectively degrades 
misfolded or unwanted proteins within the 
cell; Utilizes several proteases to perform 
its function; Composed of the 19S and 20S 
subcomplexes 
Bre1 RING finger protein; Recruits Rad6 to 
chromatin to catalyze the ubiquitylation of 
histone H2B at lysine 123; Ubiquitin 
protein ligase (E3) 
Dsk2 Selectively targets poly-ubiquitylated 
proteins to the proteasome for destruction; 
Functionally overlaps with Rad23 
DUB De-ubiquitylating enzyme; removes 
ubiquitin groups that have been covalently 
attached to substrate proteins 
E1 (Uba1) Ubiquitin-activating enzyme; Activates 
ubiquitin through an ATP dependent 
process; Passes ubiquitin to E2s; Yeast 
contain 1 E1 enzyme 
E2 (Ubc proteins) Ubiquitin-conjugating enzyme; Receives 
ubiquitin from E1; Conjugates ubiquitin to 
substrate proteins with the help of E3s; 
Yeast contain 11 ubiquitin E2s 
E3 Ubiquitin-protein ligase; Catalyzes the 
transfer of ubiquitin from the E2 to the 
substrate protein; Important for defining 
substrate specificity to E2s; Often contain a 
RING or HECT domain that interacts with 
the E2 
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HECT domain Secondary structure formed by the 
chelation of 2 zinc ions with 8 conserved 
cysteine and histidine residues within a 
protein; Proteins that contain this domain 
often act as E3s to define substrate 
specificity to the ubiquitylation pathway; 
HECTs act as an intermediate in the 
ubiquitylation pathway 
Not4 Ubiquitin protein ligase that targets EGD 
complex (transcription and ribosome 
related functions); Required for histone H3 
K4 methylation, but not histone H2B 
ubiquitylation 
Rad23 Selectively targets poly-ubiquitylated 
proteins to the proteasome for destruction; 
Functionally overlaps with Dsk2 
Rad6 Ubiquitin-conjugating enzyme (E2); 
Ubiquitylates many proteins in yeast, 
including histone H2B at lysine 123 
RING domain Secondary structure formed by the 
chelation of 2 zinc ions with 8 conserved 
cysteine and histidine residues within a 
protein; Proteins that contain this domain 
often act as E3s to define substrate 
specificity to the ubiquitylation pathway 
Rpn/Rpt proteins 19S proteasome proteins; Rpt proteins are 
AAA+ ATPases 
San1 RING finger protein; Recruits Cdc34 to 
ubiquitylate misfolded or mutant 
transcription factors within the nucleus; 
Ubiquitin protein ligase (E3) 
SUMO Ubiquitin-like post-translational protein 
modification; This modification is often 
associated with transcriptional repression 
Ubiquitin 76 amino acid post-translational 
modification; Mono-ubiquitylation changes 
the function of  protein; Poly-ubiquitylation 
targets a protein for destruction 
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1.4.1 What is ubiquitylation? 
Protein ubiquitylation is a highly regulated process that is often the first step in targeting a 
protein for degradation.  Ubiquitin is a 76 amino acid peptide that is post-translationally added to 
a substrate protein at lysine residues.  Ubiquitylation regulates many cellular processes including, 
but not limited to, cell cycle progression (KOEPP et al. 1999), transcription (BOEGER et al. 2005), 
and DNA repair (HOFMANN and PICKART 1999; SPENCE et al. 1995).  Up to 20% of yeast 
proteins are targeted for ubiquitylation when the cells are grown in rich medium (PENG et al. 
2003; WELCHMAN et al. 2005).   
Proteins can be monoubiquitylated or polyubiquitylated.  Monoubiquitylation can change 
the affinity of a given protein for another protein or change the enzymatic activity of the 
ubiquitylated protein (reviewed in FERDOUS et al. 2007; SOMESH et al. 2007).  Polyubiquitylation 
occurs when ubiquitin chains are formed on a substrate protein.  Ubiquitin contains seven 
conserved lysines itself (K6, 11, 27, 29, 33, 48, and 63), all of which are potential branching sites 
for polyubiquitylation chains.  However, in yeast, only K27- and K48-linked ubiquitin chains are 
utilized in targeting proteins for degradation (GLICKMAN and CIECHANOVER 2002).  
Polyubiquitylation often targets a protein for degradation by the proteasome (PICKART 2001; 
VARSHAVSKY 1997) (see section 1.4.3 for more information).   
1.4.2 Components of the ubiquitylation pathway 
Covalent attachment of ubiquitin to a substrate protein requires the coordinated functions of a 
ubiquitin-activating enzyme, a ubiquitin-conjugating enzyme, and a ubiquitin-protein ligase 
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(reviewed in FANG and WEISSMAN 2004; PICKART 2001) (Figure 11). While yeast contain only 
one ubiquitin-activating enzyme (Uba1) and eleven ubiquitin-conjugating enzymes (Ubc1-8, 
Ubc10, Ubc11 and Ubc13), there are many predicted ubiquitin-protein ligases, consistent with 
their proposed roles in determining substrate specificity (reviewed in PICKART 2001).  
Ubiquitylation is also reversible through the action of deubiquitylation enzymes.  The next 
several paragraphs will describe the roles of each of these factors in the ubiquitylation pathway.  
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Figure 11. The ubiquitylation pathway.  
Ubiquitylation of a substrate protein occurs through multiple steps.  E1 (gray), E2 (purple), E3 
(yellow), ubiquitin (red) and substrate (teal) proteins are shown.  See text for additional details.  
From Fang, S. and A. Weissman. (2004) Cell Mol Life Sci. 61:1546-61. 
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1.4.2.1 Ubiquitin-activating enzymes 
The ubiquitin activating enzyme (also known as E1) forms a thiol ester bond between the 
active site cysteine within the E1 and the carboxy-terminal glycine of ubiquitin (HAAS and ROSE 
1982; HAAS et al. 1982).  To accomplish this reaction, the E1 binds to Mg-ATP and then 
ubiquitin to form a ubiquitin adenylate intermediate that serves as the donor for the active site 
cysteine (HAAS and ROSE 1982; HERSHKO et al. 1983).  Each E1 molecule carries two ubiquitin 
groups, one as an adenylate intermediate and the other at the active site through a thiol ester bond 
(reviewed in PICKART 2001).  The active site ubiquitin is transferred to the ubiquitin-conjugating 
enzyme (Figure 11).   
1.4.2.2 Ubiquitin-conjugating enzymes 
Ubiquitin-conjugating enzymes (also known as E2s) contain a conserved 150 amino acid 
UBC domain that contains an active site cysteine that accepts the ubiquitin group from the E1 
(PICKART 2001).  Some E2s also contain amino-or carboxy-terminal extensions around the UBC 
domain that are required for E3 and substrate interactions (PICKART 2001).  While there is a 
single E1 that is found throughout the cell, E2s confine some selection on substrate specificity 
through interactions with a subset of E3s and through localization within certain cellular 
compartments (HOCHSTRASSER 1996; PICKART 2001) (Figure 11).  Transfer of ubiquitin to the 
E2 is rapid, and the downstream transfer to substrates is the rate limiting step in the 
ubiquitylation pathway (HAAS and BRIGHT 1988).  The low number of E2s relative to E3s 
suggest that each E2 works with multiple E3s, however, in vitro experiments show that many 
E3s can catalyze the transfer of ubiquitin to substrates in combination with several E2 enzymes 
(FANG and WEISSMAN 2004).   
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1.4.2.3 Ubiquitin-protein ligases 
Ubiquitin-protein ligases (also known as E3s) contain functional domains known as 
RING or HECT domains that interact with ubiquitin-conjugating enzymes (HUIBREGTSE et al. 
1995; LORICK et al. 1999) (Figure 11).  RING and HECT domains differ in both sequence and 
structure (BORDEN 2000; HUANG et al. 1999; ZHENG et al. 2000), but both domains interact with 
E2s to facilitate substrate ubiquitylation.  For example, the mammalian E2 UbcH7 interacts with 
the HECT domain E3, E6-AP (HUANG et al. 1999; KUMAR et al. 1997; NUBER et al. 1996), and 
several RING containing E3s, including c-Cbl, HHARI, and H7-AP1 (MOYNIHAN et al. 1999; 
YOKOUCHI et al. 1999; ZHENG et al. 2000).  RING domains and HECT domains facilitate 
ubiquitylation through distinct mechanisms that I will describe in the next few paragraphs. 
The RING domain was first identified in a protein encoded by Really Interesting New 
Gene 1 (FREEMONT et al. 1991).  Unlike tandem zinc finger motifs, RING domains consist of 
eight critical amino acids, often 7 cysteine residues and one histidine residue, which bind two 
zinc ions to form a cross-brace structure (reviewed in JACKSON et al. 2000) (Figure 12).  The 
consensus RING sequence is C-x2-C-x9-39-C-x1-3-C/H-x2-3-C/H-x2-C-x4-48-C-x2-C, where C 
represents a cysteine residue, H represents a histidine residue, and x represents any amino acid 
(FANG and WEISSMAN 2004).   However, some RING domains contain eight cysteines or amino 
acids other than cysteine and histidine in the zinc-binding positions (YANG et al. 2005).   
RING domain-containing E3s catalyze the transfer of ubiquitin from the E2 to the 
substrate by interacting with the E2 through the RING domain and interacting with the substrate 
in a region outside of the RING domain (FANG and WEISSMAN 2004).  A general mechinsm for 
how RING E3s recognize their substrates is not understood (FANG and WEISSMAN 2004), 
although some E3s recognize specific sequences within their targets.  Specifically, the anaphase 
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promoting complex (APC) recognizes its targets through motifs called “KEN boxes” (CHEN et 
al. 2002; DESHAIES 1999; HENDRICKSON et al. 2001) and “A boxes” (HARPER et al. 2002; 
LITTLEPAGE and RUDERMAN 2002).   
HECT domain containing proteins were first identified as having homology with the 
carboxy terminus of E6-AP, which mediates the human papillomavirus encoded E6-dependent 
ubiquitylation of p53 in mammalian cells (SCHEFFNER et al. 1994).  HECT proteins contain a 
conserved 350 amino acid domain at their carboxy termini (FANG and WEISSMAN 2004) while 
the amino termini interact with substrates and determine the cellular localization of the protein 
(WEISSMAN 2001).  Unlike RING domain-containing E3s, HECT domain proteins are 
intermediates in the ubiquitylation pathway (reviewed in FANG and WEISSMAN 2004)).  The 
amino terminus of the HECT protein interacts with the substrate while a conserved cysteine 
residue within the HECT domain accepts the ubiquitin group from the E2.  The HECT protein 
then transfers ubiquitin to the substrate.  A subset of HECT domain proteins contain WW 
domains that recognize PPXY or PPLP sequences within their substrates (MACIAS et al. 2002; 
SUDOL et al. 2001).  WW domains consist of tryptophan-rich sequences that are approximately 
35 amino acids in length (FANG and WEISSMAN 2004).  Little is known about the process by 
which HECT domain proteins that do not contain WW domains interact with their substrates.   
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Figure 12.  RING domain architecture. 
A) Schematic representing RING domain architecture.  Seven cysteines and one histidine residue 
chelate two zinc ions to form a cross-brace structure as shown.  B) Solution structure of the 
RING domain from the Kaposi’s sarcoma-associated herpesvirus protein K3.  This RING 
domain consists of the C4HC3 pattern of conserved zinc chelating residues.  Zinc ions are 
represented by magenta spheres, side chains of chelating amino acids are shown, and the 
conserved tryptophan residues found within RING domains are highlighted in purple.  Alpha 
helices are green and beta sheets are blue.  From Dodd, R. B. et al. (2004). J. Biol. Chem. 
279:53840-53847. 
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1.4.2.4 Deubiquitylating enzymes 
Deubiquitylating enzymes (DUBs) reverse the activities of E2s and E3s.  Most DUBs are 
cysteine proteases, which means that the active site cysteine performs a nucleophilic attack on 
the bond that attaches ubiquitin to the substrate, forming an intermediate in which ubiquitin is 
covalently bound to the protease (reviewed in NIJMAN et al. 2005).  These DUBs fall into one of 
two classes, 1) ubiquitin carboxy-terminal hydrolases (UCHs), 2) ubiquitin-specific processing 
proteases (UBPs), (reviewed in NIJMAN et al. 2005).  The structures of these DUBs are distinct, 
despite the fact that both classes cleave ubiquitin (NIJMAN et al. 2005).  Each of these classes of 
enzymes target specific types of ubiquitylated targets.  For example, UBPs are important for 
cleaving and disassembling polyubiquitin chains (FANG and WEISSMAN 2004; NIJMAN et al. 
2005).    
The S. cerevisiae genome encodes for 17 putative DUBs, 16 of which fall into the UBP 
class (HOCHSTRASSER 1996).  A significant amount of work has shown that Doa4 is a DUB in 
yeast with a wide range of functions.  Doa4 works late in the ubiquitin-proteasome pathway by 
recycling ubiquitin from proteins targeted to the proteasome (PAPA and HOCHSTRASSER 1993).  
In fact, most of the Doa4 protein in the cell is physically associated with the proteasome (PAPA et 
al. 1999).  Doa4 activity has been shown to be important for the degradation of many proteins in 
yeast, including the α2 repressor (PAPA and HOCHSTRASSER 1993).  Doa4 overexpression leads 
to accelerated α2 repressor degradation, suggesting that Doa4 levels are limiting in vivo (PAPA 
and HOCHSTRASSER 1993). 
Interestingly, mutations of specific DUBs in metazoans are correlated with disease, 
including embryonic development defects and tumor suppression and growth.  This suggests that 
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DUBs do not act stochastically in the cell and at least some DUBs may target specific substrates 
(FANG and WEISSMAN 2004).  Specifically, HAUSP (herpes virus-associated ubiquitin-specific 
protease) deubiquitylates p53 in vitro and in vivo and stabilizes p53 protein levels (LI et al. 
2002).   
1.4.3 The proteasome degrades ubiquitylated proteins 
Once a protein has been polyubiquitylated, it is targeted for destruction by the 26S proteasome.  
Several factors in the cell ensure that this process is efficient and thorough.  In this section, I will 
describe what happens to a protein after it is polyubiquitylated.   
1.4.3.1 How do ubiquitylated proteins get to the proteasome? 
Substrate proteins that have had a chain of at least four ubiquitin groups attached to them 
are targeted for destruction by the 26S proteasome (PICKART 2001; VARSHAVSKY 1997).  The 
proteasome subunit Rpn10 (S5a in humans) binds to chains of ubiquitin at least 4 groups long 
through its ubiquitin-interacting motif (UIM) (DEVERAUX et al. 1994).  Rpn10 functionally 
overlaps with related factors Dsk2 (Dph1 in S. pombe) and Rad23 (Rph23 in S. pombe) (CHEN 
and MADURA 2002; FUNAKOSHI et al. 2002; LAMBERTSON et al. 1999; RAO and SASTRY 2002; 
SCHAUBER et al. 1998; WILKINSON et al. 2001).  These proteins are conserved in eukaryotes 
from yeast to humans (HARTMANN-PETERSEN et al. 2003).  Dsk2 and Rad23 interact with 
polyubiquitylated proteins using ubiquitin-associated (UBA) domains (HOFMANN and BUCHER 
1996) and transiently interact with the 19S proteasome subunit Rpn1 via ubiquitin-like (UBL) 
domains (ELSASSER et al. 2002).  Thus, these proteins act as “destruction chaperones” by 
targeting polyubiquitylated proteins to the proteasome for degradation (HARTMANN-PETERSEN et 
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al. 2003).   
This is not the only mechanism that cells use to target ubiquitylated proteins for 
destruction.  Several components of the ubiquitylation machinery in S. cerevisiae and humans 
have also been shown to physically interact with the proteasome.  Specifically, the yeast E3, 
Ubr1, binds to the proteasome subunit Rpn2 (XIE and VARSHAVSKY 2000), and in humans, the 
E3 KIAA10 interacts with the proteasome subunit S2 (YOU and PICKART 2001).  These results 
suggest that the ubiquitylation machinery may tag proteins for destruction at the same time that 
they take them to the proteasome.   
1.4.3.2 The 26S proteasome selectively degrades ubiquitylated proteins 
Studies using the model organism Saccharomyces cerevisiae led the way in determining 
that the proteasome degraded ubiquitylated proteins in eukaryotes.  Yeast that contained a 
mutation that disrupted the chymotrypsin-like activity of cells led to an accumulation of 
ubiquitylated proteins (HEINEMEYER et al. 1991).  The proteasome is made up of two sub-
complexes, the 19S and 20S proteasomes (reviewed in PETERS 1994) (Figure 13).  These 
complexes utilize distinct functions to tightly regulate protein degradation, which I will describe 
in the next few paragraphs. 
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Figure 13. The proteasome structure. 
The proteasome is composed of 19S and 20S subunits.  The 19S subunit consists of Rpt and Rpn 
proteins, and the 20S subunit consists of α and β proteins.  The 20S subunits with yellow dots 
possess proteolytic activity.  Space filling model represents the three-dimensional structure of the 
proteasome.  From Wolf and Hilt (2004) Biochim Biophys Acta. 1695:19-31.   
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The 19S proteasome in yeast consists of more than 19 subunits (reviewed in WOLF and 
HILT 2004).  The Rpn (regulatory particle non-ATPase) and Rpt (regulatory particle triple A 
protein) proteins of the 19S subunit form the lid and base subcomplexes, respectively (reviewed 
in WOLF and HILT 2004) (Figure 13).  Rpn10 physically connects these two subcomplexes 
(reviewed in WOLF and HILT 2004).  The 19S proteasome performs several functions to control 
protein degradation.  It: 1) recognizes proteins that are tagged for degradation, 2) unfolds these 
proteins, 3) cleaves ubiquitin tags from proteins, 4) allows access to the 20S core, and 5) unfolds 
the protein prior to feeding it into the 20S core (reviewed in WOLF and HILT 2004).  Rpn10 and 
Rpt5 have been shown to recognize polyubiquitylated proteins (DEVERAUX et al. 1994; 
ELSASSER et al. 2002; LAM et al. 2002).  Alternatively, Dsk2 or Rad23 can chaperone 
ubiquitylated proteins to the proteasome via interactions with Rpn1 (ELSASSER et al. 2002; KIM 
et al. 2004a; SAEKI et al. 2002).  Rpn11 is a DUB that is a component of the 19S proteasome 
(VERMA et al. 2002; YAO and COHEN 2002), but other DUBs, including Doa4 and Ubp6, have 
been shown to interact with the proteasome and remove ubiquitin from proteins that are to be 
degraded (LEGGETT et al. 2002; PAPA et al. 1999).  The 19S subunit Rpt2 is thought to be the 
gatekeeper of the 20S core, since it is required for displacement of the α subunits from the 20S 
core (KOHLER et al. 2001).  Little is known about how proteins are denatured prior to entering 
the 20S proteasome, but the ATPases Rpt1-6 are thought to provide this function to the 19S 
proteasome (RUBIN et al. 1998).   
The 20S subunit of the proteasome structure is conserved in eukaryotes and prokaryotes, 
and consists of a barrel-shaped complex (HEGERL et al. 1991) formed by four stacks of α and β 
subunits with the α subunits on the outside layers and the β subunits within the inner layers 
(GROLL et al. 1997; GRZIWA et al. 1991; LOWE et al. 1995; PUHLER et al. 1992) (Figure 14).  
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There are seven different α and β subunits within each layer of the eukaryotic 20S proteasome 
(LOWE et al. 1995), which are encoded by 14 genes in yeast (HEINEMEYER et al. 1994).  The 20S 
proteasome degrades proteins into small peptides and single amino acids that can be recycled 
into new proteins.  Three different β subunits of the eukaryotic proteasome confer trypsin-like, 
chymotrypsin-like and peptidyl-glutamyl-peptide cleaving activities to degrade proteins (CHEN 
and HOCHSTRASSER 1996; GROLL et al. 1997; HEINEMEYER et al. 1997).  The 20S proteasome 
can only degrade denatured proteins, limiting the destructive activity of this complex (reviewed 
in WOLF and HILT 2004).   
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Figure 14.  The 20S proteasome structure. 
The 20S proteasome is a barrel shaped structure consisting of layers of α and β subunits.  Seven 
different α subunits and seven different β subunits comprise each layer.  See text for additional 
details.  From Wolf and Hilt. (2004) Biochim Biophys Acta. 1695:19-31.   
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1.4.4 The ubiquitin-proteasome machinery functions within the nucleus 
The ubiquitin-proteasome machinery localizes to the nucleus and affects many processes, 
including chromatin structure, DNA replication and repair, and transcription.  In fact, some 
components of the ubiquitylation machinery are specific to the nucleus, like the E2 Cdc34 and 
several E3s, including San1 and Bre1 (described in more detail in section 1.4.4.2).  In the next 
few sections I will focus on the functional connections between the ubiquitin-proteasome 
machinery and transcription.  Specifically, I will spotlight several characterized nuclear, RING 
domain-containing proteins and their targets.   
1.4.4.1 Proteolytic and nonproteolytic activities of the proteasome regulate many nuclear 
events 
The proteasome itself has been shown to reside within the nucleus and regulate many 
nuclear processes, including DNA repair and transcription.  Specifically, the proteasome has 
been shown to regulate gene expression through both proteolytic and nonproteolytic mechanisms 
(reviewed in COLLINS and TANSEY 2006). The 19S and 20S proteasome subunits localize to most 
genes in yeast in a transcription dependent manner, however not all genes were bound by both 
subunits, suggesting that each subunit affects transcription through a unique mechanism (SIKDER 
et al. 2006).   
When arrested in transcription elongation by DNA damage, Pol II is polyubiquitylated 
and degraded as part of the repair process (BEAUDENON et al. 1999; BREGMAN et al. 1996; LUO 
et al. 2001; RATNER et al. 1998).  In vitro experiments with highly purified components show 
that stalled elongation complexes are targeted for ubiquitylation by the ubiquitin-protein ligase 
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Def1 (SOMESH et al. 2005; WOUDSTRA et al. 2002).  Serine 5 phosphorylation on the CTD of 
RNA Pol II (discussed in section 1.2.2) inhibits ubiquitylation, suggesting that the ubiquitylation 
machinery uses the modification state of the CTD as a signal to specifically target elongating 
RNA Pol II and not free or initiating Pol II during transcription-coupled DNA repair (SOMESH et 
al. 2005).  Very recently, the HECT domain E3 Rsp5 was shown to bind to the CTD of RNA Pol 
II and direct ubiquitylation of the largest subunit of RNA Pol II (Rpb1) (SOMESH et al. 2007).  
Interestingly, this study shows that the E2, Ubc5, recognizes two different lysine residues within 
the body of Rpb1 (K330 and K695) and recruits Rsp5 to catalyze the codependent ubiquitylation 
of these sites (SOMESH et al. 2007).  Strains containing mutations of these lysine residues are 
sensitive to 6-azauracil and UV irradiation, suggesting that these ubiquitylation modifications are 
important for regulating transcription elongation and DNA damage repair (SOMESH et al. 2007).   
Several proteins important for Pol II transcription are modified by the protein 
ubiquitylation machinery within the nucleus (reviewed in LIPFORD and DESHAIES 2003; 
MURATANI and TANSEY 2003). Ubiquitylation of numerous transcriptional activators has been 
observed and for several of these, including the well-studied yeast activators Gcn4 and Gal4, 
ubiquitylation and proteasome-dependent proteolysis correlate with gene activation (LIPFORD et 
al. 2005; MURATANI and TANSEY 2003).  However, whether proteolytic turnover of activator 
proteins is obligatory for activation remains a topic of debate (NALLEY et al. 2006).  Very 
recently, Ferdous and colleagues showed that the proteasomal ATPases are recruited to 
promoters to encourage promoter escape and transcription elongation by disrupting activator-
DNA interactions (FERDOUS et al. 2007).  However, monoubiquitylation of the activator proteins 
prevents disruption of the activator-DNA contacts by the 19S proteasome, suggesting that 
monoubiquitylation increases the performance of the activator (FERDOUS et al. 2007). 
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Components of the proteasome 19S regulatory complex facilitate interactions between 
the SAGA histone acetyltransferase complex and transcriptional activators (LEE et al. 2005a).  
Specifically, direct interactions between the 19S proteasome and transcription activators can be 
detected at low levels (LEE et al. 2005a).  SAGA is recruited to promoters by activators like Gal4 
(see section 1.2.3.2), but this recruitment is increased in a dose-dependent manner by the 19S 
proteasome (LEE et al. 2005a).  Direct interactions between the 19S proteasome and Gal4 are not 
detected in vivo, but the 19S proteasome physically recruits SAGA to promoters, where the 19S 
proteasome promotes physical interactions between Gal4 and SAGA and stimulates SAGA’s 
histone acetyltransferase activity (LEE et al. 2005a).   
Interestingly, the 19S proteasome is also important for several chromatin modifications.  
As described in section 1.1.2.2, histone H2B ubiquitylation is required for subsequent 
methylation of histone H3 at lysines 4 (K4) and 79 (K79).  Surprisingly, the proteasomal 
ATPases Rpt4 and Rpt6 are required to couple these modifications (EZHKOVA and TANSEY 
2004).  In strains containing mutations that disrupt Rpt4 or Rpt6 function, histone H2B 
ubiquitylation occurs at similar levels to wildtype strains, but histone H3 K4 and K79 
methylation is lost (EZHKOVA and TANSEY 2004).  Histone H2B ubiquitylation is required to 
recruit the 19S proteasome to an activated gene (EZHKOVA and TANSEY 2004).  Consistent with a 
role for these modifications in maintaining telomeric and mating loci silencing (discussed in 
section 1.3.4.1), strains expressing mutant Rpt4 or Rpt6 have defects in silencing both of these 
regions (EZHKOVA and TANSEY 2004).  However, strains containing mutations in the catalytic 
subunits of the proteasome, including Rpn4, Rpn10 or Pre1, did not disrupt silencing, suggesting 
that Rpt4 and Rpt6 affect chromatin modification in a proteolysis-independent manner 
(EZHKOVA and TANSEY 2004).  Ezhkova and colleagues propose that H2B ubiquitylation recruits 
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the 19S proteasome to promoters, and once transcription begins, the 19S proteasome traverses an 
open reading frame with RNA Pol II to facilitate Set1 and Dot1 (the K4 and K79 
methyltransferases, respectively) activity (EZHKOVA and TANSEY 2004).   
1.4.4.2 Nuclear ubiquitin-protein ligases 
Several nuclear RING domain-containing ubiquitin protein ligases have been 
characterized in yeast. These include Rad5 and Rad18, which direct the ubiquitylation of PCNA 
during DNA damage repair (HOEGE et al. 2002).  The E3s Rad5 and Rad18 recruit the E2s 
Ubc13-Mms2 and Rad6, respectively, to chromatin (BAILLY et al. 1994; ULRICH and JENTSCH 
2000).   Rad6 and Rad18 facilitate monoubiquitylation of proliferating cell nuclear antigen 
(PCNA), and Ubc13-Mms2 and Rad5 facilitate lysine 63-linked polyubiquitylation of PCNA at 
the same lysine residue (HOEGE et al. 2002).  PCNA is a DNA polymerase sliding clamp that 
participates in DNA replication and repair (FUKUDA et al. 1995).  These modifications are 
conserved in yeast and humans, and are required for DNA repair (HOEGE et al. 2002).  While the 
exact mechanism is unclear, the different modification states are proposed to affect the function 
of PCNA (HOEGE et al. 2002).   
 San1 is an E3 that is required for the degradation of certain misfolded nuclear proteins 
(DASGUPTA et al. 2004; GARDNER et al. 2005).  San1 (Sir antagonist 1) was originally identified 
as a suppressor of a mutation in SIR4, a protein required for silencing at telomeres and mating 
loci (RINE and HERSKOWITZ 1987; SCHNELL et al. 1989).  San1 contains a noncanonical 
C3HGC3 RING domain, which possesses ubiquitin-protein ligase activity in vitro (DASGUPTA et 
al. 2004; GARDNER et al. 2005).  A functional understanding of the suppression phenotype came 
when it was shown that mutations in SAN1 stabilize Sir4 protein levels, and that San1, along with 
the E2 Cdc34, is important for targeting mutant Sir4 proteins for destruction by the proteasome 
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(DASGUPTA et al. 2004; GARDNER et al. 2005).  Microarray experiments were performed on 
strains lacking SAN1.  The results show that San1 is not important for the expression of genes 
when the cells are grown in rich medium (DASGUPTA et al. 2004; GARDNER et al. 2005).  
However, when san1Δ strains were grown in minimal medium, the expression of 30 genes is 
affected, with most of these genes encoding proteins involved in cellular stress response 
(GARDNER et al. 2005).  These results suggest that San1 is required to degrade mutant proteins in 
vivo, preventing cellular stress by reducing the buildup of aberrant proteins in the nucleus 
(GARDNER et al. 2005).   
 BRE1 encodes an E3 that, in cooperation with the RING domain protein Lge1, 
ubiquitylates histone H2B at lysine 123 (K123) (HWANG et al. 2003; WOOD et al. 2003a).  The 
significance of this modification is described in more detail in section 1.1.2.2.  In brief, this 
modification is associated with active transcription, and is required for subsequent di- and 
trimethylation of histone H3 at lysines 4 and 79 (WOOD et al. 2003b).   
The conserved Ccr-Not complex contains nine subunits that regulate transcription at 
many levels.  The Not4 subunit of this complex contains a noncanonical C4C4 RING domain 
(HANZAWA et al. 2001).   The E2s Ubc4 and Ubc5 interact with Not4 in a yeast two-hybrid 
screen (ALBERT et al. 2002; WINKLER et al. 2004).  In yeast, Not4 ubiquitylates the EGD 
(enhancer of Gal4 DNA binding) complex, which is composed of the subunits Egd1 and Egd2 
(PANASENKO et al. 2006).  The EGD complex is involved in ribosomal and transcription related 
functions in yeast (MONCOLLIN et al. 1986; PARTHUN et al. 1992; QUELO et al. 2004; ZHENG et 
al. 1990; ZHENG et al. 1987).  Not4 ubiquitylates both subunits, and proper cellular localization 
of Egd2 depends on this modification (PANASENKO et al. 2006).   Interestingly, the Ccr-Not 
complex was recently connected to Paf1 complex-dependent chromatin modification.  The Not 
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proteins were shown to be required for histone H3 lysine 4 trimethylation, but not histone H3 
lysine 79 methylation (MULDER et al. 2007).  Specifically, Not4 is required for histone H2B 
ubiquitylation via recruitment of the Paf1 complex (MULDER et al. 2007), which is required for 
recruitment and activity of Rad6 and Bre1, the proteins that are responsible for ubiquitylating 
H2B at lysine 123 (described in more detail in section 1.2.4.1 and section 1.1.2.2).   
1.5 THESIS AIMS 
A former graduate student in the Arndt lab, Patrick Costa, performed a synthetic lethal screen to 
identify a cellular function for Rtf1.  This screen identified nine complementation groups, eight 
of which are connected to transcription.  These results provided a great deal of support for a role 
for Rtf1 in the regulation of transcription elongation.  This screen also identified a mutation in an 
uncharacterized open reading frame, YMR247c, as synthetically lethal with rtf1Δ.  The goal of 
my thesis work is to characterize this novel gene and to gain an understanding of the function of 
the encoded protein.  Through information obtained in my work, I was able to rename YMR247c 
as RKR1, or RING domain mutant killed by rtf1Δ.  I will refer to this gene as RKR1 throughout 
this document. 
When I began my thesis work, very little information was available regarding RKR1.  I 
performed several experiments that addressed basic questions regarding Rkr1, including 
determining the cellular localization of this protein and extending the genetic analysis to connect 
RKR1 to transcription and Rtf1 function.  I used multiple approaches to gain a functional 
understanding of the role of Rkr1 in vivo, including database analyses, genetic and biochemical 
approaches, as well as microarray analysis to determine if Rkr1 affected global transcription.  All 
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of these approaches characterized a role for Rkr1 as a nuclear ubiquitin-protein ligase that works 
in parallel with Rtf1-dependent histone modifications to affect the expression of a subset of 
genes in yeast.   
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2.0  GENETIC ANALYSIS TO INVESTIGATE A FUNCTION FOR RKR1 
2.1 INTRODUCTION 
Functional analysis of the Paf1 transcription elongation complex has suggested that the Rtf1 
subunit is important for regulating events during transcription.  Much of these data came from 
the dissertation research of Patrick Costa, a former member of the Arndt lab.  This work showed 
that Rtf1 was part of the Paf1 complex and was functionally important for the regulation of 
transcription elongation (COSTA and ARNDT 2000).  Subsequent analyses from other labs 
demonstrated that Rtf1 primarily affects transcription by regulating the post-translational 
modification of histones (NG et al. 2003a; WOOD et al. 2003b; XIAO et al. 2005).  Rtf1 is 
required for histone H2B ubiquitylation at lysine 123 and subsequent methylation of histone H3 
at lysines 4 and 79 (NG et al. 2003a; WOOD et al. 2003b).  These modifications, like Rtf1, are 
associated with actively transcribing genes (POKHOLOK et al. 2005; XIAO et al. 2005).  Rtf1 is 
important for the recruitment and activity of Rad6 and Bre1, which, in association with Lge1, are 
the ubiquitin conjugating enzyme and ubiquitin-protein ligase that are responsible for H2B 
ubiquitylation at lysine 123 (NG et al. 2003a; WOOD et al. 2003b).  Set1 and Dot1 methylate 
histone H3 at lysines 4 and 79 (FENG et al. 2002; SANTOS-ROSA et al. 2002), respectively, only 
after histone H2B is ubiquitylated at lysine 123 (WOOD et al. 2003a).  Therefore, these 
methylation events are also Rtf1-dependent.  
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One method used to gain a better understanding of Rtf1’s function in the cell was a 
synthetic lethal screen.  This screen identified a nonsense mutation in YMR247c as synthetically 
lethal with the loss of RTF1.   Since synthetic lethality often arises from the loss of factors that 
function in parallel pathways (OOI et al. 2006), we predict that Ymr247c functions in parallel 
with Rtf1 to regulate a common, essential process.  The ymr247c mutation that was identified in 
the rtf1Δ synthetic lethal screen is predicted to encode a protein that is truncated at amino acid 
1133 and lacks a conserved RING domain at the extreme carboxy-terminus (see Chapter 3 for 
details).  Because this RING domain is the only identifiable functional domain or motif in the 
protein, we renamed YMR247c as RKR1, or RING domain mutant killed by rtf1Δ.   
Genetic interactions can often provide insight into the function of a gene product in the 
cell.  To gain further insight into which function of Rtf1 is required when Rkr1 is absent, I 
performed extensive genetic analysis through directed crosses.  The results of these analyses 
suggest that Rkr1 functions in parallel with Rtf1-dependent chromatin modifications.   My 
studies do not indicate that Rkr1 directly affects the post-translational modification of histones, 
but loss of Rkr1 disrupts telomeric silencing, a process that depends heavily on the proper 
arrangement of histone modifications in euchromatin and heterochromatin.   
2.2 METHODS 
2.2.1 Genetic methods 
The strains used in this chapter are listed in Table 3.  With the exception of O660 and KA102-
106, OKA91 and OKA92, all strains are isogenic to FY2, a GAL2+ derivative of S288C 
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(WINSTON et al. 1995). RKR1, RTF1, PAF1, BRE1, LGE1, DOT1, SET1 and SET2 disruptions 
were created by a PCR-based method using the HIS3-marked plasmid pRS303 and the kanMX4-
marked plasmid pRS400 (AUSUBEL 1988). The primers used to amplify these deletion cassettes 
are listed in Table 4.  In each case, disruptions were made in diploid strains and confirmed by 
PCR or Southern analysis. Haploid mutant progeny were obtained by tetrad dissection. All 
disruptions remove the entire open reading frame and replace it with the indicated selectable 
marker. Genetic crosses, tetrad analyses, and yeast transformations were performed using 
standard methods (GIETZ and WOODS 2002; ROSE 1990). 
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Table 3. Strains used in Chapter 2. 
Strain Genotype 
FY245 MATa spt4Δ::URA3 ura3-52 trp1Δ63 
FY406 MATa (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 trp1Δ63 [pSAB6 = URA3 HTA1-HTB1 CEN/ARS] 
FY623 MATα rad6Δ::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52 suc2ΔUAS (-
1900/-390) 
FY632 MATa/α his4-917δ/ his4-917δ lys2-173R2/ lys2-173R2 leu2Δ1/ leu2Δ1 
ura3-52/ura3-52 trp1Δ63/ trp1Δ63 
FY896 MATa spt10Δ::TRP1 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
suc2ΔUAS (-1900/-390) 
FY2199 MATa spt21Δ::HIS3 his3Δ200 lys2-128δ leu2Δ0 ura3Δ0 
GHY1094 MATα ctr9Δ::kanMX4 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KA104 MATα TELVR::URA3 lys2-128δ ura3-52 
KA105 MATα spt10Δ201::HIS3 TELVR::URA3 his3Δ200 lys2-128δ ura3(-52 or 
Δ0) trp(1Δ63 or 1-) [pMB27 = SPT10 TRP1 CEN/ARS] 
KA106 MATα spt10Δ201::HIS3 TELVR::URA3 his3Δ200 lys2-128δ ura3(-52 or 
Δ0) trp(1Δ63 or 1-) [pMB27 = SPT10 TRP1 CEN/ARS] 
KA21 MATα srb5Δ::HisG-URA3 his3Δ200 leu2 ura3-52 trp1Δ63 arg4-12 
KY303 MATα his4-912δ lys2-128δ leu2Δ1 ura3-52 
KY423 MATa his3Δ200 ura3-52 trp1Δ63 
KY425 MATa rtf1Δ100::URA3 his4-912δ lys2-128δ ura3-52 
KY581 MATα ctk1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 [pRS316-CTK1] 
KY595 MATa ura3-52 
KY661 MATa his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52 
KY685 MATα paf1Δ::URA3 his4-912δ lys2-128δ leu2Δ(0 or 1) ura3(Δ0 or -52) 
KY714 MATa ppr2Δ::HISG-URA3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY715 MATa spt5-194 his3Δ200 leu2Δ1 ura3-52 
KY766 MATα his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY802 MATa paf1Δ::URA3 his3Δ200 lys2-173R2 ura3(-52 or Δ0) 
KY806 MATa leo1Δ::URA3 his3Δ200 lys2-173R2 ura3-52 
KY811 MATα  (hht1-hhf1)Δ::LEU2 (hht2-hhf2)Δ::kanMX4 his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 trp1Δ63 [pDM1 = HHT2-HHF2 URA3, CEN/ARS] 
 
KY858 MATa spt10Δ201::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 [pFW217 = 
URA3, SPT10, CEN/ARS]  
KY903 MATa dot1Δ::HIS3 his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52 
KY907 MATa set1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY912 MATa set2Δ::HIS3  his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY957 MATa rtf1Δ101::LEU2 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY960  MATa rtf1 Δ::LEU2  rkr1Δ::kanMX4  his4-912δ lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 [pKA69 = RTF1 URA3 CEN/ARS]  
KY968 MATa bre1Δ::kanMX4 his3Δ200 ura3-52 
KY981 MATa  rkr1Δ::kanMX4 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 
lys2-128δ leu2Δ1 ura3-52 trp1Δ63 [pSAB6 = HTA1-HTB1 URA3 
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CEN/ARS] 
KY982 MATa  rtf1Δ::kanMX4 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 
lys2-128δ leu2Δ1 ura3-52 trp1Δ63 [pSAB6 = HTA1-HTB1 URA3 
CEN/ARS] 
KY1023 MATa his3Δ200 trp1Δ63 
KY1064 MATα rkr1Δ::HIS3 (hht1-hhf1)Δ::LEU2 (hht2-hhf2)Δ::kanMX4 his3Δ200 
lys2-128δ, leu2Δ1 ura3-52 trp1Δ63 [pDM1 = HHT2-HHF2 URA3 
CEN/ARS] 
KY1072 MATα siz2Δ::kanMX4 his4-912δ lys2-128δ ura3-52 trp1Δ63 suc2ΔUAS (-
1900/-390) 
KY1123 MATa lge1Δ::kanMX4 rkr1Δ::HIS3 his3Δ200 leu2Δ1 trp1Δ63 
KY1124 MATα lge1Δ::kanMX4 his3Δ200 leu2Δ1 trp1Δ63 
KY1131 MATα bre1Δ::kanMX4 his3Δ200 ura3-52 trp1Δ63 
KY1141 MATa bre1Δ::kanMX4 rkr1Δ::HIS3 his3Δ200 leu2Δ1 
KY1143 MATα rkr1Δ::kanMX4 rtf1-108-110A leu2Δ1 ura3-52 trp1Δ63 
KY1162 MATα cdc73Δ::kanMX4 his3Δ200 leu2Δ0 ura3-52 
KY1163 MATα spt5-242 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY1164 MATα spt6-14 his3Δ200 lys2-128δ leu2Δ1 
KY1165 MATa spt16-197 his3Δ200 his4-912δ leu2Δ1 ura3-52 
KY1166 MATa rkr1Δ::kanMX4 his3Δ200 leu2Δ1 trp1Δ63 
KY1168 MATα rkr1Δ::kanMX4 his3Δ200 trp1Δ63 
KY1171 MATα rkr1Δ::HIS3 his3Δ200 his4-912δ leu2Δ1 
KY1172 MATα rkr1Δ::kanMX4 leu2Δ1 ura3-52 trp1Δ63 
KY1173 MATa/α RKR1/rkr1Δ::HIS3 his3Δ200/ his3Δ200 LEU2/ leu2Δ1 URA3/ 
ura3-52 TRP1/trp1Δ63 
KY1174 MATα rtf1Δ3 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 arg4-12 
KY1175 MATα rtf1Δ4 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 arg4-12 
KY1176 MATα rkr1Δ::HIS3 his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY1177 MATα rkr1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY1178 MATa rkr1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 
KY1179 MATα rkr1Δ::HIS3 his3Δ200 his4-912δ lys2-128δ leu2Δ1 trp1Δ63 
KY1180 MATa rkr1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 trp1Δ63 
KY1222  MATα rkr1Δ::kanMX4 set1Δ::HIS3 his3Δ200  leu2Δ1 ura3-52 [pMB77 = 
rkr1-C1508A LEU2 CEN/ARS] 
MBY21 MATa rkr1Δ::kanMX, his3Δ200 leu2Δ1 
MBY251 MATa rkr1Δ::kanMX4, rtf1Δ3, his4-912δ lys2-128δ leu2Δ1, ura3-52 
trp1Δ63 
MBY260 MATα rkr1Δ::kanMX4 rtf1-102-104A his4-912δ lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 
MBY264 MATa rkr1Δ::kanMX4 rtf1-F123S his4-912δ lys2-128δ leu2Δ1 
MBY30 MATa rkr1Δ::kanMX4 ura3-52 
MBY31 MATα rkr1Δ::kanMX4 his3Δ200, leu2Δ1 trp1Δ63 
MBY36 MATα rkr1Δ::kanMX4 his3Δ200 trp1Δ63 
MBY40 MATα rkr1Δ::kanMX4 his3Δ200 lys2-128δ ura3-52 
MHY178 MATa rtf1Δ3 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
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MHY182 MATa rtf1-102-104A his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
MHY186 MATa rtf1-F123S his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
MHY204 MATα rtf1-108-110A his4-912δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
O660 MATα TELVR::URA3 his3- ura3-52 trp1- 
OKA91 MATα hmra::URA3 his3Δ200, lys2-801, leu2Δ1, ura3-52, trp1Δ63, ade2-
101 
OKA92 MATα hmlα::URA3 his3Δ200, lys2-801, leu2Δ1, ura3-52, trp1Δ63, ade2-
101 
SHY15 MATa rkr1Δ::HIS3 his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52 
SHY16 MATα rkr1Δ::HIS3 his3Δ200 his4-912δ lys2-128δ leu2Δ1 
 
FY, GHY, KY, MBY, MHY and SHY strains were generated in the labs of Fred Winston, Grant 
Hartzog, or Karen Arndt, or made by Maggie Braun, Marcie Warner or Steve Hancock 
respectively.  OKA strains have been obtained from other labs. 
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2.2.2 Plasmids 
pPC65, a pRS314 (SIKORSKI and HIETER 1989) derivative of a library plasmid (pPC62) that was 
obtained through complementation of the SL505 mutation, contains a 7447 bp insert which 
includes tA(AGC)M2 (alanine tRNA), RKR1, SNR86, and part of FAA4.  pMB11 is identical to 
pPC65, except for the addition of the triple HA epitope sequence (3xHA) at the amino terminus 
of Rkr1. To introduce the epitope tag, Stephen Hancock created pSH3 by subcloning the 
XhoI/AatII fragment of pPC65 (containing the promoter/5’ end of RKR1) into pRS406 
(SIKORSKI and HIETER 1989). Stephen Hancock used site-directed mutagenesis (Stratagene 
Quikchange) to introduce an NdeI site at the ATG of RKR1 in pSH3, and I inserted a PCR 
fragment encoding the 3xHA tag flanked by NdeI sites at this site. I subcloned the XhoI/AatII 
fragment back into pPC65 to create pMB11.  pMB26, which contains HTA1, FLAG-htb1-K123R, 
and HIS3, was created by replacing a 737 bp XhoI/SphI fragment from a plasmid (NG et al. 
2002c) containing FLAG-HTB1 with a 737 bp fragment containing htb1-K123R (NG et al. 
2002c). The presence of FLAG-htb1-K123R in pMB26 was confirmed by DNA sequencing. 
Derivatives of pRS314 that contain HHT2 and myc-HHF2 (pNOY436) (KEENER et al. 1997), 
wild-type HHT2 and HHF2 (pJH18) (HSU et al. 2000) or hht2-K4R and HHF2 (BRIGGS et al. 
2001) were described previously.  pMB27, which contains SPT10 and TRP1, was created by 
ligating a 2503 bp SpeI/XhoI fragment from pGN1101 (NATSOULIS et al. 1994) to SpeI/XhoI 
digested pRS314 (SIKORSKI and HIETER 1989). 
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2.2.3 Media 
Rich (YPD), YPGlycerol (YPG), synthetic complete (SC), synthetic dextrose (SD), 5- 
fluoro-orotic acid (5-FOA) and sporulation media were prepared as described (ROSE 1990). 
Media lacking (-Ino) or containing 200 μM inositol (+Ino) were prepared with yeast nitrogen 
base that contained ammonium sulfate but lacked inositol (Q-Bio Systems). NaCl, LiCl, caffeine, 
and hydroxyurea were added to YPD medium to final concentrations of 1.4 M, 0.3 M, 15 mM, or 
100mM, respectively. 6-azauracil (6AU) was added to SC-Ura medium to a final concentration 
of 50 μg/ml. G418 medium for selection of yeast strains expressing the kanMX4 gene was 
prepared as described previously (JAUERT et al. 2005). 
2.2.4 Growth assays  
Saturated cultures of each strain were grown in appropriate media. Cells were collected by 
centrifugation, and cell pellets were washed two times with sterile water. Ten-fold serial 
dilutions (1 x 108 cells/ml to 1 x 104 cells/ml) were made in sterile water and two or three 
microliters of each dilution were spotted onto appropriate media. Spots were allowed to dry and 
plates were incubated at 30oC for 3-5 days. YPD and YPG plates were used in every assay to 
ensure even spotting and to assay for petite cells, respectively.  Specific strains and plasmids 
used in individual experiments are described in the figure legends. 
2.2.5 Sporulation efficiency assay   
Strains KY1177 (rkr1Δ), KY1180 (rkr1Δ), KY766 (WT), and KY423 (WT) were used in these 
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assays.  Liquid sporulation medium (2.45 g potassium acetate in 250 ml ddH2O) was used to 
determine sporulation efficiency.  Amino acids were added to cultures to supplement 
auxotrophies.  Cultures were inoculated and incubated at room temperature overnight prior to 
incubation at 30oC for 2 additional days.  Undiluted, unsonicated cultures were counted with the 
hemacytometer.  Sporulation efficiency was calculated by dividing the number of triads and 
tetrads in 20 squares by the total number of cells in 20 squares.  Cultures were counted 3, 5, and 
8 days post-inoculation.   
2.2.6 Indirect immunofluorescence  
Yeast strain FY632 was transformed with pPC65 (untagged RKR1) or pMB11 (3xHA-RKR1) and 
transformants were grown in SC medium lacking tryptophan to a density of approximately 1 x 
107 cells/ml. A total of 1.4 x 108 cells were processed for indirect immunofluorescence as 
described previously (SIKORSKI and HIETER 1989). The primary antibody, anti-HA (Roche), was 
added at a 1:3000 dilution, and the secondary antibody, Cy3-conjugated goat anti-mouse IgG 
(Molecular probes Alexa Fluor 488), was added at a 1:250 dilution. DAPI (4', 6-diamidino-2-
phenylindole dihydrochloride) was used to stain the DNA, as described previously (PRINGLE et 
al. 1989). Cells were visualized with an Olympus BX60 epifluorescence microscope and 
photographed with QED in vivo software. 
2.2.7 Northern analysis 
MBY30 and KY595 were grown to approximately 1 x 107 cells/ml in SD medium supplemented 
with 200 μM inositol.  Cells were washed into inositol starvation medium and aliquots were 
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taken from the culture for analysis at 2, 4 and 6 hours after induction.  RNA isolation and 
Northern analysis were performed as described previously (SHIRRA and ARNDT 1999).  The 
INO1 probe was synthesized by random-prime labeling of a PCR fragment containing INO1.  
The SCR1 probe (loading control) was synthesized by random-prime labeling of a PCR fragment 
containing SCR1.  Phosphorimaging analysis was performed with Image Gauge software.   
2.2.8 Chromatin immunoprecipitation (ChIP) analysis 
KY811 and KY1064 were transformed with TRP1-marked CEN/ARS plasmids expressing either 
myc-tagged histone H4 (pNOY436) (KEENER et al. 1997) or untagged H4 (BRIGGS et al. 2001).  
Transformants were passaged on medium containing 5FOA to select against the URA3-marked 
plasmid that expressed wildtype histone H4 in these strains.  5FOAR colonies were grown to 0.9–
2.0 x 107 cells/ml (early log-phase) in 250 ml SD minimal medium supplemented with lysine and 
uracil (and histidine for wildtype cultures).  Cells were treated with formaldehyde and collected 
as described previously (SIMIC et al. 2003).  Cells were lysed and the chromatin fraction was 
sonicated to obtain 200-500 basepair chromatin fragments.  Histones were immunoprecipitated 
from 700 µl of chromatin with 2 µl anti-histone H2B (Upstate), 3 µl anti-histone H3 (Abcam), 2 
µl anti-tetra acetylated histone H4 (Upstate), or preconjugated myc-agarose beads (to 
immunoprecipitate histone H4) (Santa Cruz).  Protein-A secondary beads (Amersham 
Biosciences) were used to immunoprecipitate H2B, H3, and tetra-acetylated H4 immune 
complexes.  Immunoprecipitates were washed and DNA was purified from chromatin after the 
crosslinks were reversed with heat.  Quantitative PCR was performed using primers that 
hybridize at chromosomal regions 0.2, 3.5, and 20 kb from the telomere on the right arm of 
chromosome VI, as well as primers that hybridize at the 3’ end of the GAL1 open reading frame 
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(primer sequences can be found in Table 4).  Phosphorimaging analysis was performed with 
Image Gauge software.  Immunoprecipitated (IP) samples were quantitiated relative to input 
signal for each culture.   
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Table 4. Primers used in Chapter 2 studies. 
 
ChIP primer sequence distances are relative to the telomere on the right arm of 
chromosome VI.   
Oligo 
name 
Used for: Sequence (5’ to 3’) 
SHO1 rkr1Δ GGCAAGGTATAGGGCTGGATTGTATAATTTGTAGAGAGCACAGATTG
TACTGAGAGTGCAC 
SHO2 rkr1Δ GTTCAAGCAATAGTTGGTTCTTAATGTCGTTTGGTGGAATCCTGTGCG
GTATTTCACACCG 
MBO34 bre1Δ GTTGGATGGATGTTGTTTGAACGGTAAACTAACAGAGAGCCTGTGCG
GTATTTCACACCG 
MBO35 bre1Δ CTCACCCGGCCGCCCAAAGTATTATATGAATCTTTAGGGCAGATTGTA
CTGAGAGTGCAC 
MBO41 rtf1Δ GATGCCATTGCTGACTTGAA 
MBO42 rtf1Δ CTGAATCTGGCAAAGCCTTC 
MBO97 lge1Δ GTTTTAAGGGGCGGGGCAAGAGTGGCGGGGAATTCCGCCGCTGTGCG
GTATTTCACACCG 
MBO98 lge1Δ CTTGCGTTTACGTAGTTTATCTATTTATAGGTACGGTATACAGATTGT
ACTGAGAGTGCAC 
MBO139 ChIP 0.2 kb CAAGCGGCTGGACTACTTTCTGG 
MBO140 ChIP 0.2 kb CAATTTTATGTAGATATCCACCAC 
MBO141 ChIP 20 kb GGCTGCTTCTATCACTACGCGTC 
MBO142 ChIP 20 kb CGTCTGTGAAAACAGATTTAATG 
MBO151 ChIP 3.5 kb CAACCATCTAGTAGCCAATGTTTGC 
MBO152 ChIP 3.5 kb GATAAAGCAGAATCATTTCCGCTG 
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2.3 RESULTS 
2.3.1 rtf1Δ is synthetically lethal with rkr1Δ 
The Paf1 complex functions in transcription elongation, RNA 3' end formation, and histone 
modification. Original support for a role of the Paf1 complex in transcription elongation came 
from a genetic screen for mutations that cause lethality in combination with an rtf1Δ mutation 
(COSTA and ARNDT 2000).  This screen identified synthetic lethal mutations in CTK1, FCP1, and 
POB3, which encode an RNA Pol II CTD kinase, an RNA Pol II CTD phosphatase, and a 
component of the FACT transcription elongation complex, respectively. In addition to these 
well-characterized RNA Pol II transcription factors, this screen also identified a synthetic lethal 
mutation, the SL505 mutation, in a previously uncharacterized gene, RKR1.  RKR1 is a 4686 bp 
open reading frame that is predicted to encode a protein of 1562 amino acids. Patrick Costa used 
linkage analysis to confirm that RKR1 contained the SL505 mutation, and Steve Hancock 
performed DNA sequence analysis of a gap-repaired plasmid containing the RKR1-SL505 
mutation and showed that it led to a premature stop codon at amino acid 1133 (BRAUN et al. 
2007).   
I confirmed the results of the plasmid-based synthetic lethal screen using tetrad analysis 
of spores derived from diploid strains that were doubly heterozygous for complete deletions of 
RTF1 and RKR1. No viable haploid rtf1Δ rkr1Δ strains were obtained after tetrad dissection 
(Figure 15). This synthetic lethal interaction indicates that Rkr1 and Rtf1 regulate similar 
processes in yeast. 
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Figure 15. Strains lacking RTF1 and RKR1 are inviable. 
Yeast strains of opposite mating types containing deletions of RKR1 (KY1172) or RTF1 
(KY957) were mated and sporulated.  Tetrads were dissected and incubated for 3 days at 30° C.
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To better define why Rtf1 is required for viability when Rkr1 is absent, I took advantage 
of a set of rtf1 internal deletion mutations that disrupt specific functions of the protein (M. H. 
Warner, K. L. Roinick, and K. M. Arndt, submitted for publication).  Discrete regions of Rtf1 are 
important for its association with actively transcribed genes, interactions with other members of 
the Paf1 complex, and post-translational histone modifications. Strains lacking RKR1 and RTF1, 
which were kept alive with a URA3-marked plasmid containing RTF1, were transformed with 
TRP1-marked plasmids containing thirteen individual deletions of RTF1 (#1-13) (Figure 16).  I 
counter-selected the URA3-marked plasmid by growing these transformants on medium 
containing 5-FOA.  Growth defects were seen in rkr1Δ rtf1Δ strains that expressed rtf1Δ1, Δ3, 
Δ4, Δ6, Δ8 or Δ9 (Figure 16).  Strains expressing rtf1Δ1, Δ3 or Δ4 have the most severe growth 
defects, while strains expressing rtf1Δ6, Δ8 or Δ9 grow less well.  This suggests that the 
functions of Rtf1 that are associated with regions 1, 3 and 4 are more important for growth in 
strains lacking RKR1.  The significance of these growth defects will be discussed separately in 
the next few paragraphs.  Interestingly, regions 6-9 are important for the association of the Paf1 
complex with RNA Pol II during transcription (M. H. Warner, K. L. Roinick, and K. M. Arndt, 
submitted for publication), suggesting that low levels of Rtf1 chromatin association provide 
enough function to sustain viability to rkr1Δrtf1Δ strains.   
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Figure 16. Specific regions of Rtf1 are required when Rkr1 is absent. 
A) Thirteen deletion mutations were generated throughout the RTF1 coding sequence (Rtf1Δ1-
13).  Numbers on the left describe the amino acids that are lost with the deletion mutation.  B) 
An rtf1Δ rkr1Δ strain (KY960) was transformed with TRP1-marked plasmids expressing wild 
type RTF1, each of the rtf1Δs, or vector alone (Rtf1Δ11 was omitted for technical reasons).  
Transformants were serially diluted and spotted onto medium containing or lacking 5FOA.  
Plates were incubated at 30° C for 3 days.   
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To confirm the growth defects seen in these transformants, I crossed strains lacking 
RKR1 to strains containing integrated forms of the different rtf1 deletion mutations and found 
that the rtf1Δ3 and rtf1Δ4 mutations, which together eliminate amino acids 62-152 from the Rtf1 
protein, show a strong genetic interaction with rkr1Δ. Specifically, the rkr1Δ rtf1Δ3 and rkr1Δ 
rtf1Δ4 double mutants grow very poorly on minimal synthetic dextrose medium (Figure 17). 
Notably, deletion of amino acids 62-152 in Rtf1 eliminates histone H2B ubiquitylation and 
histone H3 K4 and K79 methylation (M. H. Warner, K. L. Roinick, and K. M. Arndt, submitted 
for publication).  The results of these analyses suggest that Rkr1 functions in parallel with Rtf1-
dependent chromatin modifications.   
Marcie Warner generated several site-directed alanine scanning mutations within the 
region covered by deletions 3 and 4 of Rtf1.  Groups of 3 charged amino acids were mutated to 
alanines with the goal of disrupting protein-protein interaction sites, important for histone 
modification.  In a separate study, Jill Dembowski generated mutations in RTF1 with PCR-based 
mutagenesis, and characterized phenylalanine at position 123 (F123) as being required for 
histone H3 K4 methylation.  To determine whether these residues within Rtf1 are required in the 
absence of Rkr1, I crossed rkr1Δ strains by strains that contained integrated versions of rtf1-102-
104A, rtf1-108-110A, and rtf1-F123S.  Interestingly, rkr1Δ rtf1-108-110A and rkr1Δ rtf1-F123S 
double mutant strains grow poorly on minimal medium, while rkr1Δ rtf1-102-104A double 
mutant strains grow as well as either parent strain on minimal medium (Figure 17).  Marcie 
Warner has shown that strains containing the rtf1-102-104A mutation contain reduced levels of 
H3 K4 methylation, while rtf1-108-110A and rtf1-F123S mutant strains lose this histone 
modification.  Interestingly, the rtf1-102-104A and rtf1-108-110A mutations result in 
approximately a two-fold reduction in histone H3 K79 methylation, and the rtf1-F123S mutation 
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results in approximately a ten-fold reduction in K79 methylation, while strains containing rtf1Δ4 
lose this modification entirely (M. H. Warner and K. M. Arndt, unpublished observations).  
These results further suggest that Rkr1 functions in parallel with Rtf1-dependent histone 
modifications. 
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Figure 17. Genetic interactions suggest that Rkr1 functions in parallel with Rtf1 dependent histone 
modifications. 
Serial dilutions of strains with the genotypes listed on the left of the figure were serially diluted 
and spotted onto SD or SC complete medium.  Plates were incubated at 30° C for 3 days.  Wild 
type and rkr1Δ strains for all panels are a wild type strain derived from crossing KY1023 and 
KY1072, and MBY36, respectively.  Other strains used (top to bottom): MHY178, MBY251, 
MHY182, MBY260, MHY204, KY1143, MHY186, and MBY264, respectively.
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Synthetic growth defects were seen in rkr1Δ rtf1Δ transformants expressing rtf1Δ1.  The 
rtf1Δ1 mutation results in an Rtf1 protein that lacks amino acids 3-30 (Figure 16).  This region of 
Rtf1 is required for a physical interaction with the chromatin remodeler Chd1 (M. H. Warner, K. 
L. Roinick, and K. M. Arndt, submitted for publication).  To confirm the results of the plasmid-
based assay, I also crossed rkr1Δ strains by strains lacking CHD1.  Double mutant strains grow 
very poorly on minimal medium (Figure 18).  This suggests that Rkr1 is important for growth on 
minimal medium in the absence of Chd1 chromatin remodeling activity.  The genetic interaction 
between RKR1 and CHD1 further connects Rkr1 function to chromatin function.   
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Figure 18. Genetic interactions suggest that Rkr1 functions in parallel with Chd1. 
Strains with the genotypes listed on the left were serially diluted and spotted onto SD or SC 
complete medium.  Plates were incubated at 30° C for 3 days.   
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2.3.2 RKR1 is not synthetically lethal with other members of the Paf1 complex or other 
transcription elongation factors 
To determine if the genetic interaction between RKR1 and RTF1 extended to the remaining 
members of the Paf1 complex, strains lacking RKR1 were crossed by strains containing 
mutations in the genes that encode for the individual members of the Paf1 complex.  
Interestingly, although rkr1Δ paf1Δ and rkr1Δ ctr9Δ double mutants grow very slowly, only 
rkr1Δ rtf1Δ double mutants are inviable (Table 5). This result is particularly striking because 
deletion of PAF1 or CTR9 generally causes stronger mutant phenotypes than deletion of any 
other member of the Paf1 complex, including RTF1 (BETZ et al. 2002; SQUAZZO et al. 2002). 
Therefore, the synthetic lethality between RKR1 and RTF1 most likely relates to a function of the 
Paf1 complex that is primarily carried out by Rtf1, potentially histone H2B ubiquitylation or 
histone H3 K4 or K79 methylation.  
The Paf1 complex physically and genetically interacts with several transcription 
elongation factors, including Spt4-Spt5, and Spt16-Pob3 (yFACT) (SQUAZZO et al. 2002). To 
determine if Rkr1 is involved in transcription elongation, I performed genetic crosses with rkr1Δ 
strains and strains containing mutations in genes that encode transcription elongation factors, 
including SPT4, SPT5, SPT6, SPT16 and PPR2, which encodes TFIIS. While I observed several 
enhanced mutant phenotypes in the double mutant strains, I found no severe genetic interactions 
to indicate that Rkr1 is solely or primarily involved in transcription elongation (Table 5). 
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Table 5. Genetic interactions suggest that Rkr1 does not primarily function to promote elongation. 
 
 
 
 
 
 
 
 
a The parents for the crosses in the order listed are: KY1172 and KY957, KY1177 and KY802, 
KY1180 and GHY1094, KY1180 and KY1162, KY1177 and KY806, KY1178 and a strain 
derived from FY245, KY1179 and KY715, KY1180 and KY1163, KY1180 and KY1164, 
KY1179 and KY1165, KY1176 and KY714. 
 
b All phenotypes listed correspond to the synthetic phenotypes observed for the double mutant 
strains. The 6AUS phenotype caused by spt6-14 and the Ino- phenotype caused by rkr1Δ are 
enhanced in the double mutants as indicated. Slow growth, small colonies after 3-5 days of 
growth at 30°C; NaCl-, sensitive to 1.4 M NaCl; LiCl-, sensitive to 0.3 M LiCl; Caff-, sensitive to 
15 mM caffeine. 
Mutationa Phenotypesb 
rtf1Δ rkr1Δ Dead 
paf1Δ  rkr1Δ Slow growth 
ctr9Δ  rkr1Δ Slow growth 
cdc73Δ  rkr1Δ NaCl-, Caff- 
leo1Δ  rkr1Δ None 
spt4Δ  rkr1Δ LiCl- 
spt5-194  rkr1Δ LiCl-, NaCl- 
spt5-242  rkr1Δ LiCl-, NaCl- 
spt6-14  rkr1Δ Increased 6AUS, NaCl-, LiCl- 
spt16-197  rkr1Δ LiCl-, NaCl-, enhanced Ino- 
ppr2Δ  rkr1Δ Caff- 
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2.3.3 Strains lacking RKR1 have phenotypes that suggest a role for Rkr1 in transcription 
and sporulation 
In an attempt to identify a cellular process that requires Rkr1, rkr1Δ strains were exposed to a 
wide range of phenotypic tests.  rkr1Δ mutants were tested for their ability to grow on media 
lacking inositol or on media containing 6-azauracil, caffeine, formamide, hydroxyurea, benomyl, 
sucrose, raffinose, glycerol, or high concentrations of salt (sodium chloride or lithium chloride).  
These strains were also assayed for growth defects at 37° and 15°C on YPD.  For most of these 
phenotypes, the rkr1Δ strains appeared similar to wild type.  However, I observed that rkr1Δ 
strains grow poorly on media lacking inositol, a phenotype associated with general defects in 
transcription (Figure 19) (HAMPSEY 1997).  This phenotype correlates well with the genetic 
interaction with RTF1, as defects in the Paf1 complex also cause inositol auxotrophy (BETZ et al. 
2002). 
Strains that are Ino- often have defects in transcribing INO1, which encodes a protein that 
is important for the production of inositol phosphates and inositol containing phospholipids 
(reviewed in SHIRRA et al. 2005) .  This gene is induced in low inositol conditions, and previous 
studies have shown that loss of other transcription factors, including members of the Paf1 
complex, affect INO1 expression (ARNDT et al. 1995; BETZ et al. 2002; GANSHEROFF et al. 1995; 
ROBERTS and WINSTON 1996; SCAFE et al. 1990).  To better characterize the cause of the poor 
growth on media lacking inositol, I assayed the transcription of INO1 in rkr1Δ strains.  Northern 
analysis shows that, upon induction, INO1 is expressed at similar levels in wild type and rkr1Δ 
strains (Figure 19).  While the cause of the inositol auxotrophy in rkr1Δ strains remains 
unknown, this phenotype appears to be unrelated to defects in INO1 expression.  Further analysis 
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to investigate genome-wide transcription defects in rkr1Δ strains is described in Chapter 5.   
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Figure 19. Strains lacking RKR1 grow poorly on medium lacking inositol. 
A) A rkr1Δ strain (KY1168) was transformed with TRP1-marked plasmids expressing RKR1 or 
empty vector.  Transformants were serially diluted and spotted onto medium that lacked 
tryptophan and either lacked or contained inositol.  Plates were incubated at 30° C for three days. 
B) Wild type (KY661), rkr1Δ (SHY16), and paf1Δ (KY685) strains were grown to early log 
phase in medium containing inositol, and then shifted into medium lacking inositol.  Cells were 
collected at the indicated times and RNA was prepared.  Northern blots were performed with 
probes to INO1 and SPT15 (loading control). A representative Northern blot is shown. C) 
Quantitation of INO1 Northerns.  The results of two independent experiments are shown.  Error 
bars represent the maximum and minimum levels of expression detected in the two experiments.   
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In the process of creating double mutant strains for genetic analysis, rkr1Δ homozygous 
diploids were created.  It was observed that these diploids failed to sporulate.  This finding was 
confirmed by quantitating the sporulation frequency of wild type (RKR1+/RKR1+), heterozygous 
(RKR1+/rkr1Δ) and homozygous (rkr1Δ/rkr1Δ) diploid strains.  The data show that homozygous 
rkr1Δ strains do not sporulate, and heterozygous rkr1Δ strains sporulate at a lower frequency 
compared to wild type strains (Table 6).  Interestingly, diploid strains that contain homozygous 
mutations in genes for the members of the Paf1 complex members also fail to sporulate 
(ENYENIHI and SAUNDERS 2003). 
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Table 6. Strains lacking RKR1 do not sporulate.  
 
Cross Total # cells # Triads/tetrads % Sporulation 
MATa rkr1Δ x MATα rkr1Δ 849 0 0 
MATa rkr1Δ x MATα WT 613 27 4.5 +/- 1.7 
MATa WT x MATα rkr1Δ 449 26 6.7 +/- 3.3 
MATa WT x MATα WT 936 119 11.45 +/- 3.2 
 
Strains used for these crosses are as follows (top to bottom): KY1180 and KY1177, KY1180 and 
KY766, KY423 and KY1177, KY423 and KY766, respectively.  Error values represent the 
difference in percent sporulation in two independently grown cultures of each diploid.   
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2.3.4 Rkr1 is a nuclear protein 
A large-scale study has been performed to determine the subcellular localization of all yeast 
proteins (HUH et al. 2003). This study involved the construction of carboxy-terminal GFP 
fusions for the majority of open reading frames in yeast and microscopy to detect localization of 
the GFP signal. Rkr1 was not localized to any cellular compartment in this study, possibly 
because incorporation of the GFP tag at the carboxy terminus disrupted the structure and/or 
function of the RING domain. Database analyses did not reveal any cellular localization signals 
within the primary amino acid sequence of Rkr1. Therefore, I used indirect immunofluorescence 
to determine the cellular localization of Rkr1. To detect Rkr1, I constructed an amino-terminal 
HA-epitope tagged version of the protein. This tag does not appear to disrupt activity as 
determined by complementation of the Ino- phenotype of a rkr1Δ strain (Figure 20), and 
immunoblotting analysis showed that HA-Rkr1 migrates in denaturing gels at its predicted 
molecular mass of approximately 180 kilodaltons (Figure 20). Indirect immunofluorescence 
experiments showed that HA-Rkr1 is localized to the nucleus (Figure 20). 
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Figure 20. Rkr1 is a nuclear protein. 
A) HA-RKR1 complements a rkr1Δ mutation.  A rkr1Δ strain (KY1168) was transformed with 
TRP1-marked plasmids expressing untagged or HA-tagged RKR1, or empty vector.  
Transformants were serially diluted and spotted onto medium containing tryptophan and either 
lacking or containing inositol.  Plates were incubated at 30° C for 3 days. B) Immunoblot 
analysis shows that HA-Rkr1 is expressed. C) Indirect immunofluorescence analysis shows that 
Rkr1 is a nuclear protein.  See methods section for more information.
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2.3.5 RKR1 genetically interacts with factors involved in chromatin modification 
To further investigate a potential connection between RKR1 and post-translational histone 
modifications, rkr1Δ strains were crossed with strains lacking specific histone modifying 
enzymes.  Rad6 is the ubiquitin-conjugating enzyme and Bre1, in association with Lge1, is the 
ubiquitin-protein ligase required for histone H2B K123 ubiquitylation (HWANG et al. 2003; 
ROBZYK et al. 2000; WOOD et al. 2003a).  Set1, Set2, and Dot1 are the methyltransferases 
responsible for methylating K4, K36, and K79 of histone H3, respectively (FENG et al. 2002; 
SANTOS-ROSA et al. 2002; STRAHL et al. 2002). The Paf1 complex is required for each of these 
modifications (KROGAN et al. 2003a; KROGAN et al. 2003b; NG et al. 2003a; NG et al. 2003b; 
WOOD et al. 2003b).  Interestingly, rkr1Δ rad6Δ double mutants exhibit a strong synthetic 
growth defect (Table 7). Further genetic analysis using strains lacking both RKR1 and the H2B 
ubiquitylation site (htb1-K123R) indicates that Rkr1 is important for cell growth in the absence 
of H2B ubiquitylation (Figure 21). Moreover, rkr1Δ strains lacking BRE1, LGE1, or SET1 grow 
very poorly on SD medium, similar to the rtf1Δ3 or Δ4 genetic interactions (Figure 21 and data 
not shown). Defective growth on SD medium was also observed for a rkr1-C1508A set1Δ double 
mutant strain, indicating a requirement for the Rkr1 RING domain when Set1 is absent (Table 7). 
Because Set1 has been shown to methylate substrates other than histone H3 K4 (ZHANG et al. 
2005b), I examined the phenotype of a rkr1Δ strain in which histone H3 K4 could not be 
methylated (hht2-K4R). Similar to a rkr1Δ set1Δ strain, the rkr1Δ hht2-K4R strain grows poorly 
on SD medium (Figure 21), suggesting that the synthetic phenotype between rkr1Δ and set1Δ is 
due to a lack of histone H3 K4 methylation. 
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Table 7. Genetic interactions between RKR1 and genes encoding proteins involved in chromatin 
modification. 
 
 
 
 
 
 
 
 
a Double mutants were generated from the following genetic crosses unless stated otherwise: 
KY1166 and KY1174, KY1166 and KY1175, MBY30 and FY623, KY1171 and KY968, the 
lge1Δ was created in a RKR1/rkr1Δ diploid (KY1173) prior to sporulation and tetrad dissection, 
KY1168 and KY907, the set1Δ rkr1-C1508A double mutant (KY1222) was generated by 
transformation, KY1168 and KY903, KY1168 and KY912, FY896 and KY1168, and FY2199 
and KY1168. 
 
b All phenotypes listed correspond to the synthetic phenotypes observed for the double mutant 
strains. SD-, poor growth on SD media; Slow growth, small colonies after 7 days of growth at 
30o C on YPD; Gly-, inviable on YP glycerol media; HUS, sensitive to 100 mM hydroxyurea; 
NaCl-, sensitive to 1.4 M NaCl. 
 
c Growth on SD medium was the only phenotype tested for this double mutant. 
 
Genotypesa Phenotypesb 
rtf1Δ3 rkr1Δ SD- 
rtf1Δ4 rkr1Δ SD- 
rad6Δ rkr1Δ Slow growth, SD-, Gly- 
bre1Δ rkr1Δ SD-, Gly- 
lge1Δ rkr1Δ SD- 
set1Δ rkr1Δ SD-, HUS, NaCl- 
set1Δ rkr1-C1508A SD-c 
dot1Δ rkr1Δ None 
set2Δ rkr1Δ None 
gcn5Δ rkr1Δ NaCl-. Enhanced Ino- 
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Figure 21. Genetic interactions between RKR1 and genes that encode proteins that affect histone H2B 
ubiquitylation and histone H3 K4 methylation.  
A) Wild type (KY406), rtf1Δ (KY982), and rkr1Δ (KY981) strains that lacked the genomic 
copies of histone H2B genes were transformed with URA3-marked plasmids expressing either 
wildtype or K123R derivatives of a gene encoding histone H2B (HTB1).  Transformants were 
serially diluted and spotted onto medium either containing or lacking 5FOA.  Plates were 
incubated at 30° C for 3 days. B) Strains with the genotypes listed on the left were serially 
diluted and spotted onto SD or SC complete medium.  Plates were incubated at 30° C for 3 days.  
Strains used (from top to bottom): KY595, MBY31, KY1124, KY1123, a wild type strain 
derived from crossing KY1023 and KY1072, MBY36, KY1131 and KY1141, respectively.  C) 
Wild type (KY811) and rkr1Δ (KY1064) strains that lacked the genomic copies of histone H3 
genes were transformed with TRP1-marked plasmids expressing either wild type or K4R 
derivatives of a gene encoding histone H3 (HHT2).  Transformants were serially diluted and 
spotted onto SD or SC complete medium.  Plates were incubated at 30° C for 3 days. 
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While deletion of RKR1 causes significant growth defects in strains defective for histone 
H2B K123 ubiquitylation or H3 K4 methylation, Rkr1 itself does not appear to affect these 
modifications.  Histone H3 K4 trimethylation and K79 dimethylation as well as histone H2B 
K123 ubiquitylation occur at wild-type levels in strains lacking RKR1 (Figure 22). Taken 
together, my findings suggest that Rkr1 acts in parallel with Rtf1-dependent histone 
modifications. 
 Although many strong genetic interactions between Rkr1 and factors that are important 
for some Rtf1-dependent histone modifications are observed, RKR1 does not genetically interact 
with all factors involved in histone modification.  Interestingly, while histone H3 K4 and K79 
methylation both require histone H2B K123 ubiquitylation, no strong genetic interactions were 
observed in rkr1Δ dot1Δ double mutant strains.  Paf1 and Ctr9 are required for histone H3 K36 
trimethylation (KROGAN et al. 2003b), which is found on histones in active genes (POKHOLOK et 
al. 2005); however, no strong genetic interactions were observed in rkr1Δ set2Δ double mutant 
strains. Furthermore, rkr1Δ gcn5Δ double mutant strains show only mild phenotypes (Table 7).  
Gcn5 is the catalytic subunit of the SAGA histone acetyltransferase complex (RUIZ-GARCIA et 
al. 1997), and its modifications are associated with transcriptional activity (POKHOLOK et al. 
2005).  These data further support the idea that Rkr1 functions in parallel with specific Rtf1-
dependent histone modifications and not all histone modifications that are associated with active 
transcription.   
 142 
Figure 22. Rtf1-dependent histone modifications are not dirupted in rkr1Δ strains. 
A) Wild type (KY943), rkr1Δ (KY981), and rtf1Δ (KY982) strains that lacked the genomic 
copies of histone H2B were transformed with plasmids that express either untagged wild type 
H2B, FLAG-tagged wild type H2B, or FLAG-tagged H2B–K123R, as well as plasmids that 
express HIS-tagged ubiquitin.  Ubiquitylated proteins were isolated using a nickel resin and 
enriched proteins were separated on a 7-20% gradient SDS-PAGE gel.  Immunoblot analysis was 
performed using antibodies to FLAG-H2B.  Experiments using untagged ubiquitin were 
performed in parallel and no FLAG signal was detected using immunoblot analysis (data not 
shown).  B) Wild type (KY303), rtf1Δ (KY425) and rkr1Δ (SHY15) strains were grown in rich 
medium and cell lysates were collected.  Immunoblot analysis was performed with antibodies 
specific to histone H3 K4 trimethylation, anti-histone H3 K79 dimethylation, and ribosomal 
protein L3 (loading control).  
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2.3.6 Strains lacking RKR1 have defects in telomeric silencing 
Transcriptional silencing of genes that are positioned near telomeres requires a particular histone 
modification profile. Telomeric chromatin is enriched in hypo-acetylated and hypo-methylated 
histones, which provide interaction sites for the Sir proteins (reviewed in RUSCHE et al. 2003)). 
Strains lacking Paf1 complex members exhibit defects in telomeric silencing (KRISHNAMURTHY 
et al. 2004; NG et al. 2003a), most likely because the genome-wide loss of histone H3 
methylation leads to the redistribution of Sir proteins away from their normal sites of action 
(SANTOS-ROSA et al. 2004).  To determine if Rkr1 is important for telomeric silencing, wild-type 
and rkr1Δ strains that contain a telomeric URA3 reporter gene were constructed.   These strains 
were serially diluted and plated to medium containing 5-FOA.  Wild-type strains grow robustly 
on this medium, indicating silencing of the telomeric URA3 reporter (Figure 23). However, 
strains lacking RKR1 grow poorly on the 5-FOA medium, suggesting that telomeric silencing is 
disrupted in the rkr1Δ strains (Figure 23).  In contrast, transcriptional silencing at the rDNA and 
silent mating type loci occur normally in rkr1Δ strains (Figure 23 and data not shown).  These 
regions utilize different mechanisms to facilitate silencing (described in the section 1.3.4), which 
may explain why Rkr1 only affects one type of silencing.  A role in telomeric silencing is 
consistent with the idea that Rkr1 modulates chromatin structure or function. 
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Figure 23. Strains lacking RKR1 have telomeric silencing defects. 
A) The telomeres of all chromosomes are silenced by the Sir family of proteins.  See section 
1.3.4.1 of the Introduction for additional information.  B) Wild type and rkr1Δ strains that 
contained the URA3 gene positioned near the right arm of chromosome VI (O660, KA105 and 
KA106, respectively) were serially diluted and spotted onto medium that either contained or 
lacked 5FOA.  Strains were incubated at 30° C for 3 days.  C) The mating loci in yeast are 
subject to silencing by the Sir proteins.  See Introduction for additional information.  D) Wild 
type (OKA91 and OKA92), rtf1Δ and rkr1Δ strains (derived from OKA91 and OKA92) that 
contained the URA3 gene positioned near the HML or HMR locus were serially diluted and 
spotted onto medium that either contained or lacked 5FOA.  Strains were incubated at 30° C for 
3 days.  rtf1Δ strains serve as positive controls for HM silencing assay.  HMR silencing is more 
easily perturbed due to differences in the way the URA3 gene was integrated at the HMR and 
HML loci  (SINGER et al. 1998).   
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2.3.6.1 Histone deposition at telomeres is not affected in rkr1Δ strains 
In an attempt to determine the cause of the telomeric silencing defects in rkr1Δ strains, 
histone deposition at telomeres was quiantified in wild type and rkr1Δ strains.  Using chromatin 
immunoprecipitation (ChIP) analysis, the levels of histones H2B, H3 and myc-tagged H4 were 
determined at three different distances (0.2 kb, 3.5 kb, and 20 kb) from the telomere on the right 
arm of chromosome VI (Figure 24).  As a control, the levels of histones at the GAL1 gene were 
quantified. This gene is strongly repressed in the glucose conditions used for this experiment and 
therefore should be associated with high levels of histones.  The results show that histone 
deposition at telomeres is not reduced in rkr1Δ strains (Figure 24).  The levels of histones at the 
telomeres are similar to the levels found at the repressed GAL1 gene (data not shown).  While the 
cause of the telomeric silencing defect is currently unknown, it appears to not be due to loss of 
the core histones at telomeric regions.   
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Figure 24.  Histone deposition at telomere VI is not affected by the loss of Rkr1. 
Wild type (KY811) and rkr1Δ (KY1064) strains were transformed with plasmids expressing 
either myc-tagged histone H4 or untagged histone H4.  ChIP experiments were performed using 
antibodies directed towards myc-tagged histone H4 and total H3.  Radioactive PCR was 
performed using primers that amplify sequences at 0.2, 3.5 and 20 kb from the telomere.  Signals 
for myc-H4 and total H3 were quantitated relative to input.  H3 data represent results from 3 
independent experiments, and myc-H4 data represent the results from 2 independent 
experiments.  Error bars represent the standard error in H3 ChIP experiments.   
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2.3.6.2 Telomeric histone H4 acetylation is not affected by the loss of RKR1 
Telomeric silencing is a process that depends heavily on the proper modification of 
histones (reviewed in RUSCHE et al. 2003)).  Silenced regions are hypomethylated and 
hypoacetylated, and this hypo-modified state is maintained by the Sir proteins (reviewed in 
section 1.3).  Specifically, Sir2 is a histone deacetylase (HDAC) that reduces histone H4 
acetylation in silenced regions (IMAI et al. 2000).  To determine if Sir2 function was disrupted in 
rkr1Δ strains, ChIP analysis was performed with anti-tetra-acetylated histone H4 antibody.  The 
same primer sets described in the previous section (0.2, 3.5 and 20 kb from the telomere) were 
used to amplify DNA that was immunoprecipitated as part of acetylated nucleosomes.  As 
expected, histone acetylation increases in correlation with increasing distance from the telomere 
(Figure 25).  However, histone H4 acetylation at the telomeres is not disrupted in rkr1Δ strains 
(Figure 25).  Therefore, the mechanistic basis for the telomere silencing defect of rkr1Δ strains 
remains unknown and will require further investigation. 
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Figure 25. Histone H4 acetylation at telomere VI is not affected by the loss of Rkr1.  
Chromatin immunoprecipitation experiments were performed in wild type (KY811) and rkr1Δ 
(KY1064) strains using antibodies directed towards tetra-acetylated histone H4 (K5, K8, K12 
and K16 acetylated) and total H3.  Radioactive PCR was performed using primers that amplify 
sequences at 0.2, 3.5 and 20 kb from the telomere.  Signals for acetylated H4 and total H3 were 
quantitated relative to input, and Ac H4 signal was calculated relative to total H3. 
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2.3.7 RKR1 genetically interacts with other factors involved in transcription 
While much of the information that I have discussed so far suggests that Rkr1 is functionally 
connected to specific Rtf1-dependent chromatin modifications, I have also uncovered other 
genetic interactions that support a role for Rkr1 in chromatin function and transcription.  While 
providing more insight into the role of Rkr1 in vivo, these studies are still at their beginning 
stages, and will require more work to fully understand their meaning.   
2.3.7.1 Deletion of RKR1 is synthetically lethal with a deletion of SPT10, a gene encoding a 
potential histone acetyltransferase 
SPT10 is one of many SPT genes that were originally identified in a screen for 
suppressors of transposable element insertion mutations in yeast (FASSLER and WINSTON 1988; 
NATSOULIS et al. 1994). Strains lacking Spt10 exhibit global changes in chromatin structure and 
gene expression (ERIKSSON et al. 2005; XU et al. 2005). Spt10 and its interacting partner Spt21 
bind to the promoters of histone genes and activate their transcription, providing a potential 
explanation for the broad transcriptional effects of spt10 mutations (DOLLARD et al. 1994; 
ERIKSSON et al. 2005; HESS et al. 2004; XU et al. 2005). Interestingly, Spt10 contains a predicted 
acetyltransferase domain (NEUWALD and LANDSMAN 1997) that is required for its transcription 
activation activity (HESS et al. 2004), and spt10 mutants have reduced histone H3 K56 
acetylation at histone gene promoters (XU et al. 2005). However, direct acetylation of histones 
by Spt10 has yet to be demonstrated (HESS et al. 2004; XU et al. 2005), and recent studies 
indicate that global levels of histone H3 K56 acetylation are greatly reduced in strains lacking 
Rtt109 or Asf1 (DRISCOLL et al. 2007; HAN et al. 2007a; HAN et al. 2007b; TSUBOTA et al. 
2007), but not Spt10 (SCHNEIDER et al. 2006b). A synthetic lethal screen involving spt10Δ 
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identified mutations in RKR1 (D. Hess and F. Winston, personal communication). I confirmed 
this result by tetrad analysis using complete deletions of RKR1 and SPT10 (Figure 26). 
Because Spt10 has a well-studied role in histone gene transcription, Elia Crisucci 
measured histone mRNA levels in a rkr1Δ strain using RT-PCR analysis and oligonucleotide 
primers that distinguish among the highly related histone genes (HESS et al. 2004).  Elia found 
that all of the histone genes are expressed at nearly wild-type levels in the rkr1Δ strain (BRAUN 
et al. 2007), while HTA2, HTB2, and HHF2 mRNA levels are significantly decreased in the 
spt10Δ strain, as expected from earlier studies (ERIKSSON et al. 2005; HESS et al. 2004).  I 
confirmed by immunoblotting analysis that histone H2B, H3, and H4 levels are unaffected by the 
rkr1Δ mutation (Figure 26; H2A levels were not tested).  Therefore, the inviability of rkr1Δ 
spt10Δ double mutant strains is most likely not due to insufficient histone gene expression.  
Consistent with this idea, rkr1Δ spt21Δ double mutants are viable (Table 7), even though spt21Δ 
and spt10Δ mutations both reduce histone mRNA levels (DOLLARD et al. 1994; HESS et al. 
2004). 
To determine if Rkr1 is essential in the absence of Spt10 because histone H3 K56 
acetylation is defective, I performed a plasmid shuffle experiment with RKR1+ and rkr1Δ strains 
that lacked both chromosomal copies of the genes for histones H3 and H4 and carried a URA3-
marked HHT2-HHF2 CEN/ARS plasmid. Cells were transformed with a TRP1-marked plasmid 
that expressed a histone H3 derivative in which K56 was replaced with arginine or glutamine 
(MASUMOTO et al. 2005).  Following growth on synthetic medium containing 5-FOA, the histone 
H3 K56R or K56Q derivative was the only version of histone H3 available in the cell. The 
results of the plasmid shuffle revealed that rkr1Δ strains grow as well as RKR1+ strains in the 
presence of the histone H3 K56R and K56Q derivatives (Figure 26). In addition, histone H3 K56 
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acetylation occurs at wild-type levels in rkr1Δ cells (Figure 26). Therefore, the basis for the 
synthetic lethality between rkr1Δ and spt10Δ remains unclear but it appears not to be related to 
Spt10's proposed role in histone H3 K56 acetylation (XU et al. 2005).   
Since loss of Rkr1 or Rtf1 alleviates telomeric silencing, I wanted to determine if loss of 
SPT10 also causes this phenotype. Strains lacking SPT10 and containing the telomeric URA3 
reporter gene were constructed and plated on 5-FOA medium to monitor URA3 expression.  
Consistent with a role for Spt10 in chromatin structure or function, the spt10Δ strains grow 
extremely poorly in the presence of 5-FOA, indicating a strong defect in telomeric silencing 
(Figure 26). 
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Figure 26.  rkr1Δ is synthetically lethal with spt10Δ. 
A) rkr1Δ (MBY40) and spt10Δ (FY896) strains of opposite mating types were mated and 
sporulated.  Tetrads were dissected and incubated at 30° C for 5 days.  B) Immunoblot analysis 
of histone levels show that the core histones are expressed at wild type levels in a rkr1Δ strain.  
Immunoblot analysis using antibodies toward the ribosomal protein L3 serve as a loading control 
for the FLAG-H2B immunoblot.  Asterisks represent cross-reacting bands that serve as loading 
controls for the H3 and myc-H4 immunoblots.  C) Plasmid shuffle experiment shows that rkr1Δ 
is not essential in the absence of histone H3 K56 acetylation.  D) Immunoblot analysis shows 
that histone H3 K56 acetylation is not defective in rkr1Δ strains.  The anti-K56 Ac antibody was 
the kind gift of Dr. Alain Verrault (University of Montreal).  E) Strains lacking SPT10 have 
telomeric silencing defects.  Wild type (KA104) and spt10Δ (KA106 and KA105) strains that 
contain the telomeric URA3 gene were serially diluted and spotted onto medium containing 
5FOA or control medium.  Plates were incubated at 30° C for 5 days. 
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2.3.7.2 RKR1 shows genetic interactions with other transcription factors that were 
identified in the synthetic lethal screen with rtf1Δ 
Patrick Costa identified nine complementation groups in his synthetic lethal screen with 
rtf1Δ (Table 8).  These groups, except for the group containing RKR1, contained genes that all 
suggested Rtf1 was important for the regulation of transcription.  Genetic analysis was used to 
determine if Rkr1 was functionally connected to any of the other genes that were identified in the 
rtf1Δ synthetic lethal screen.  Interestingly, rkr1Δ is synthetically lethal with srb5Δ  (Figure 27).  
Srb5 is a component of the Mediator complex, which is important for establishing connections 
between transcriptional activators and the general transcription machinery (reviewed in section 
1.2.3.3).  This genetic interaction suggests that Rkr1 may play a role in the regulation of 
transcription initiation. 
In the course of these genetic studies, I observed that rkr1Δ ctk1Δ strains are very slow 
growing (Figure 27).  Ctk1 is a kinase that is primarily responsible for phosphorylating the 
carboxy-terminal domain (CTD) of the largest subunit of RNA Pol II (Rpb1) (PATTURAJAN et al. 
1999).  The CTD in yeast is composed of 26 tandem copies of a heptapeptide repeat (YSPTSPS).  
Ctk1 phosphorylates the serine at position two of the repeat.  This modification occurs while the 
polymerase is at the 3’ end of transcribing genes and is important for the proper recruitment of 
many factors that are involved in late stages of mRNA processing, including the poly-
adenylation factors (AHN et al. 2004).   The cause of this interesting genetic interaction remains 
unknown, but supports a role for Rkr1 in RNA Pol II transcription elongation. 
Double mutant strains were constructed that contain rkr1Δ and arg82Δ, plc1Δ, swi4Δ, 
swi6Δ, or fcp1-110 mutations (data not shown).  No detectable phenotypes were observed in the 
double mutants.  Due to the genetic instability of pob3-272 strains, genetic interactions were not 
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tested between RKR1 and POB3. 
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Table 8. List of genes that are synthetically lethal with rtf1Δ. 
 
 
 
 
Complementation group (# isolates) Gene Function 
A (4) SWI6 Transcriptional activator 
B (2) SWI4 Transcriptional activator 
C (2) PLC1 Signal transduction 
D (1) SRB5 Mediator component 
E (1) CTK1 Pol II CTD kinase 
F (1) FCP1 Pol II CTD phosphatase 
G (1) POB3 FACT, elongation factor 
H (1) ARG82 Signal transduction 
I (1) RKR1 Ubiquitin-protein ligase, 
Functionally connected to 
chromatin function 
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Figure 27. rkr1Δ is synthetically lethal with srb5Δ and rkr1Δ ctk1Δ strains grow very poorly 
A) rkr1Δ (KY1178) and srb5Δ (KA21) strains of opposite mating types were mated and 
sporulated.  Tetrads were dissected and incubated at 30° C for 4 days.  B) A ctk1Δ strain that was 
transformed with a URA3-marked plasmid expressing CTK1 (KY581) was crossed to a rkr1Δ 
(MBY21) strain of opposite mating type.  The resulting diploid was plated to medium containing 
5-FOA to counter-select for the URA3-marked CTK1 plasmid.  The resulting ura3- strain was 
sporulated.  Tetrads were dissected and incubated at 30° C for 7 days.   
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2.4 CONCLUSIONS 
To try to determine a function for Rkr1 in vivo, we turned to the “awesome power of yeast 
genetics”.  Strains lacking RKR1 have phenotypes that indicate that Rkr1 globally affects 
transcription and sporulation (inositol auxotrophy and Spo-, respectively).  Indirect 
immunofluorescence experiments show that Rkr1 is a nuclear protein.  The results of Patrick 
Costa’s synthetic lethal screen were confirmed to show that rkr1Δ is synthetically lethal with 
rtf1Δ.  Further analysis suggests that Rkr1 functions in parallel with Rtf1-dependent histone 
modifications.  Strains lacking RKR1 in combination with RAD6, BRE1, or LGE1 are sick and 
grow poorly on minimal medium.  Strains lacking RKR1 where histone H2B ubiquitylation at 
K123 is disrupted exhibit a strong growth defect, suggesting that Rkr1 functions in parallel with 
histone H2B K123 ubiquitylation.  Also, rkr1Δ set1Δ strains grow poorly on minimal medium, 
but rkr1Δ dot1Δ strains show no detectable phenotypes.  These observations suggest that Rkr1 
functions in parallel with histone H3 K4 methylation but not histone H3 K79 methylation, yet 
both of these modifications depend on histone H2B K123 ubiquitylation (Figure 28).   
Strains lacking Paf1 complex members have defects in telomeric silencing, due to loss of 
global histone H3 methylation marks (SANTOS-ROSA et al. 2004).  My results indicating that 
strains lacking RKR1 also have this phenotype support the idea that Rkr1 affects chromatin 
modifications and/or function.  Histone H4 acetylation at the telomere is found at similar levels 
in wildtype and rkr1Δ strains; and histone deposition at the telomeres is not affected in rkr1Δ 
strains.   The cause of the telomeric silencing defect in a rkr1Δ strain is therefore unknown. 
No genetic interactions were found to suggest that Rkr1 functions primarily in 
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transcription elongation.  While rkr1Δ paf1Δ and rkr1Δ ctr9Δ strains are sick, strains lacking 
RKR1 and other elongation factors like CDC73, LEO1, SPT4, SPT5, SPT6, SPT16 or TFIIS do 
not show strong synthetic phenotypes.  The synthetic lethality between RKR1 and RTF1 suggests 
that Rkr1 functions in parallel with a role of the Paf1 complex that is primarily carried out by 
Rtf1, most likely histone H2B ubiquitylation and histone H3 K4 methylation.   
Preliminary results from the Winston lab were confirmed to show that strains lacking 
RKR1 and SPT10 are inviable.  This result suggests that this strong genetic interaction is 
probably not due to the known roles for Spt10 (histone gene expression and K56 acetylation), 
and may instead be due to an as-yet-undiscovered role of Spt10.  While I have shown that strains 
lacking RKR1 have wild type histone mRNA and histone protein levels, histone deposition in the 
genome or subsequent modification may be disrupted in these strains.  My analysis shows that 
histone H3 K56 acetylation occurs at wild type levels in rkr1Δ strains.  Strains lacking SPT10 or 
RKR1 have defects in telomeric silencing, a process that depends heavily on proper chromatin 
structure.  These data further support a role for Rkr1 in chromatin structure and/or function. 
I also observe genetic interactions between rkr1Δ and srb5Δ and ctk1Δ.  Strains lacking 
RKR1 and SRB5 are inviable, while strains lacking RKR1 and CTK1 are sick.  Srb5 is a subunit 
of the Mediator coactivator complex and Ctk1 is a kinase that targets the CTD of RNA Pol II.  
While further characterization is needed to fully understand the meaning of these interactions, 
they functionally connect Rkr1 to transcription.     
 165 
Figure 28. Model for Rkr1 function based on genetic interactions. 
Based on the genetic interactions described in Chapter 2, I believe that Rkr1 functions in parallel 
with Rtf1-dependent histone modifications to affect chromatin structure and/or function.  
Specifically, Rkr1 appears to function in parallel with histone H2B ubiquitylation and histone H3 
K4 methylation, but not histone H3 K79 methylation.  Rad6/Bre1/Lge1 and Set1 are the H2B 
ubiquitylation machinery and the H3 K4 methyltransferase, respectively.   
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3.0  FUNCTIONAL ANALYSIS OF RKR1 USING DATABASE ANALYSIS AND IN 
VITRO ASSAYS 
3.1 INTRODUCTION 
Covalent attachment of ubiquitin to a substrate protein requires the coordinated functions 
of a ubiquitin-activating enzyme, a ubiquitin-conjugating enzyme, and a ubiquitin-protein ligase 
(reviewed in FANG and WEISSMAN 2004). While yeast contain only one ubiquitin-activating 
enzyme and eleven ubiquitin-conjugating enzymes, there are many predicted ubiquitin-protein 
ligases, consistent with their proposed roles in determining substrate specificity (reviewed in 
PICKART 2001). Ubiquitin-protein ligases contain functional domains known as RING or HECT 
domains that interact with ubiquitin-conjugating enzymes (HUIBREGTSE et al. 1995; LORICK et 
al. 1999). Several nuclear RING domain-containing ubiquitin-protein ligases have been 
characterized in yeast. These include Rad5 and Rad18 which direct the ubiquitylation of PCNA 
during DNA damage repair (HOEGE et al. 2002), San1 which is required for the degradation of 
certain misfolded nuclear proteins (DASGUPTA et al. 2004; GARDNER et al. 2005), Bre1 which 
ubiquitylates histone H2B at K123 (HWANG et al. 2003; WOOD et al. 2003a), and Not4 which is 
a component of the multi-functional Ccr4-Not complex (PANASENKO et al. 2006). 
In parallel with the studies described in Chapter 2, I performed several database analyses 
to identify functional domains or motifs within the primary amino acid sequence of Rkr1.  These 
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analyses show that Rkr1 contains a conserved RING domain at its extreme carboxy terminus.  I 
show that this RING domain is required for Rkr1’s in vivo function, and that this domain has 
ubiquitin-protein ligase activity in vitro.  This information, combined with results that I 
described in Chapter 2, suggests that Rkr1 may use its ubiquitin-protein ligase activity to 
ubiquitylate nuclear proteins, which directly or indirectly affect chromatin modifications or 
function. 
3.2 METHODS 
3.2.1 Plasmids 
Standard cloning techniques were used to construct all plasmids (AUSUBEL 1988).  pMB66 was 
created by site-directed mutagenesis using pMB11 (described in section 2.2.2) as a template to 
replace cysteine 1508 of Rkr1 with alanine.  pMB30 was created by ligating a 1137 bp blunt-
ended BanI/StuI fragment from pPC65 to SmaI digested pGEX-3X (SMITH and JOHNSON 1988) 
to generate a GST fusion protein containing amino acids 1251-1562 of Rkr1.  pMB81 was 
created by site-directed mutagenesis of pMB30, replacing cysteine 1508 of Rkr1 with an alanine.  
pMB81 was sequenced throughout the RKR1 ORF to ensure that no secondary mutations were 
created. 
 
3.2.2 Media 
Media lacking (-Ino) or containing 200 μM inositol (+Ino) were prepared with yeast nitrogen 
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base that contained ammonium sulfate but lacked inositol (Q-Bio Systems).  Ampicillin was 
added to Luria Broth (LB) medium as necessary to a final concentration of 50 µg/ml.   
3.2.3 Sequence analysis.  
PROSITE (http://ca.expasy.org/prosite) sequence analysis tools were used to predict the presence 
of any functional motifs or domains within the primary amino acid sequence of Rkr1. A RING 
domain is predicted at the carboxy terminus of Rkr1, consisting of amino acids 1508-1554. The 
sequence alignment in Figures 29 and 30 were obtained from BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST) searches, using S. cerevisiae Rkr1 protein sequence in its 
entirety as the query. Sequences of the most similar proteins from H. sapiens (accession # 
NP_056380.1; E value = 4 e-41), M. musculus (accession # XP_982690.1; E value = 7 e-42), D. 
melanogaster (accession # NP_730427; E value = 1 e-21), A. thaliana (accession # 
NP_200649.1; E value = 2 e-36), and S. pombe (accession # CAA20765.1; E value = 3 e-51) 
were aligned with S. cerevisiae Rkr1 sequence using the Clustal W program 
(http://www.ebi.ac.uk/clustalw). The alignments were copied into Jalview 
(http://www.jalview.org) and purple shading was added using a threshold of 50% sequence 
identity. 
3.2.4 Growth assays 
Growth assays were performed as described in the methods section of Chapter 2 (section 2.2). 
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3.2.5 Immunoblotting analysis.  
Transformed cells were grown under selective conditions to a density of approximately 4 x 107 
cells/ml. Whole cell extracts were prepared by glass bead lysis in lysis buffer (100 mM sodium 
acetate, 20 mM HEPES, pH 7.4, 2 mM magnesium acetate, 10 mM EDTA, 10% glycerol, 1 mM 
DTT, plus protease inhibitors), as previously described (SHIRRA et al. 2005).  Proteins (25 μg 
extract per lane) were separated on 7.5% SDS polyacrylamide gels and transferred to 
nitrocellulose membranes. The following antibodies were used: anti-HA (1:3000 dilution; 
Roche), anti-L3 (1:5000 dilution) (VILARDELL and WARNER 1997), anti-FLAG M2 (1:1000; 
Sigma), anti-ubiquitin (1:50) (KAHANA and GOTTSCHLING 1999), anti-GST (1:500; Invitrogen).  
HRP-conjugated secondary antibodies (Amersham Biosciences) were used at a 1:5000 dilution. 
Immunoreactive proteins were detected by chemiluminescence (Perkin Elmer) and visualized 
with a Kodak 440CF digital imaging station. 
3.2.6 Purification of recombinant proteins.   
BL21 (DE3) cells were transformed separately with plasmids expressing wild type (pMB30) or 
mutant (pMB81) GST-Rkr1 fusion proteins, or GST alone (pGEX-3X). Cells were grown at 
37°C and induced for 1.5 hours at OD600 of 0.6-0.7 with 0.3 mM IPTG. Cell lysates were made 
by sonication in a buffer containing 50 mM Tris-Cl, pH 8.0 and 1 mM EDTA as described 
previously (DASGUPTA et al. 2004). Lysate (10 ml) was incubated for 1 hr at 4o C with 1 ml 
prewashed GST Sepharose beads in the presence of 1% Triton X-100 and protease inhibitors. 
Sepharose beads were pelleted and washed 3 times with phosphate-buffered saline (PBS) pH 7.3 
(AUSUBEL 1988) plus 10% glycerol, 1% Triton X-100 and protease inhibitors. Fusion proteins 
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were eluted in PBS plus 1% Triton X-100 and 50 mM glutathione for 10 minutes at room 
temperature.  Eluate protein amounts were estimated by comparing Coomassie staining 
intensities of eluted proteins to those of known amounts of BSA.   
3.2.7 In vitro ubiquitylation assays 
Ubiquitylation assays were performed as previously described (GARDNER et al. 2005), with some 
modifications. Ubiquitin-activating enzyme (yeast recombinant Uba1), ubiquitin-conjugating 
enzyme (human recombinant UbcH5a) and ubiquitin (human recombinant) were purchased from 
Boston Biochem. 100 ng Uba1, 200 ng UbcH5a, and ~500 ng GST fusion proteins were 
combined in reaction buffer (50 mM Tris-Cl, pH 7.5, 2 mM ATP, 2.5 mM MgCl2, 0.5 mM DTT) 
with 2.5 μg ubiquitin in 30 μl reactions. Reactions were incubated for 1.5 hrs at 30o C. Proteins 
were separated on a 7-20% gradient SDS-PAGE gel and transferred to a nitrocellulose 
membrane. Immunoblotting analysis was performed with anti-ubiquitin antibody (KAHANA and 
GOTTSCHLING 1999) at a 1:50 dilution to detect ubiquitin-conjugated substrates and anti-GST 
antibody (Invitrogen) at a 1:500 dilution to detect and normalize levels of GST fusion proteins. 
HRP-conjugated secondary antibodies (Amersham Biosciences) were used at 1:5000 dilutions. 
Chemiluminescent signals (Perkin Elmer) were detected with a Kodak 440CF digital imaging 
station. 
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3.3 RESULTS 
3.3.1 Database analyses reveal that Rkr1 contains a RING domain at its extreme carboxy 
terminus 
In parallel with the genetic analyses, I performed several database searches in an effort to 
identify a cellular role for Rkr1.  BLAST analysis showed that the protein is conserved with 
other uncharacterized proteins of similar size in many eukaryotes, including humans (Figure 29). 
There is significant homology throughout the protein, but a region at the carboxy terminus is 
most highly conserved (Figure 30).  Sequence analysis indicated that a RING domain exists in 
this region, between amino acids 1508 and 1554 (Figure 30).  Importantly, the same proteins are 
identified at a significant level if BLAST analysis is performed with the S. cerevisiae Rkr1 
sequence without the RING domain (data not shown).  This suggests that the proteins from other 
eukaryotes are mostl likely true Rkr1 homologs.  
RING domains consist of eight critical amino acids, often 7 cysteine residues and one 
histidine residue, that bind two zinc ions to form a cross-brace structure (reviewed in JACKSON et 
al. 2000) (see Figure 12 in the Introduction).  The RING domain of Rkr1 is of the C4HC3 type 
and is the only recognizable domain or motif within the protein.  RING domains bind to 
ubiquitin-conjugating enzymes (E2s) to catalyze the transfer of ubiquitin from the E2 to the 
substrate.  In most RING domains, the cysteine and histidine residues are arranged in either a 
C3HC4 or C3H2C3 sequence (reviewed in PICKART 2001). The C4HC3 pattern of the Rkr1 
RING domain appears to be less common (DODD et al. 2004; HASSINK et al. 2005).  The solution 
structure of the C4HC3 RING domain of the Kaposi's sarcoma-associated herpesvirus K3 protein 
has been solved (DODD et al. 2004) (Figure 12 in the Introduction). Chemical mutagenesis and 
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two-hybrid analysis showed that this non-canonical RING domain interacts with ubiquitin-
conjugating enzymes on the same face of the RING domain as classical RING domains (DODD et 
al. 2004).   
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Figure 29. Rkr1 protein sequence is conserved among eukaryotes. 
Alignment of  primary amino acid sequence for S. cerevisiae Rkr1 and homologs identified in H. 
sapiens, M. musculus, D. melanogaster, A. thaliana, and S. pombe (top to bottom, respectively).  
The individual residues are not meant to be read.  Instead, this figure is shaded to 50% sequence 
identity, with darker shades of blue representing higher degrees of conservation.  Note the 
conservation at the amino terminus as well as the higher level of conservation at the carboxy 
terminus. 
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Figure 30. The RING domain of Rkr1 is highly conserved. 
A) Rkr1 contains a conserved RING domain at its extreme carboxy terminus.  Enlargement of 
the alignment shown in Figure 29.  The last 150 amino acids from each of the organisms listed is 
shaded at 50% sequence identity, with darker shading representing higher conservation.  The 
residues within the RING domain are underlined, and those residues that are critical for RING 
domain formation are marked with asterisks. 
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3.3.2 Mutational analysis shows that the RING domain of Rkr1 is required for in vivo 
function 
To determine if the RING domain is important for the in vivo function of Rkr1, I mutated the 
first cysteine of the RING domain, changing it to an alanine (Rkr1-C1508A). Similar 
substitutions have been shown to disrupt the functions of other RING domain-containing 
proteins (DASGUPTA et al. 2004; TAKAGI et al. 2005). Strains lacking the genomic copy of RKR1 
were transformed with plasmids expressing wild-type and C1508A forms of Rkr1.  Growth 
assays showed that strains expressing wildtype Rkr1 grow on media lacking inositol, while 
strains expressing Rkr1-C1508A grow as poorly as rkr1Δ strains (Figure 31).  Furthermore, 
using a plasmid shuffle experiment, I showed that the Rkr1-C1508A derivative fails to 
complement the synthetic lethality between rtf1Δ and rkr1Δ (Figure 31).  Immunoblotting 
analysis demonstrated that the inability of Rkr1- C1508A to complement the rkr1Δ allele is not 
due to instability of the Rkr1 mutant protein (Figure 31). Together, these data demonstrate that 
the conserved RING domain of Rkr1 is required for the function of the protein in vivo. 
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Figure 31. The RING domain of Rkr1 is required for in vivo function. 
A) HA-RKR1-C1508A does not complement a rkr1Δ mutation.  A rkr1Δ strain (KY1168) was 
transformed with TRP1-marked plasmids expressing untagged RKR1, HA-tagged RKR1, HA-
tagged RKR1-C1508A, or empty vector.  Transformants were serially diluted and spotted onto 
medium lacking tryptophan and either lacking or containing inositol.  Plates were incubated at 
30° C for 3 days. B) Immunoblot analysis shows that HA-Rkr1-C1508A is expressed at levels 
equivalent to HA-Rkr1.  L3 levels serve as loading controls.  C) A rkr1Δ rtf1Δ (KY960) strain 
was transformed with TRP1-marked plasmids expressing either untagged, HA-tagged wildtype, 
or HA-tagged RING mutant derivatives of Rkr1.  An untransformed strain (KY960) was also 
spotted to show the requirement for the RTF1 plasmid for survival.  Transformants were serially 
diluted and spotted onto medium either containing or lacking 5FOA.  Plates were incubated at 
30° C for 3 days. 
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3.3.3 The RING domain of Rkr1 possesses ubiquitin-protein ligase activity in vitro 
Proteins that contain a RING domain often possess ubiquitin-protein ligase activity (FANG and 
WEISSMAN 2004).  Within the ubiquitylation pathway, RING-domain ubiquitin-protein ligases 
are thought to bring the ubiquitin-conjugating enzyme and substrate together to facilitate the 
transfer of ubiquitin to the substrate (FANG and WEISSMAN 2004).  Since the only identified 
domain or motif in Rkr1 is the carboxy-terminal RING domain, I tested Rkr1 for this activity.  
Because attempts to express full-length, recombinant Rkr1 were unsuccessful, GST fusions to 
the carboxy terminus of Rkr1 (amino acids 1251-1562) were constructed. Wild-type Rkr1 and 
Rkr1-C1508A GST fusions, as well as GST alone, were purified from bacteria.  In vitro 
ubiquitin-protein ligase assays were performed using recombinant ubiquitin, ubiquitin-activating 
enzyme (yeast Uba1), ubiquitin conjugating enzyme (human UbcH5a), and GST-RING proteins.  
These conditions have been used previously to show that other RING domain-containing 
proteins can facilitate polyubiquitylation (GARDNER et al. 2005).  Reactions lacking individual 
components of the ubiquitylation pathway were performed to show that all components of the 
pathway are required for efficient ubiquitylation.  The results of my experiments show that the 
RING domain of Rkr1 has ubiquitin-protein ligase activity that is dependent on the presence of 
the first cysteine residue in the RING motif (Figure 32).  Neither the Rkr1-C1508A fusion 
protein nor GST yielded detectable levels of protein ubiquitylation.  
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Figure 32. The RING domain of Rkr1 possesses ubiquitin protein ligase activity in vitro. 
Purified, recombinant proteins were added in various combinations to reactions containing ATP 
and ubiquitin.  Reactions were separated on a 7-20% gradient SDS polyacrylamide  gel and 
immunoblot analysis was performed using anti-ubiquitin and anti-GST antibodies.  See methods 
and text for additional information. 
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3.4 CONCLUSIONS 
In my attempts to determine an in vivo function for Rkr1, I performed several database analyses.  
My analysis shows that Rkr1 is conserved in eukaryotes, including humans.  The RING domain 
at the extreme carboxy terminus is the most highly conserved region of the protein, but there is 
also significant homology at the amino terminus of Rkr1.  The RING domain is the only 
recognizable domain in Rkr1.  To determine if the RING domain is required for Rkr1’s in vivo 
function, I used site-directed mutagenesis to destroy this structural domain.  Rkr1-C1508A fails 
to complement the Ino- phenotype of a rkr1Δ strain.  In Chapter 2 I showed that this RING 
domain mutation fails to complement a rkr1Δ for synthetic lethality with rtf1Δ and fails to 
complement the SD- phenotype of a set1Δ rkr1Δ strain.  These results suggest that the RING 
domain is required for the in vivo function of Rkr1.   
Biochemically, proteins that contain RING domains often act as ubiquitin-protein ligases 
(JACKSON et al. 2000).  I used an in vitro ubiquitylation assay to show that the RING domain of 
Rkr1 can catalyze efficient poly-ubiquitylation.  This activity is dependent on a functional RING 
domain, as Rkr1-C1508A RING domain does not catalyze detectable levels of poly-
ubiquitylation in vitro.  These data suggest that Rkr1 may function as a ubiquitin-protein ligase 
in vivo, possibly targeting factors that affect chromatin structure or function (Figure 33).  In 
Chapter 4, I will describe several nonbiased approaches that we took to uncover targets of this 
ubiquitin ligase activity.   
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Figure 33.  Model for Rkr1 activity in vivo. 
Based on the data that were presented in Chapters 2 and 3, I believe that Rkr1 uses its ubiquitin 
ligase activity to either directly or indirectly affect chromatin structure and/or function in a 
manner that parallels the function of Rtf1-dependent histone H2B ubiquitylation and histone H3 
K4 methylation. 
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4.0  IDENTIFICATION OF PROTEINS THAT PHYSICALLY INTERACT WITH 
RKR1 
4.1 INTRODUCTION 
Rkr1 has been shown to physically interact with two protein complexes in yeast.  Work from the 
laboratory of Raymond Deshaies has shown that Rkr1 and the Paf1 complex copurify with the 
19S cap of the proteasome, but only in the absence of ATP (VERMA et al. 2000).  This study 
purified FLAG-tagged Rpt1 (a subunit of the 19S proteasome) and performed mass spectroscopy 
to determine the identity of copurifying proteins.  Interestingly, Rtf1 contains a non-canonical 
FLAG sequence, which may explain why the Paf1 complex was purified with a FLAG-purified 
protein.  I performed coimmunoprecipitation experiments and detected no physical interaction 
between Rkr1 and Rtf1 or Paf1 (Figure 34).   This suggests that Rkr1 may physically interact 
with the 19S proteasome in a Paf1 complex-independent manner.  A second study, performed in 
the laboratory of Andrew Link,  purified ribosomes using three different approaches with the 
hope of identifying previously uncharacterized translation-machinery-associated factors 
(FLEISCHER et al. 2006).  They 1) fractioned 40S, 60S and 80S ribosomes using sucrose 
gradients, 2) purified ribosomes with increasing salt concentrations using discontinuous sucrose 
gradients, and 3) purified ribosomes and applied washes containing increasing salt 
concentrations to dissociate regulatory factors from core ribosomes.  These studies were all 
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followed by mass spectroscopic analysis to identify any proteins that physically interact with the 
ribosome.  Rkr1 copurified with 60S ribosomes in the sucrose gradients and purified with 
ribosomes washed with 1M ammonium chloride.  These data suggest that Rkr1 may associate 
with ribosomes, although we have yet to obtain a functional understanding of this interaction.   
To complement the genetic analysis described in Chapter 2, I investigated Rkr1’s 
physical interactions in vivo.  The results of these studies could confirm previously identified 
interactions, lead us to a new functional complex, or identify possible substrates for Rkr1’s 
ubiquitin ligase activity.  However, identification of ubiquitin ligase substrates presents a 
difficult problem, since these proteins are most often destroyed as a result of the interaction.  In 
an attempt to circumvent the degradation of proteins that interact with wild type Rkr1, two 
different regions of Rkr1 were used as bait in separate yeast two-hybrid screens.  We used a 
conserved amino-terminal fragment as well as a carboxy-terminal fragment that contains the 
RING domain as baits.  We identified 20 proteins that interact with the amino terminus of Rkr1.  
I performed preliminary experiments to determine if these proteins are substrates of Rkr1’s 
ubiquitin ligase activity.  No interactions with the carboxy-terminal fusion were identified, most 
likely due to the ubiquitylation and degradation of any interacting proteins. 
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Figure 34. Coimmunoprecipitation experiments do not detect a physical interaction between Rkr1 
and Rtf1. 
Coimmunoprecipitation experiments were performed to detect physical interactions between 
HA-Rkr1 and Rtf1 or Paf1.  Immunoprecipitations were performed using either anti-HA or anti-
Rtf1 antibodies, or preimmune serum as a control for the Rtf1 antibody.  Immunoblot analysis 
was performed using antibodies anti-HA, anti-Rtf1 and anti-Paf1 antibodies.  Immunoblot 
analysis shows that no physical interactions were detected.  However, a physical interaction was 
detected between Rtf1 and Paf1 as expected.  B= bound fraction, U=unbound fraction, E=cell 
extract, PI=pre-immune serum. 
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Ubiquitin-protein ligases have been shown to work both in the context of a complex or by 
themselves.  Ligases that act alone presumably interact only briefly with their partner ubiquitin 
conjugating enzyme and the substrate(s).  There are examples of both types of ligases that act 
within the context of the nucleus.  Bre1 and Lge1, both RING domain containing proteins, 
interact with each other and the ubiquitin-conjugating enzyme Rad6 to facilitate histone H2B 
ubiquitylation at lysine 123 (HWANG et al. 2003; WOOD et al. 2003a).  The Skp1-Cullin-F-Box 
(SCF) complex incorporates many E3s to define substrates that are ubiquitylated throughout the 
cell cycle (SKOWYRA et al. 1997).  Rad18 works with the E2 Ubc2 to target proteins involved in 
DNA repair for ubiquitylation (BAILLY et al. 1994).  In parallel with two-hybrid analysis, I 
purified Rkr1 from yeast under native conditions to attempt to define a functional complex for 
Rkr1.  The results of this analysis suggest that Rkr1 does not maintain any stable interactions in 
vivo, and support a model in which the proteins that interact in the two-hybrid screen are 
potential targets of Rkr1’s ubiquitin ligase activity.   
4.2 METHODS 
4.2.1 Plasmids 
pMB11, pMB66, and pPC65 were described in Chapter 2 methods section (section 2.2).   
pMB67 and pMB68 were created by PCR cloning.  The protein-A-TEV portion of the modified 
TAP tag was amplified using PCR with primers that hybridized to the protein-A-TEV sequence 
in pBS1761 (PUIG et al. 2001).  The 5’ primer added an NdeI restriction sequence.  The 3’ 
primer added sequences that are identical to those found in the 5’ FLAG sequence.  In a separate 
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set of reactions, the 3xFLAG sequence was PCR amplified using a 5’ primer that added 
sequences that are identical to those found at the 3’ end of the protein-A-TEV PCR product.  The 
3’ primer added an NdeI restriction site.  These PCR products were gel purified and combined 
into a PCR reaction, where they would hybridize to each other and prime a longer PCR product 
that contained protein-A-TEV-3xFLAG, with NdeI restriction sites on the 5’ and 3’ ends of the 
product.  This product was purified, digested with NdeI, and ligated into pSH3 (which contains 
the 5’ end of RKR1) that had been linearized at the NdeI site at the ATG codon of RKR1.  This 
plasmid was sequenced over the new tag to confirm that no mutations were introduced by PCR.  
An XhoI/AatII fragment from the resulting plasmid was subcloned into XhoI/AatII digested 
pMB11 and pMB66, to create plasmids containing modified TAP-tagged, full-length, wildtype 
RKR1 (pMB67), and modified TAP-tagged, full-length RKR1-C1508A (pMB68), respectively.   
4.2.2 Yeast Strains and Media 
Yeast strains used in these studies are listed in Table 9.  TAP-tagged strains that were used in the 
coimmunoprecipitations and cycloheximide-chase experiments are from the TAP-tag collection 
(GHAEMMAGHAMI et al. 2003), and are not isogenic with FY/KY strains.  Yeast strains were 
generated as described in Chapter 2 methods section (section 2.2).  RSC8 was tagged by 
transforming a PCR fragment that contained 3xHA sequence and the kanMX selectable marker 
into MBY193.  The following primers were used for amplifying the tag for Rsc8: MBO71 (5’ 
tgcaaaattgcagccccaggtgtacaaaccgtggtcattgCGGATCCCCGGGTTAATTAA 3’), MBO72 
(5’tattagaaatataaaatatgacaatagtacactttgtaggGAATTCGAGCTCGTTTAAAC 3’).  YPD medium 
was made as described in the Methods section of Chapter 2 (section 2.2).   
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Table 9. Table of Strains for Chapter 4. 
Strain Genotype 
KY1241 MATα rkr1Δ::HIS3, RSC8-HA-kanMX4, his3Δ200, leu2Δ1, ura3-52, trp1Δ63 
KY1242 MATa RSC8-HA-kanMX4, his3Δ200, leu2Δ1, ura3-52, trp1Δ63 
KY592 MATα leu2Δ1, ura3-52, trp1Δ63 
MBY151 MATa gal4Δ, gal80Δ, LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-LacZ, 
his3Δ200, leu2-3, 112, ura3-52, trp1-901 [pGBT9 = GAL4 DBD, TRP1, 2μ] 
MBY152 MATa gal4Δ, gal80Δ, LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-LacZ, 
his3Δ200, leu2-3, 112, ura3-52, trp1-901 [pGBT9+RKR1-N-term = GAL4 DBD-
RKR1 N-term, TRP1, 2μ] 
MBY168 MATa rkr1Δ::kanMX4, his3Δ200, leu2Δ1, ura3-52, trp1Δ63 
MBY205 MATa KGD2-TAP-HIS3MX6, (his3Δ200?), lys2-128δ, leu2Δ1, ura3(Δ0 or -52), 
trp1Δ63 
MBY226 MATa HPA3-TAP-HIS3MX6, (his3Δ200?), ura3(Δ0 or -52), trp1Δ63 
MBY243 MATa STE12-TAP-HIS3MX6, his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY244 MATa MAC1-TAP-HIS3MX6, his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY245 MATa GZF3-TAP-HIS3MX6, his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY246 MATa DSK2-TAP-HIS3MX6, his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY247 MATa STE12-TAP-HIS3MX6, rkr1Δ::kanMX4his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY248 MATa MAC1-TAP-HIS3MX6, rkr1Δ::kanMX4his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY249 MATa GZF3-TAP-HIS3MX6, rkr1Δ::kanMX4his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY250 MATa DSK2-TAP-HIS3MX6, rkr1Δ::kanMX4his3Δ1, leu2Δ0, ura3Δ0, met15Δ0 
MBY36 MATα rkr1Δ::kanMX4, his3Δ200, trp1Δ63 
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4.2.3 Coimmunoprecipitation experiments 
2 mg of total protein extract were raised to 750 µl volume with 1x lysis buffer (100 mM sodium 
acetate, 20 mM HEPES, pH 7.4, 2 mM magnesium acetate, 10 mM EDTA, 10% glycerol, 1 mM 
DTT, plus protease inhibitors) and Tween 20 was added to 0.05% final concentration.  IgG-
sepharose beads were prewashed with 1x lysis buffer and 25 µl were added per IP reaction.  
Reactions were mixed at 4o C for 2 hours.  Immune complexes were collected by centrifugation 
at 5000 rpm and washed 5 times with 1 ml lysis buffer plus 200 mM NH4OAc plus 0.05% 
Tween 20.  Immunoprecipitated proteins were eluted from beads in 1x sample buffer (80 mM 
Tris-Cl, pH 6.8, 2% SDS, 0.1% bromophenol blue, 100 mM DTT, 10% glycerol, 2 mM PMSF) 
by boiling at 100o C for 3 minutes.  Samples were loaded onto SDS polyacrylamide gels prior to 
being transferred to nitrocellulose for immunoblot analysis.    
4.2.4 Immunoblot analysis 
Whole cell extracts were prepared as described in Chapter 2 methods.  Proteins (25 μl 
extract/immunoprecipitate or the entire in vitro ubiquitylation reaction) were separated on 10% 
or 7-20% gradient SDS polyacrylamide gels and transferred to nitrocellulose membranes. The 
following antibodies were used: anti-TAP (peroxidase-anti-peroxidase) (1:3000 dilution; Sigma), 
anti-HA (1:3000 dilution; Roche), and anti-Sec61 (1:1000 dilution; a gift of the Brodsky lab).  
HRP-conjugated secondary antibodies (Amersham Biosciences) were used at a 1:5000 dilution.  
Immunoreactive proteins were detected by chemiluminescence (Perkin Elmer) and visualized 
with a Kodak 440CF digital imaging station. 
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4.2.5 Cycloheximide-chase experiments 
Cycloheximide-chase experiments were performed as described previously (GARDNER et al. 
1998).  Briefly, 10 ml cultures of MBY245 (Gzf3-TAP, RKR1+), MBY249 (Gzf3-TAP, rkr1Δ), 
and KY592 (untagged Gzf3, RKR1+) or KY1241 (Rsc8-HA, rkr1Δ), KY1242 (Rsc8-HA, 
RKR1+) and another strain derived from the same cross (untagged Rsc8, RKR1+) were grown to 
1 x 107 cells/ml (early log-phase) in YPD, SC complete, or SD minimal medium.  
Cycloheximide was added to 50 µg/ml final concentration.  Cultures were mixed and the zero 
timepoint sample (2 ml) was collected by centrifugation.  The rest of the culture was incubated at 
30o C for 90 minutes, and 2 ml of each culture were collected at 30, 60 and 90 minutes.  Samples 
from each timepoint were processed as follows.  Cells were harvested in 2 ml round-bottomed 
screw-capped tubes.  Cells were resuspended in 200 µl SUMEB buffer (1% SDS, 8M Urea, 10 
mM MOPS, pH 6.8, 10 mM EDTA, 0.01% bromophenol blue) plus protease inhibitors.  100 µl 
glass beads were added, and samples were shaken for 3 minutes on setting #7 in the multi-tube 
vortexer.  Samples were incubated at 100o C for 10 minutes prior to centrifugation at 13,000 rpm 
for 5 minutes.  Supernatants were transferred to new Eppendorf tubes and stored at 4o C until all 
samples were collected and processed.  25 µl of each sample was loaded onto 10% SDS 
polyacrylamide gels and transferred to nitrocellulose prior to immunoblot analysis.  
4.2.6 Modified TAP purification 
Strains lacking RKR1 (MBY36) that were transformed with pPC65 (untagged Rkr1), pMB67 
(protein A-TEV-3xFLAG-Rkr1), or pMB68 (protein A-TEV-3xFLAG-Rkr1-C1508A) were 
grown to 4-5 x 107 cells/ml (mid-log-phase) and cells were collected by centrifugation (4000 
 196 
rpm, 4 minutes, 4o C) in a GS3 rotor.  Cells were resuspended in 2 ml cold sterile water per gram 
weight of wet cells.  Cells were transferred to a 50 ml Falcon tube, and washed 1 time with 1.3 
volumes TAP-MB1 (50 mM Tris, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 10 µM ZnCl2, 5 mM 
β-mercaptoethanol) without protease inhibitors and washed 1 time with 1.3 volumes TAP-MB 
plus protease inhibitors.  Cell pellets were frozen in liquid nitrogen.  Cell lysates were made 
using a Krups coffee grinder with dry ice pellets.  The cell pellets/dry ice were ground for 2.5 
minutes.  The powder was transferred to a sterile beaker and thawed at room temperature.  Once 
thawed, 0.8 volumes of TAP-MB1 plus protease inhibitors were added to each sample.  Samples 
were transferred to Oak Ridge tubes and centrifuged at 15,000 rpm for 20 minutes at 4o C 
(SA600 rotor).  Supernatant was separated by ultracentrifugation at 33,500 rpm, for 1 hour at 4o 
C (Ti70i rotor).  Soluble fractions of the extracts were mixed with pre-washed IgG-sepharose 
(Amersham Biosciences) in batch at 4o C for 1 hour.  Immune complexes were collected by 
centrifugation and transferred to siliconized microfuge tubes.  The complexes were washed 4 
times with TAP-MB2 (50 mM Tris, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 10 µM ZnCl2, 5 mM 
β-mercaptoethanol, 0.05% NP-40) plus protease inhibitors and 5 times with TAP-MB2 without 
protease inhibitors.  Bead-protein complexes were resuspended in 200 µl TAP-MB2 plus 10 
units of AcTEV protease (Invitrogen), and incubated at 16o C for 2 hours.  Cleaved protein 
complexes (supernatants) were collected after centrifugation (1 minute, 2000 rpm, 4o C).  
Supernatant was mixed with 100 µl pre-washed FLAG-M2 resin in siliconized microfuge tubes 
for 2 hours at 4o C.  Resin was collected by centrifugation (2000 rpm, 1 minute, 4o C) and the 
resin was washed 5 times with 1 ml TAP-MB2 without protease inhibitors and 5 times with 1 ml 
TAP-MB3 (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, and 10 µM ZnCl2).  
Samples were mixed for 4 minutes at 4o C each wash.  Rkr1 protein complexes were eluted with 
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20 µl of 10 mg/ml FLAG peptide (University of Pittsburgh Peptide Synthesis Facility) plus 80 µl 
TAP-MB4 (50 mM Tris-Cl, pH 7.5, 200 mM NaCl, 1.5 mM MgCl2, 10 µM ZnCl2).  Samples 
were rotated at room temperature for 30 minutes.  Elution was repeated 1 time at 4o C.  Elutions 
were combined and half of each sample was TCA precipitated prior to loading on 7-20% SDS 
polyacrylamide gels.  Gels were silver stained as described in the next section (section 4.2.7).   
4.2.7 Silver staining SDS-PAGE gels 
SDS polyacrylamide gels were silver stained using a rapid, low background protocol obtained 
from Jeff Brodsky.  Briefly, gels were fixed for at least 30 minutes in 50% ethanol, 12% acetic 
acid, and 0.5 ml/L formaldehyde.  Gels were washed in 50% ethanol for 20-40 minutes and 
washed quickly with 0.01% sodium thiosulfate.  Gels were stained with fresh 0.1% silver nitrate 
for 20 minutes and developed with 0.28 M sodium carbonate, 0.0002% sodium thiosulfate, and 
240 µl/0.5 L formaldehyde.  The development was stopped by soaking the gel in 10 mM EDTA.     
4.3 RESULTS 
4.3.1 A yeast two-hybrid screen shows that Rkr1 physically interacts with proteins 
involved in chromatin function, transcription, and ubiquitylation 
Our laboratory performed two separate yeast two-hybrid screens using different fragments of 
Rkr1 fused to the Gal4 DNA binding domain as bait.  The first screen, performed by Alexis 
Carulli, used a fusion that contained amino acids 1251-1562 of Rkr1 as bait.  This region of Rkr1 
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contains the RING domain that is predicted to interact with ubiquitin-conjugating enzymes and 
~275 amino acids amino-terminal to the RING domain.  This screen detected no physical 
associations with Rkr1, presumably because proteins were degraded as a result of the interaction.  
Rebecca Gonda performed another two-hybrid screen using a fusion that contained amino acids 
1-257 of Rkr1 as bait.  This portion of Rkr1 is conserved in eukaryotes and may serve as a 
substrate binding region (Figure 29 in Chapter 3).  This screen identified 20 proteins that interact 
with Rkr1 (Table 10).   
The proteins that interact with the amino terminus of Rkr1 fall into several interesting 
classes.  There are proteins that modify and remodel chromatin (Hpa3 and Rsc8, respectively), 
and several transcription activators and a repressor (Gcr2, Dal82, Mac1, Mga1, Ste12, Hap1, and 
Gzf3, respectively).  One interacting protein, Dsk2, is important for transporting 
polyubiquitylated proteins to the proteasome.  The interacting proteins Bbp1 and Red1 are 
important for cell division.  The amino terminus of Rkr1 also interacts with a few mitochondrial 
proteins (Mgm101, Kgd2, Mdj1), a protein involved in ER-Golgi transport (Emp47), and several 
uncharacterized proteins (Jjj2, Tma23, Hua1, and Muk1).  Table 10 also contains brief 
descriptions of the known functions of each of these proteins.  Figure 35 illustrates known 
physical and genetic interactions among these proteins.  The next few sections describe 
experiments that I performed to follow up these results. 
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Table 10. Proteins that physically interact with the amino terminus of Rkr1, as determined by a two-
hybrid screen. 
Protein # 
isolates 
Group Description 
Hpa3 5 Histone Histone and other protein acetyltransferase; acetylates histones 
weakly in vitro 
Rsc8 1 Histone Remodel the structure of chromatin 8; Subunit Rsc complex 
Gcr2 2 Transcription 
regulator 
Glycolysis regulatory protein 2; activator of glycolytic genes 
Dal82 1 Transcription 
regulator 
Degradation of Allentoin 82; positive and negative transcription 
regulator, activates allophanate- inducible genes, DNA binding 
protein 
Gzf3 1 Transcription 
regulator 
Gata Zinc Finger protein 3; Dal80 homolog;  negative regulator of 
nitrogen response genes 
Mac1 2 Transcription 
regulator 
Metal-binding transcriptional activator 1; Copper-sensing factor 
involved in regulation of genes required for high affinity Cu 
transport 
Mga1 1 Transcription 
regulator 
 
Ste12 1 Transcription 
regulator 
Sterile 12; Transcription activator of mating and 
pseudohyphal/invasive growth genes 
Hap1 1 Transcription 
regulator 
Heme Activator Protein 1; Zn-finger transcription factor of Zn(2)-
Cys(6) binuclear cluster 
Dsk2 3 Ubiquitin Nuclear enriched ubiquitin-like poly-ubiquitin binding protein; 
Interacts with the proteasome 
Bbp1 1 Cell division Bfr1 binding protein 1; essential; required for spindle pole body 
duplication 
Red1 2 Cell division Reductional division 1; involved in centrosome segregation in first 
meiotic division, component of axial elements in synaptonemal 
complex 
Mgm101 2 Mitochondrial Mitochodrial genome maintenance 101; binds to DNA, involved in 
DNA repair 
Kgd2 3 Mitochondrial Alpha-ketoglutarate dehydrogenase 2; catalyzes step in TCA 
cycle; DNA-binding activity; phosphotidyl-inositol binding; 
important in maintaining stability of mitochondrial DNA 
Mdj1 2 Mitochondrial Member of the DnaJ family of molecular chaperones 1; DnaJ 
homolog; involved in folding proteins in mitochondrial matrix; 
interacts w/ Rad6 (2-hyb) 
Emp47 1 ER/Golgi Glycolytic transport; Integral ER-derived COPII-coated residues; 
Ubiquitylated in vivo 
Jjj2 1 Uncharacterized Contains J-domain; homolog to DnaJ protein; Similar to Hlj1; null 
is Spo- 
Tma23 1 Uncharacterized Nucleolar, contains putative RNA binding domain; Nucleoloar 
protein that copurifies with ribosomes 
Hua1 1 Uncharacterized Zn-finger domain; Similar to type 1 J-proteins; Possible role in 
actin patch assembly 
Muk1 1 Uncharacterized Localized to cytoplasm; possible role in transcription regulation 
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 Figure 35. Network of physical and genetic interactions among the proteins identified in the yeast 
two-hybrid screen with Rkr1. 
Many of the proteins that physically interact with Rkr1 in a yeast two-hybrid screen actually 
physically and genetically interact with each other and other functional complexes, including the 
proteasome and ribosomes.  Physical interactions are designated by a solid black line, genetic 
interactions are represented by dashed black lines, and enzyme-substrate interactions are 
depicted by solid gray lines.  Synthetically lethal (SL) and synthetically sick (SS) interactions are 
shown.  The proteins that physically interact with Rkr1 fall into several functional classes, which 
are designated with similarly colored circles (see legend within the figure).  
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4.3.1.1 Dsk2 physically interacts with Rkr1 
The amino terminus of Rkr1 interacts with 2 different Gal4-activation domain fusions to 
Dsk2.  One fusion contains amino acids 83-373 and the other contains amino acids 85-373 
(DSK2 encodes a 373 amino acid protein).  Dsk2 contains a ubiquitin-like (UBL) domain at its 
amino terminus and a ubiquitin-associated (UBA) domain at its carboxy terminus.  The UBL 
domain interacts with the 19S proteasome subunit Rpn1, and the UBA domain associates with 
polyubiquitin chains on other proteins (FUNAKOSHI et al. 2002), and thus Dsk2 acts as a 
“destruction chaperone” by targeting polyubiquitylated proteins to the proteasome.  Hartmann-
Petersen et al. suggest that Dsk2 may “pick up” polyubiquitylated proteins just as they are tagged 
for destruction, and therefore may interact with the ubiquitylation machinery (HARTMANN-
PETERSEN et al. 2003).  The human homolog of Dsk2 has been shown to interact with a 
ubiquitin-protein ligase, E6AP (KLEIJNEN et al. 2000).  The physical interaction between Rkr1 
and Dsk2 suggests that Rkr1 may be important for the polyubiquitylation of proteins in yeast, 
and these substrates are targeted to the proteasome by Dsk2.   
It is possible that this physical interaction should be somewhat stable and detectable in 
coimmunoprecipitation experiments if Dsk2 contacts Rkr1 and is not a target of its ubiquitin-
protein ligase activity.  I therefore performed coimmunoprecipitation experiments to detect a 
physical interaction between Rkr1 and Dsk2.  The results of these experiments suggest that Rkr1 
and Dsk2 do physically interact, although whether or not a functional RING domain is required 
for this interaction is not known (Figure 36).  In the first of two experiments, a very weak 
interaction between Rkr1-C1508A and Dsk2 was detected, and the second experiment showed 
that Rkr1-C1508A interacted with Dsk2 more robustly (Figure 36).   
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Figure 36. Rkr1 physically interacts with Dsk2. 
Coimmunoprecipitation experiments with TAP-Dsk2 and HA-Rkr1 were performed as described 
in the Methods section (Immunoprecipitate TAP-Dsk2 and immunoblot for HA-Rkr1).  
Immunoblot analysis was performed using anti-HA antibody to detect Rkr1 and anti-TAP 
antibody to detect Dsk2.  (*) represents relevant coimmunoprecipitation lanes.  A) Experiment 
#1. B) Experiment #2.  B= bound fraction, U=unbound fraction, E=cell extract 
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4.3.1.2 The global levels of proteins identified in the two-hybrid screen are not significantly 
affected by the loss of Rkr1 in rich medium 
The results of the two-hybrid screen show that the amino terminus of Rkr1 interacts with 
20 proteins.  We hypothesized that these proteins may be ubiquitylated and subsequently 
degraded in a Rkr1-dependent manner.  I used immunoblot analysis to determine if global levels 
of these proteins increased in the absence of Rkr1.  These experiments were performed using 
carboxy-terminal TAP-tagged proteins that were obtained from the TAP-tagged collection 
(ref*).   Strains were grown in rich medium (YPD) to log-phase prior to lysis in sample buffer.  
Cell extracts were loaded onto SDS-PAGE gels and proteins were transferred to nitrocellulose 
for immunoblot analysis.  The results of this analysis show that the levels of the proteins that 
were assayed in these experiments are not affected by the loss of Rkr1 (Figure 37). This suggests 
that Rkr1 may not be responsible for degrading these proteins in rich medium.  It is possible that 
a redundant ubiquitin ligase may act to destroy these proteins, or Rkr1 may not be important for 
degrading these proteins at all.   
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Figure 37. The levels of proteins that physically interact with Rkr1 are not significantly affected by 
the loss of Rkr1. 
rkr1Δ strains that express TAP-tagged versions of the proteins listed across the top of the figure 
were transformed with plasmids that either contained wild type RKR1 or empty vector.  Total 
cell lysates were separated on a 7-20% gradient SDS-PAGE gel.  Immunoblot analysis of cell 
lysates from these strains was performed with antibodies to detect the TAP-tag fusion proteins 
and L3 (loading control).   
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4.3.1.3 Rsc8 and Gzf3 are not degraded in a Rkr1-dependent manner in rich medium 
The amino terminus of Rkr1 interacts with amino acids 341-557 of Rsc8 (RSC8 encodes 
a 557 amino acid protein).  Rsc8 is a component of the ATP-dependent RSC chromatin 
remodeling complex (CAIRNS et al. 1996).  The RSC complex was identified by homology to the 
SWI/SNF chromatin remodeling complex, and biochemical purification of RSC shows that there 
are 17 subunits (CAIRNS et al. 1996).  This complex interacts with acetylated nucleosomes 
(HASSAN et al. 2002; WINSTON and ALLIS 1999) to facilitate transcription (CAREY et al. 2006).  
Rsc8 is 30% identical and 52% similar to the Swi3 component of the SWI/SNF complex 
(CAIRNS et al. 1996).  Rsc8 contains a SWIRM domain, which is important for maintaining 
associations with other RSC complex members and nucleosomes (DA et al. 2006), and a ZZ-type 
zinc finger, which may be important for protein-protein interactions (CAIRNS et al. 1996).   
The amino terminus of Rkr1 interacts with the carboxy-terminal 132 amino acids of Gzf3 
(amino acids 419-551).  Gzf3 is a RNA Pol II transcription factor that represses nitrogen 
catabolite genes (SOUSSI-BOUDEKOU et al. 1997).  Gzf3 contains a zinc finger which binds to 
GATA DNA sequences in promoter elements of nitrogen responsive genes (SOUSSI-BOUDEKOU 
et al. 1997).  Gzf3 is similar in sequence and function to Dal80, which also represses nitrogen 
responsive genes (SOUSSI-BOUDEKOU et al. 1997).   
To determine if Rkr1 was important for the degradation of Rsc8 and Gzf3, I performed 
cycloheximide-chase experiments using rkr1Δ strains that express carboxy-terminally HA-
tagged Rsc8 and TAP-tagged Gzf3.  Strains were grown to log-phase in rich medium and 
cycloheximide was added to stop protein synthesis.  Samples were collected over a 90 minute 
period, and extracts were made from cells collected at each point.  Immunoblot analysis of these 
strains shows that Rsc8 and Gzf3 protein levels are not stabilized by the loss of Rkr1 (Figure 38).  
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Because differences in gene expression were observed in rkr1Δ strains grown in SD minimal 
medium (see Chapter 5), but not rich medium, Rkr1 may only affect the stabilization of these 
factors under certain growth conditions.  Future experiments are required to investigate this 
possibility.   
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Figure 38. Rsc8 and Gzf3 protein levels are not affected by the loss of Rkr1 in rich medium. 
Cycloheximide chase experiments were performed as described in the methods section.  Time 
(minutes) after cycloheximide addition is noted above each lane.  Sec61 (endoplasmic reticulum 
membrane protein) immunoblots are used for loading controls (antibody is described in 
(STIRLING et al. 1992)).   
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4.3.2 Modified TAP purification 
In parallel with the yeast two-hybrid screen, I isolated Rkr1 using a technique that many other 
labs have used to purify proteins in native complexes from yeast (PUIG et al. 2001).  Rkr1 was 
amino-terminally tagged with the traditional TAP tag, which contains a protein-A module and 
calmodulin binding peptide separated by a TEV cleavage site (PUIG et al. 2001).  This tag was 
added to the amino-terminus of Rkr1 to avoid disrupting the RING domain at the carboxy 
terminus.  Using this approach, no proteins copurified with Rkr1.  I also had difficulty eluting 
Rkr1 from the calmodulin column.  To overcome the elution difficulties, I created a new tag that 
I will refer to as the modified TAP tag.  This tag contains the protein-A module and 3xFLAG 
peptide, separated by the TEV cleavage site.  This method allows for elution of purified proteins 
using excess FLAG peptide, which should overcome the previous elution difficulties.  To 
enhance for interacting proteins that may be destroyed by wildtype Rkr1, I also tagged Rkr1-
C1508A for purification.  Using this method I was able to purify both forms of Rkr1, however, I 
saw no co-purifying proteins.  I tried many different buffer conditions (chloride and acetate 
buffers with high and low salt concentrations) and I tried purifying Rkr1 from up to 18 liters of 
cells to enhance for minute levels of interacting proteins.  The results of the purification 
experiments showed that no proteins (detectable by silver stain) co-purify with either wildtype or 
mutant Rkr1 (Figure 39).  These results suggest that Rkr1 may not stably interact with any 
proteins in yeast. 
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Figure 39. Purification of Rkr1. 
A) Modified TAP purification strategy. See Methods section for more information.  B) Wild type 
and C1508A derivatives of Rkr1 were purified using the modified TAP tag strategy.  Half of the 
eluates (representing 1 liter of cells) were TCA precipitated and proteins were separated in a 7-
20% gradient SDS-PAGE gel.  The gel was silver stained to identify purified proteins. 
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4.4 CONCLUSIONS 
This chapter describes our attempts to characterize Rkr1’s physical interactions.  A yeast two-
hybrid screen identified 20 proteins that physically interact with the amino terminus of Rkr1.  
These proteins fall into several functional classes that are involved in chromatin function, 
transcription regulation, and ubiquitylation.  These proteins may be targets of Rkr1’s ubiquitin 
ligase activity, but my results show that steady-state levels of many of these proteins are not 
increased in rkr1Δ strains grown in rich medium.  Further analysis is required to determine if 
Rkr1 ubiquitylates these proteins under specific conditions. 
The amino terminus of Rkr1 interacted with Dsk2 in the two-hybrid screen.  Dsk2 is 
important for binding poly-ubiquitylated proteins and transporting them to the proteasome for 
destruction (reviewed in HARTMANN-PETERSEN et al. 2003).  Coimmunoprecipitation 
experiments show that Rkr1 and Dsk2 do physically interact.  This connects Rkr1’s function to 
the ubiquitin-proteasome pathway, and further supports a model in which Rkr1 acts as a 
ubiquitin ligase to target proteins within the nucleus for destruction.   
The two-hybrid screen also showed that Rkr1 interacts with Rsc8 and Gzf3.  Rsc8 is a 
subunit of an essential chromatin remodeling complex (CAIRNS et al. 1996), and Gzf3 is a 
transcriptional repressor that regulates nitrogen responsive genes (SOUSSI-BOUDEKOU et al. 
1997).  Interestingly, several Gzf3 regulated genes are affected by the loss of RKR1 when the 
strains are grown in minimal medium (see Chapter 5).  The results of my cycloheximide-chase 
experiments show that Rkr1 may not be important for degrading these proteins in rich medium.  
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The proteins identified in the yeast two-hybrid screen may be targets of Rkr1’s ubiquitin ligase 
activity, but more analysis is required to fully understand these interactions. 
I purified Rkr1 from yeast using a gentle method that allows for native purification of 
protein complexes (PUIG et al. 2001).  Because I had difficulty eluting Rkr1 with traditional TAP 
tag purification, I created the modified TAP tag.  Biochemical purification of wild type and 
mutant Rkr1 with this method failed to show any copurifying proteins.  This suggests that Rkr1 
does not stably associate with any proteins in yeast.   
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5.0  IDENTIFICATION OF YEAST GENES REGULATED BY RKR1 USING 
MICROARRAY ANALYSIS 
5.1 INTRODUCTION 
The goal of my research has been to investigate the synthetic lethal interaction caused by the 
combined loss of Rkr1, a previously uncharacterized protein, and Rtf1, a member of the Paf1 
transcription elongation complex.  Multiple parallel pathways often act coordinately to elicit 
proper transcription of downstream genes.  Synthetic lethality is believed to result when parallel 
pathways that impinge on an essential process are disrupted simultaneously.  A former graduate 
student in the Arndt lab, Kathryn Sheldon, demonstrated that members of the Paf1 complex are 
essential for normal transcription of a subset of genes in yeast.  The synthetic lethality observed 
in rkr1Δ rtf1Δ strains suggests that Rkr1 may also be linked to gene expression.  My previous 
observations that Rkr1 localizes to the nucleus and that strains lacking RKR1 have phenotypes 
indicative of general transcription defects (see Chapter 2 for details) further support a role for 
Rkr1 in transcription.   
To determine if Rkr1 affected the expression of any genes in yeast, I collaborated with 
Martin Schmidt’s lab to perform microarray experiments.  This analysis shows that Rkr1 affects 
the expression of a subset of genes in yeast.  Further analysis with real-time PCR confirms the 
results of the microarrays.  Interestingly, the microarray data indicate that some genes are 
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oppositely affected by the loss of RKR1 and the loss of Paf1 complex members.  Taken as a 
whole, Rkr1 appears to affect the expression of a subset of genes in yeast, and Rkr1 and the Paf1 
complex oppositely regulate the expression of a fraction of these genes.   
5.2 METHODS 
5.2.1 Strains and media 
Strains used in these studies are listed in Table 11.  For all analyses, strains were grown to 1-2 x 
107 cells/ml (early log-phase) in 10 ml rich medium or minimal medium that was supplemented 
with appropriate amino acids.  Cells were collected by centrifugation, and total RNA was 
collected as described in the next section.   
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Table 11. Table of strains used in Chapter 5. 
Strain Genotype 
KY592 MATα leu2Δ1, ura3-52, trp1Δ63 
KY595 MATa ura3-52 
KY694 MATα ctr9Δ::kanMX4, leu2Δ1, ura3-52, trp1Δ63 
KY951 MATα rtf1Δ::kanMX4, lys2-128δ, leu2Δ1, ura3-52, trp1Δ63 
MBY169 MATα rkr1Δ::kanMX4, leu2Δ1, ura3-52, trp1Δ63 
MBY30 MATa rkr1Δ::kanMX4, ura3-52 
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5.2.2 RNA isolation, cDNA and cRNA synthesis for microarrays 
All experiments were performed in triplicate.  Total RNA was isolated from wild type (KY595) 
and rkr1Δ (MBY30) strains as previously described (ARNDT et al. 1995).  RNeasy kits (Qiagen) 
were used to DNase treat the RNA prior to cDNA synthesis.  cDNA synthesis (Invitrogen 
Superscript) was performed according to kit directions using 7 µg of RNA and oligo dT primers.  
cRNA was created using the Enzo kit with half (5 µl) of the cDNA reaction.  cRNA was purified 
using RNeasy kits (Qiagen).  Biotin labeling of cRNA and array hybridizations were performed 
at the University of Pittsburgh Medical School Core Microarray Facility.  GeneChip Yeast 
Genome S98 arrays from Affymetrix were used for hybridizations.  The hybridized array was 
stained and scanned.  The amount of light emitted from each target spot at 570 nm is 
proportional to the amount of bound target at each location on the array.   
5.2.3 Data analysis for microarrays 
We were provided with a Microsoft Excel file that contained values representing the relative 
intensities for each of the array targets (representing all ORFs in yeast).  Values representing spot 
intensities in three independent rkr1Δ strains were subtracted from respective wildtype strain 
values, providing three datasets.  These values were averaged to provide a list of changes over 
the three experiments.  These values (and their corresponding gene name) were sorted 
numerically from highest to lowest.  These numerical differences provide a log2 based 
representation of the fold change in gene expression between the two datasets.  Any values 
(positive or negative) that were larger than 0.8 (representing at least a 1.75 fold change in 
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expression) were considered significant and these genes were considered for further analysis and 
confirmed by real-time PCR (see below). 
5.2.4 Significance analysis of microarray (SAM) 
This Microsoft Excel based program was downloaded from http://www-
stat.Stanford.EDU/~tibs/SAM.  The data were entered using the “two-class paired” format, 
which compares the numbers for wild type and rkr1Δ strains separately for each experiment, 
instead of averaging all three datasets for wildtype and rkr1Δ strains together.  The genes 
highlighted in Tables 13 and 14 were found to be significantly affected at a user-defined delta 
value of 0.276, with a false discovery rate of 15.2%, and the minimum fold change was set to 
1.75.  This means that the genes listed that have a q-value of 4.87 have a 4.87% chance of being 
a false positive gene.   
5.2.5 Real-time PCR analysis 
Strains were grown to 1 x 107 cells/ml (early log-phase) in 10 ml of SD minimal medium 
supplemented with required amino acids.  RNA was extracted as described (ARNDT et al. 1995) 
and treated with DNase (Ambion).  cDNA was synthesized (Invitrogen Superscript) using 1 µg 
of RNA and 250 ng random hexamers in 20 µl reactions.  Primers for PCR were designed using 
the Primer Express Software version 3.0 (instructions available at 
http://docs.appliedbiosystems.com/pebiodocs/04362460.pdf) and their sequences are listed in 
Table 12.  Primer efficiencies were calculated using methods described on the Applied 
Biosystems website (www.appliedbiosystems.com).  Quantitative PCR analysis in real time was 
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performed with Applied Biosystems 7300 system to detect SYBR green fluorescence intensities.  
Ten-fold dilutions of cDNA, 0.5 µM primer, and SYBR green 2x PCR mix (Applied 
Biosystems) were used in 20 µl reactions.  All reactions were performed in triplicate.  PCR 
conditions were performed as follows:  1 cycle of 94o C for 10 minutes, followed by 40 cycles of 
94o C for 15 seconds, 60o C for 30 seconds, and 72o C for 45 seconds.  Data were collected 
during the 72o C stage.  Dissociation curves show that only one PCR product was created in each 
reaction.  Relative Ct values for a given gene were calculated by dividing the change in 
expression at that given gene, like ZRT1, by the change in expression at a control gene, SCR1.   
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Table 12. Table of primers used for real time PCR. 
Primer name Gene Sequence (5’ to 3’) 
MBO178 SCR1 (forward) CGCACCGTGCCCTGTT 
MBO179 SCR1 (reverse) AGCTCTGCCCAGGACAAATTT 
MBO180 ZRT1 (forward) CAAAGTATTTTGGTTCCGGTGTT 
MBO181 ZRT1 (reverse) GTACCACCAATCGCACCATAAG 
MBO182 DUR3 (forward) AGCATGTCTTGCGGTGGAA 
MBO183 DUR3 (reverse) TTTGCCTGGAACGAAGTAAGTG 
MBO184 BNA2 (forward) GGTTTATGGCGCACGCTTAT 
MBO185 BNA2 (reverse) CAACAGTGGCCTTGCAATACA 
MBO186 HXK1 (forward) AAGGTTTGACAAAGAAGGGAGGTA 
MBO187 HXK1 (reverse) CCCAAATCAATGGCCAAATAGT 
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5.3 RESULTS 
5.3.1 Microarray analysis shows that Rkr1 affects the expression of a subset of genes in 
yeast 
Many accessory transcription factors have been shown to affect only a subset of yeast genes, and 
not genome-wide transcription, presumably due to redundancy of many of these factors.  Strains 
lacking RKR1 are Ino-, a phenotype indicative of general transcription defects (HAMPSEY 1997) 
(see Chapter 2).  I also uncovered physical interactions between Rkr1 and several transcriptional 
regulators (see Chapter 4 for details).  To investigate the global role of Rkr1 in transcription, I 
performed DNA microarray analysis using Affymetrix Microarrays in collaboration with Martin 
Schmidt’s lab in the Department of Molecular Genetics and Biochemistry at the University of 
Pittsburgh Medical School.  Total RNA isolated from wild type and rkr1Δ strains (grown in 
triplicate) was used to make cDNA.  Rhonda McCartney, of the Schmidt lab, used in vitro 
transcription to generate cRNA, which was biotinylated and hybridized to Affymetrix arrays that 
contained oligonucleotides that represented every open reading frame (ORF) in yeast.  The 
Microarray Core Facility generated target intensity profiles for both wild type and rkr1Δ strains.   
My initial attempts to investigate gene expression profiles in rkr1Δ strains were 
performed using RNA from strains grown in rich medium.  However, I detected no changes in 
gene expression (greater then 1.2 fold) under these conditions (Figure 40).  I attempted to 
determine if there were conditions under which I could see Rkr1-dependent gene expression 
changes.  I recalled the observation that rkr1Δ strains that have defects in histone modifications 
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grew very poorly on minimal medium (see Chapter 2 for details).  Also, Richard Gardner had 
performed microarray experiments to characterize San1, another nuclear, ubiquitin-protein ligase 
that is important for degradation of mutant transcription factors and mutant silencing factors 
(GARDNER et al. 2005).  Dr. Gardner could not detect  significant changes in gene expression 
when san1Δ strains were grown in rich medium, but determined that the expression of many 
stress response genes changed when san1Δ strains were grown in minimal medium (GARDNER et 
al. 2005).  For these reasons, I decided to investigate gene expression profiles in rkr1Δ strains 
that were grown in minimal medium.  I again collaborated with the Schmidt lab to perform these 
experiments, and we obtained target intensity profiles for strains grown in minimal medium from 
the Core Facility.  I calculated the relative amount of gene expression in wild type and rkr1Δ 
strains and found a subset of affected genes (Figure 40).  Genes that are affected greater than 
1.75 fold (arbitrary value) are listed in Tables 13 and 14.  At this cutoff, Rkr1 appears to be 
important for the expression of 34 genes and Rkr1 appears to be important for the repression of 
76 genes in yeast (Tables 13 and 14).  The positioning of these genes in yeast suggests that Rkr1 
does not affect the expression of genes located at a particular genomic location, i.e. telomeric 
regions (data not shown).   
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Figure 40. Rkr1 affects the expression of a subset of yeast genes when strains are grown in minimal 
medium. 
A) Scatterplot representing changes in gene expression between wild type and rkr1Δ strains 
grown in rich medium.  Each dot represents a gene.  If a given gene is expressed equally in wild 
type and rkr1Δ strains, it will fall along a diagonal line with a slope of 1.0.  The majority of 
genes fall along this line when strains are grown in rich medium.  RKR1 and kanMX4 (drug 
resistance gene that replaces RKR1 in the null) are marked.  B)  Scatterplot representing changes 
in genes expression between wild type and rkr1Δ strains grown in minimal medium.  Each dot 
represents a gene.  If a given gene is expressed equally in wild type and rkr1Δ strains, it will fall 
along a diagonal line with a slope of 1.0.  Several genes fall off of this line when strains are 
grown in minimal medium.  Pink dots represent the genes whose expression changes greater than 
1.75 fold.  RKR1 and kanMX4 (drug resistance gene that replaces RKR1 in the null) are marked.   
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Table 13. . List of genes that require Rkr1 for full expression. 
Gene Fold change Standard deviation 
ERG10 -1.68 1.16 
PUT1 -1.73 1.09 
RGS2 -1.74 1.29 
PRM1 -1.74 1.21 
YPR157W -1.75 1.14 
YRF1-5 -1.75 1.30 
CAD1 -1.75 1.53 
YLR126C -1.75 1.07 
YIL080W -1.78 1.15 
DAL7 -1.79 1.27 
AGA2 -1.80 1.18 
TPO4 -1.90 2.86 
DAL5 -1.91 1.06 
SUL1 -1.92 1.66 
STP4 -1.94 1.33 
INO1 -1.95 3.81 
OPT1 -1.97 1.27 
RMD6 -1.97 1.89 
HSP30 -2.00 1.96 
PRY1 -2.00 1.05 
MUP1 -2.01 1.43 
RPI1 -2.03 1.34 
AGA1 -2.05 1.24 
MDH2 -2.12 1.39 
DAL80 -2.18 1.58 
PHO84 -2.19 1.37 
YJR088C -2.20 1.14 
DUR3 -2.33 1.19 
WSC4 -2.35 1.02 
DAL4 -2.52 1.31 
ITR1 -2.65 1.94 
YPL095C -3.16 1.45 
ZRT1 -6.51 2.23 
 
Genes that are shaded gray were found to be significant by SAM analysis. 
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Table 14. List of genes that require Rkr1 for their repression. 
Gene Fold change Standard deviation 
YOL053C 7.69 1.64 
YGP1 5.11 1.33 
HXK1 4.97 1.33 
SOL4 4.36 1.23 
YCL042W 4.21 1.67 
GLK1 4.17 1.37 
PNC1 3.60 1.20 
HSP82 3.38 1.41 
COS8 3.27 1.67 
HSP12 3.15 2.69 
HXT5 3.05 1.44 
MSC1 3.02 1.20 
HSP104 2.96 1.30 
RPP1B 2.93 1.24 
YDR034W 2.87 1.43 
AHA1 2.64 1.26 
COS8 2.64 1.90 
COS8 2.63 1.73 
HSP78 2.61 1.46 
HOR2 2.45 2.32 
YLR327C 2.42 1.27 
SSA1 2.28 1.36 
SSA1 2.22 1.36 
TFS1 2.18 1.24 
PGM2 2.16 1.21 
HSP26 2.16 1.48 
INH1 2.13 1.24 
GPH1 2.10 1.08 
YBR085C 2.07 1.46 
ALD6 2.06 1.46 
PYC1 2.05 1.16 
YMR196W 2.05 1.32 
CAR2 2.01 1.67 
OXA1 2.01 4.27 
GNA1 2.00 3.43 
ZTA1 1.98 1.27 
CIT1 1.98 1.11 
ALD4 1.97 1.12 
YFR016C 1.97 3.33 
YHR087W 1.96 1.16 
TSA2 1.94 1.18 
YNL274C 1.93 1.11 
COS5 1.93 1.32 
SSA4 1.91 1.35 
NCA3 1.91 1.62 
DCS2 1.90 1.38 
AMS1 1.89 1.20 
GSY2 1.88 1.29 
COS7 1.87 1.38 
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Gene Fold change Standard deviation 
GPG1 1.86 1.35 
BNA6 1.86 3.22 
YER163C 1.86 1.88 
BNA2 1.86 1.38 
SSA2 1.86 1.23 
HXT2 1.85 1.49 
GPD1 1.85 1.34 
TVP15 1.85 1.27 
GAD1 1.85 1.35 
TPK1 1.84 1.49 
TPS1 1.83 1.50 
TSL1 1.83 1.26 
YBR056W 1.83 1.57 
UBP5 1.82 2.51 
YBR230C 1.82 1.15 
COS1 1.82 1.21 
KAR2 1.82 1.06 
LSP1 1.81 1.22 
YMR31 1.80 2.35 
COS5 1.79 1.22 
YHR138C 1.78 1.38 
EMI2 1.77 1.36 
YFL044C 1.77 1.58 
IDH2 1.77 1.51 
RAD51 1.76 1.82 
STI1 1.76 1.06 
SEC53 1.76 2.17 
ATG18 1.75 1.81 
 
Genes that are shaded gray were found to be significant by SAM analysis. 
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5.3.2 SAM analysis suggests that Rkr1 significantly affects the expression of 73 genes in 
yeast 
 In parallel with the data analysis described above, I performed “significance analysis of 
microarrays” (SAM) analysis on the three datasets.   This program uses statistical analysis to 
determine significant changes in gene expression in microarray data sets (TUSHER et al. 2001).  
SAM calculates a value for each gene that represents a correlation in gene expression in different 
conditions, in this case, gene expression in wild type versus rkr1Δ strains.  The level of 
significance is user-defined by a delta value, which determines the false-positive rate.  The user 
can also define the minimal fold-change, to ensure that all outputs are affected by a specified 
fold-change.  I entered log2-based values that were collected from the University of Pittsburgh 
Microarray Core Facility.  I chose to pair my experiments because they were performed on 
different days with different reagents, and while the changes in gene expression were the same 
(up- versus down-regulated), the actual values for the different experiments were different 
enough to cause a large standard deviation, which may affect the output of the program.  I also 
tried many different delta values, and fold-change values.  With a delta value of 0.28 and a fold-
change value of 1.75, SAM analysis determined that there are 75 genes affected by the loss of 
Rkr1 (Tables 13 and 14), with a false-positive rate of 15.2%.  More specifically, 49 genes are up-
regulated and 24 genes are down-regulated in a rkr1Δ strain.    Most of these genes are found in 
the list of genes that are affected greater than 1.75 fold using mathematical ranking of expression 
changes that I described in the last section (Tables 13 and 14).  These results provide statistical 
significance for the observed Rkr1-dependent effects on the expression of a subset of genes in 
yeast. 
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5.3.3 Real-time PCR confirms that several genes are affected by the loss of RKR1 
Real-time PCR was performed to confirm the changes in gene expression at four yeast genes that 
were detected in the microarray experiments.  First, I chose to investigate expression changes at 
ZRT1 and HXK1, which were the two genes most affected by the loss of RKR1 (Table 15).  In 
microarray experiments, ZRT1 expression is 6.5 fold decreased, and HXK1 expression is 5 fold 
increased in rkr1Δ strains compared to wild type strains.  ZRT1 encodes a membrane protein that 
acts as a high affinity zinc transporter in yeast and this gene is up-regulated in response to zinc 
limiting conditions in wild type strains (ZHAO and EIDE 1996).  HXK1 encodes a cytoplasmic 
hexokinase isoenzyme which acts in the glucose degradation pathway (KOPETZKI et al. 1985).   
I also chose to follow up expression changes of DUR3.  According to microarray 
experiments, DUR3 expression is 2.3 fold decreased in rkr1Δ strains (Table 15).  This gene 
encodes a membrane urea transporter and its expression is regulated by the nitrogen-catabolic 
pathway (ELBERRY et al. 1993).  In wild type cells, DUR3 expression is induced by allophanate, 
the last intermediate in the allantoin degradative pathway (ELBERRY et al. 1993).  Interestingly, 
this gene is repressed by Gzf3 and activated by Dal82, two proteins that interact with the amino 
terminus of Rkr1 in a yeast-two hybrid screen (see Chapter 4 for details).   
The fourth gene that I chose to follow up is BNA2.  BNA2 expression is increased 1.85 
fold in rkr1Δ strains compared to wild type strains (Table 15).  BNA2 encodes an enzyme that 
acts in the nicotinamide-adenine-dinucleotide (NAD) biosynthesis pathway (FUKUZUMI et al. 
2001).  Interestingly, strains lacking the Paf1 complex member, Ctr9, have decreased expression 
of BNA1 and BNA6 and increased expression of ZRT1 in rich medium (SHELDON 2005) (see the 
next section for further analysis).  BNA1 and BNA6 encode enzymes that also act in the NAD 
biosynthesis pathway downstream of Bna2 (PANOZZO et al. 2002) (Figure 41).   
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I isolated RNA from wild type and rkr1Δ strains (grown in triplicate) in minimal medium 
and generated cDNA.  I used the cDNA in real-time PCR reactions with primers specific to 
ZRT1, HXK1, DUR3, BNA2, and SCR1 (internal control).  The results of this analysis show that 
all genes tested are affected by the loss of Rkr1 (Table 15).  While the absolute numbers are 
different, the trends are consistent between microarray and real-time PCR results, which suggests 
that Rkr1 does affect the expression of a subset of genes in yeast.   
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Figure 41. The NAD biosynthesis pathway in yeast. 
Schematic view of the intermediates, enzymes and genes involved in NAD+ biosynthesis via the 
kynurenine pathway or by direct incorporation of nicotinic acid.  Note that Bna1, Bna2 and Bna6 
all act in this pathway.  From Panozzo, C. et al. (2002) FEBS Letters. 517:97-102. 
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Table 15.  Confirmation of microarray results with realtime PCR. 
Gene Array results Real-time results 
HXK1 5x up 2.2x up 
ZRT1 6.5x down 4.5x down 
DUR3 2.3x down 3.5x down 
BNA2 1.9x up 1.6x up 
 
Values shown represent the fold change of gene expression in rkr1Δ strains compared to wild 
type levels.  Strains used are KY595 (wild type) and MBY30 (rkr1Δ). 
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5.3.4 Some yeast genes appear to be oppositely affected by the loss of Rkr1 and Rtf1 
Surprisingly, Rkr1 affected the expression of genes that Kathryn Sheldon had shown to be 
affected by the loss of Ctr9 (SHELDON 2005).  Specifically, these genes were oppositely affected 
by the loss of Rkr1 and Ctr9.  For example, ZRT1 expression is decreased in a ctr9Δ strain, but 
increased in a rkr1Δ strain (Table 16).  Also, BNA2 expression was increased in rkr1Δ strains, 
while BNA1 and BNA6 expression decreased in ctr9Δ strains (Table 16).  Because Dr. Sheldon’s 
data came from strains grown in rich medium and my data came from strains grown in minimal 
medium, I used real-time PCR to compare expression of ZRT1, HXK1, DUR3, and BNA2 in wild 
type, rtf1Δ, ctr9Δ and rkr1Δ strains grown in minimal medium (Table 16).  The results of this 
analysis show that DUR3 appears to be oppositely regulated by Rkr1 and the Paf1 complex 
members Rtf1 and Ctr9 in minimal medium.  ZRT1 may be oppositely regulated as well, but the 
increased expression in rtf1Δ and ctr9Δ strains is minimal.  HXK1 and BNA2 expression 
increased in all mutant strains tested compared to wild type, although BNA2 levels were more 
affected by the loss of the Paf1 complex members than by the loss of Rkr1.  Although the 
mechanism of this phenomenon is currently unknown, it appears as though Rkr1 and Paf1 
complex oppositely regulate the expression of a subset of genes in yeast.   
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Table 16. Real-time PCR shows that Rkr1, Rtf1 and Ctr9 regulate an overlapping set of genes in 
minimal medium. 
 ZRT1 HXK1 DUR3 BNA2 
rkr1Δ 4.4x down 2.2x up 3.5x down 1.6x up 
rtf1Δ 0.99 (no change) 4.3x up 5.7x up 3.9x up 
ctr9Δ 1.5x up 3.3x up 2.9x up 13.7x up 
 
*All values represent fold change in expression relative to wild type strains grown in 
minimal medium.  Strains used are KY592 (wild type), KY951 (rtf1Δ), MBY169 (rkr1Δ), and 
KY694 (ctr9Δ).   
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5.3.5 Information obtained in the yeast two-hybrid screen overlaps with information 
obtained in microarray experiments 
Interestingly, I observed an overlap in the yeast two-hybrid screen and microarray 
datasets.  Gzf3 and Dal82 negatively and positively regulate many genes involved in nitrogen 
metabolism, respectively.  The expression of many of the genes that are regulated by these 
factors was decreased in strains lacking RKR1 (Table 17).   
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Table 17.  An overlap in the microarray and yeast-two hybrid screen datasets. 
 
 
 
Description# 
hits
Protein
Transcription activator1Dal82
Transcription repressor1Gzf3
Two-hybrid screen proteins
1.9DAL5
2.4DAL4
2.3DUR3
2.2DAL80
1.8DAL7
Fold decrease in rkr1ΔGene
Microarray genes
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5.4 CONCLUSIONS 
This chapter describes my attempts to identify a role for Rkr1 in transcription in yeast.  I used 
Affymetrix microarray analysis to assess transcription levels of every gene in yeast in wild type 
and rkr1Δ strains.  When strains were grown in rich medium, I saw no attenuation in the 
expression of any genes.  However, when strains were grown in minimal medium, I detected that 
Rkr1 affects the expression of a subset of genes, specifically 34 genes are up-regulated greater 
than 1.75 fold, and 76 genes are down-regulated greater than 1.75 fold in strains lacking RKR1.  
The significance analysis of microarrays (SAM) program determined that many of these genes 
are significantly affected by the loss of Rkr1.   
I used real-time PCR to confirm changes in gene expression in strains lacking RKR1 
compared to wild type strains.  The results show that Rkr1 is important for wild type expression 
of all four genes tested with this method, ZRT1, HXK1, DUR3, and BNA2.  Interestingly, I 
noticed that Rkr1 and the Paf1 complex oppositely affect the expression of a subset of genes in 
yeast.  Specifically, DUR3 expression increased in rkr1Δ strains, and decreased in rtf1Δ and 
ctr9Δ strains.  While I have yet to uncover the mechanism that is responsible for this result, I can 
conclude that Rkr1 affects the transcription of a subset of genes and that the expression of some 
of these genes is oppositely regulated by the Paf1 complex in yeast.   
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6.0  DISCUSSION 
6.1 SUMMARY OF RESULTS 
In my work, I have characterized a previously unstudied nuclear RING domain protein, Rkr1, 
and provided evidence to suggest a role for this protein in transcription and chromatin function.  
Rkr1 was identified in a genetic screen for factors that become essential in the absence of the 
Paf1 complex component Rtf1, a protein required for several histone modifications that mark 
active genes.  Several lines of evidence implicate Rkr1 in the regulation of chromatin structure or 
function (Table 18).  In addition to Rtf1, Rkr1 exhibits genetic interactions with several other 
factors involved in chromatin modification.  Specifically, Rkr1 exhibits strong genetic 
interactions with factors required for histone H2B ubiquitylation and histone H3 K4 methylation.  
Additional evidence linking RKR1 to chromatin modification is its synthetic lethal relationship 
with SPT10, a gene that encodes a protein that is required for normal expression of the histones.  
Consistent with a role in chromatin structure and histone modification, I show that strains 
lacking either RKR1 or SPT10 have defects in telomeric silencing.   
From data obtained in my in vitro experiments, I propose that the RING domain of Rkr1 
is required for the ubiquitylation of one or more nuclear proteins.  A yeast two-hybrid screen 
identified twenty proteins that physically interact with Rkr1, many of which are involved in 
transcription and chromatin function.  Microarray experiments show that Rkr1 is required for the 
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proper expression of a subset of genes in yeast.  In summary, my results indicate the existence of 
a new nuclear protein ubiquitylation pathway that is functionally connected to chromatin and 
transcription. 
These results have established a foundation for many future experiments that will 
continue to elucidate Rkr1’s role in transcription and chromatin function.  In this section I will 
briefly discuss the results that have been described in the previous chapters and address questions 
that arise from the data that have been presented. 
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Table 18. Summary of evidence that suggests a role for Rkr1 in regulating chromatin function. 
 
 
Telomeric silencing defect in rkr1Δ strain 
Inositol auxotrophy of rkr1Δ strains 
Sporulation defect in rkr1Δ/rkr1Δ diploids 
Nuclear localization of Rkr1 
Genetic interactions with histone modifiers RAD6/BRE1 and SET1 
Physical interactions with RSC8 (chromatin remodeling complex) 
Genetic interaction with CHD1 (chromatin remodeler) 
Genetic interaction with SPT10 (activates histone gene expression) 
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6.2 GENETIC ANALYSIS SUGGESTS THAT RKR1 IS FUNCTIONALLY 
CONNECTED TO CHROMATIN MODIFICATIONS THAT MARK ACTIVE 
TRANSCRIPTION 
6.2.1 How can we interpret the synthetic lethality observed in rkr1Δ rtf1Δ strains? 
Strains lacking RTF1, but not other members of the Paf1 complex, are inviable when RKR1 is 
deleted.  This observation is noteworthy because mutant phenotypes and protein stabilities 
suggest that Paf1 and Ctr9 are integral members of the Paf1 complex, while Rtf1 appears to be a 
more peripheral member of the complex (BETZ et al. 2002; MUELLER et al. 2004; SQUAZZO et al. 
2002). Interactions between rtf1Δ and rkr1Δ indicate that Rtf1 performs a function for which 
Paf1 and Ctr9 are not sufficient.  Importantly, Rtf1 appears to be the only member of the 
complex that is essential for normal H3 K4 and K79 methylation (M.H. Warner and K.M. Arndt, 
unpublished observations).  Although Paf1 has been shown to be important for these 
modifications (KROGAN et al. 2003a; NG et al. 2003a; NG et al. 2003b), paf1Δ strains have 
significantly reduced levels of Rtf1 protein (MUELLER et al. 2004; SQUAZZO et al. 2002), which 
may explain the decreased levels of H3 K4 and K79 methylation in the absence of Paf1.  The 
synthetic lethal interaction between RTF1 and RKR1 is also specific to RKR1; deletion of SAN1, 
a gene encoding another nuclear RING protein, exhibits no synthetic interactions with rtf1Δ (data 
not shown).  
I have also observed that removal of residues 62-152 of Rtf1 (rtf1Δ3 and Δ4), which are 
responsible for histone H2B ubiquitylation and histone H3 K4 and K79 methylation, causes 
 246 
severe growth defects on minimal medium when combined with the loss of RKR1.  Genetic 
results from my work indicate that removing amino acids 62-152 of Rtf1 interferes with 
Rad6/Bre1 activity, as similar phenotypes are observed with rad6Δ rkr1Δ and bre1Δ rkr1Δ 
strains.  These results suggest that the synthetic lethality of rtf1Δ rkr1Δ strains is largely due to 
the combined loss of the Rtf1-dependent chromatin modifications and yet unknown Rkr1-
dependent chromatin function(s).  However, it is not clear why rtf1Δ3 rkr1Δ and rtf1Δ4 rkr1Δ 
double mutants are viable, while rkr1Δ cells containing a complete deletion of RTF1 are not.  
Presumably the synthetic lethality between rtf1Δ and rkr1Δ is due to the absence of more than 
one activity of Rtf1.  Considering the genetic interaction between RKR1 and CHD1, a chromatin 
remodeler that physically interacts with Rtf1 (SIMIC et al. 2003), the synthetic lethality between 
rkr1Δ and rtf1Δ may be due to the loss of a chromatin structure that is conducive to active 
transcription.  The failure to transcribe essential genes effectively may result in lethality. 
The poor growth phenotype that is observed on SD minimal medium (but not SC 
medium) could be due to a number of factors.  SD medium consists of ammonium sulfate, yeast 
nitrogen base, and glucose, and is supplemented with the minimal amino acids that yeast require 
to survive.  SC medium contains ammonium sulfate, yeast nitrogen base, glucose, and a mixture 
containing all amino acids along with other compounds, including para-aminobenzoic acid 
(PABA; component of B vitamin complexes in yeast), uracil, and inositol.  It is possible that the 
SD- strains that I have described could have defects in transcribing the genes that are required to 
synthesize the components that are found in SC but not SD medium.  To determine what these 
compounds are, SC medium that lacks individual components (or groups of components) that are 
not found in SD medium could be created and we could investigate growth of rkr1Δ rtf1Δ3 
strains on these media.  These strains should grow more poorly on the SC deficient medium than 
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wild type or single mutant strains.  We could also investigate the transcription profiles of double 
mutant strains (eg. rkr1Δ rtf1Δ3) grown in minimal medium and compare gene expression to 
single mutant and wild type strains.  This information could uncover a more global role for Rkr1 
in gene expression and assist us in understanding Rkr1’s function in vivo.   
6.2.2 Why is telomeric silencing disrupted in rkr1Δ strains? 
To gain a better understanding of Rkr1’s role in chromatin function, I investigated Rkr1’s role in 
telomeric silencing.  This process heavily depends on the proper distribution of chromatin 
modifications, where the silenced chromatin contains hypomethylated and hypoacetylated 
histones (reviewed in RUSCHE et al. 2003).  Consistent with a role for Rkr1 in chromatin 
structure and/or function, strains lacking Rkr1 exhibit telomeric silencing defects (Chapter 2).  
However, silencing is not disrupted at the mating loci or ribosomal DNA in rkr1Δ strains.  
Chromatin immunoprecipitations (ChIPs) show that incorporation of histones H3 and H4 and 
histone H4 acetylation are unaffected in rkr1Δ strains, which suggests that histone H3 and H4 
deposition and acetylation do not play a role in the Rkr1-dependent telomeric silencing 
mechanism.  Silencing at telomeres appears to be more easily perturbed than silencing at the 
other two silenced regions of the genome, suggesting that Rkr1 is not causing a severe 
disturbance in chromatin function in vivo.  This idea is supported by the lack of strong 
transcription-related phenotypes in rkr1Δ strains.   
 There are a few possible explanations for why only telomeric silencing is disrupted in 
rkr1Δ strains.  First, Rkr1 could be important for the deposition of other histones into chromatin, 
particularly at telomeric boundaries.  Specifically, the H2A variant Htz1 is important for 
establishing a “boundary element” between euchromatin and the telomeres (MENEGHINI et al. 
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2003).  Rkr1 may be important for proper positioning of this histone variant into chromatin.  
Genetic analysis of rkr1Δ and rtf1Δ strains that lack HTZ1 or SWR1 complex members (required 
for Htz1 incorporation into chromatin) could determine if this hypothesis is viable.  
Alternatively, Rkr1 may be important for histone modification(s) throughout the genome, and the 
telomeric silencing defects may be due to loss of those marks.  Support for this model is found in 
the genetic data that Rkr1 functions in parallel with transcriptionally active chromatin marks.  
Rkr1 may affect telomeric silencing through a mechanism that is similar to Rtf1, where the loss 
of global chromatin modifications dilutes the Sir proteins from the telomeres.  However, I do not 
favor this idea because Sir2 dependent histone H4 acetylation patterns are not disrupted in rkr1Δ 
strains (Chapter 2), suggesting that Rkr1 does not significantly affect Sir protein association with 
the telomeres.  A targeted approach using Western analysis or genetic analysis with strains 
containing mutations in known histone modifiers or mutations in the histone genes could be used 
to investigate Rkr1’s role in transcriptionally active histone modifications.  Additional insight 
into Rkr1’s role in telomeric silencing could be gained from studies to determine if 
overexpression of Rkr1 could suppress telomeric silencing defects caused by the loss of other 
proteins involved in silencing, including Set1, Rtf1, and the Sir proteins.  Suppression of a 
silencing defect could narrow Rkr1’s function in telomeric silencing. 
 Another possible explanation for the telomeric silencing defect could be that telomere 
length is disrupted in rkr1Δ strains.  A study of nonessential yeast genes that are required for 
proper telomere length identified many transcription factors, including components of Mediator, 
Rad6/Bre1 and members of the Paf1 complex (all but CTR9) (GATBONTON et al. 2006).  This 
study made use of the “deletion collection” of yeast strains, which consists of approximately 
4800 strains that each contain a separate deletion of a nonessential open reading frame.  While 
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this study showed that loss of the Paf1 complex or loss of Rad6/Bre1 results in shortened 
telomeres, Rkr1 was not identified as a factor that is required for proper telomere length.  
However, our lab does not regularly use the deletion collection strains.  Because of the functional 
connection between Rkr1 and the Paf1 complex and H2B ubiquitylation, I believe that it is 
possible that Rkr1 may also regulate telomere length.  While I do not know how or why the Paf1 
complex or Rad6/Bre1 affect telomere length, I could postulate that the loss of the Sir proteins 
from the telomeres results in an “unraveling” of the telomeric chromatin structure, which could 
affect the recruitment and/or activity of telomerase or DNA rearrangements involving the 
telomeres.  There could also be an unknown Paf1-dependent mechanism that affects telomere 
length maintenance, and this process could involve Rkr1. 
6.2.3 What do the genetic interactions between RKR1 and factors involved in chromatin 
modification tell us? 
Several lines of evidence implicate Rkr1 in the regulation of chromatin structure or function. 
Rkr1 exhibits strong genetic interactions with factors required for histone H2B ubiquitylation 
and histone H3 K4 methylation. Specifically, rkr1Δ strains containing an amino acid replacement 
for lysine 123 on histone H2B grow very poorly. In addition, rkr1Δ set1Δ and rkr1Δ hht2-K4R 
double mutants grow very poorly on minimal media. In contrast, no synthetic phenotypes were 
observed between rkr1Δ and dot1Δ, which methylates histone H3 at K79. This is surprising 
because both histone H3 K4 and K79 methylation depend on histone H2B K123 ubiquitylation. 
Therefore, my data suggest that these modifications have distinct functions in vivo and that Rkr1 
is most strongly connected to histone H2B ubiquitylation. 
Interestingly, strains that lack RKR1 and contain point mutations within RTF1 that disrupt 
 250 
histone modifications exhibit genetic interactions.  Specifically, rkr1Δ strains that contain the 
rtf1-108-110A and rtf1-F123S mutations, but not the rtf1-102-104A mutation, grow poorly on SD 
minimal medium.  The rtf1-108-110A and rtf1-F123S mutations disrupt histone H3 K4 
methylation but not K79 methylation, but the rtf1-102-104A mutation only moderately disrupts 
histone H3 K4 methylation levels (M. Warner, K. M. Arndt, unpublished observations).  The 
status of histone H2B ubiquitylation levels has not been investigated in these strains, but the loss 
of K4 methylation suggests that H2B ubiquitylation will be disrupted.  These observations 
further support a model in which Rkr1 functions in parallel with histone H2B ubiquitylation and 
histone H3 K4 methylation, but not histone H3 K79 methylation.   
6.2.3.1 Does Rkr1 function to regulate histone modification(s)? 
I observe strong genetic interactions between RKR1 and genes encoding histone 
modification enzymes, specifically those enzymes that are required for histone H2B 
ubiquitylation and H3 K4 methylation.  These histone modifications are Rtf1-dependent and are 
associated with actively transcribing genes (KROGAN et al. 2003a; KROGAN et al. 2003b; NG et 
al. 2003a; NG et al. 2003b; POKHOLOK et al. 2005; WOOD et al. 2003b).  This suggests that Rkr1 
functions in parallel with histone modifications that are associated with active transcription, 
possibly by mediating chromatin modifications that are associated with activate transcription,  
Specifically, histone acetylation is also associated with actively transcribing genes (POKHOLOK et 
al. 2005).  It is possible that Rkr1 is required for histone acetylation at actively transcribed genes.  
However, I did not observe any genetic interactions between RKR1 and GCN5, a histone 
acetyltransferase that functions at activated genes (IMOBERDORF et al. 2006; POKHOLOK et al. 
2005).  In addition, histone H4 acetylation levels are not altered in a rkr1Δ strains at the telomere 
on the right arm of chromosome VI (Chapter 2) This suggests that Rkr1 may not function in 
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histone H4 acetylation or Gcn5-dependent histone acetylation, but may affect transcription and 
chromatin function another way, perhaps by working with another histone acetyltransferase that 
is recruited to actively transcribing genes. 
Further genetic analysis will be required to gain a better understanding of Rkr1’s role in 
chromatin structure and function.  Genetic analysis using strains that express histones that lack 
the amino-terminal tails could provide insight into which histone tails (and possibly which 
modifications) are required in the absence of RKR1.  Subsequent analysis using strains that 
contain point mutations in the histone genes could identify the residues that function in parallel 
with Rkr1.  Genetic analysis using rkr1Δ strains and strains that lack histone chaperones could 
uncover a role for Rkr1 in chromatin architecture and formation.   
6.2.4 What do the phenotypes that are observed in rkr1Δ strains mean? 
During the course of my work, I discovered that homozygous rkr1Δ diploid strains do not 
sporulate.  This phenotype has been described for dipoid yeast strains that lack other factors that 
regulate transcription and chromatin function, including BRE1, RAD6, CTK1, GCN5, LEO1, 
PAF1, RTF1, SPT4, and SPT10 (ENYENIHI and SAUNDERS 2003).  A global study identified 334 
genes that are required for sporulation, including those genes that are listed above (ENYENIHI and 
SAUNDERS 2003).  However, RKR1 was not shown to be required for sporulation in this study.  
The discrepancy in the data may be explained by genetic variation in the strain backgrounds, or, 
is more likely due to an error in the rkr1Δ in the commercially available deletion collection.   
Therefore, the failure to identify RKR1 in global sporulation studies may not be surprising.  
Further characterization of Rkr1’s function is needed to appreciate the mechanism by which 
Rkr1 regulates sporulation.   
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rkr1Δ strains grow poorly on medium lacking inositol.  This phenotype is associated with 
general transcription defects (HAMPSEY 1997), and strains that exhibit this phenotype often have 
defects in expressing inositol biosynthesis (INO) genes.  Microarray analysis identified INO1 as 
a gene that has decreased expression in a rkr1Δ strain grown in minimal medium, suggesting that 
Rkr1 is required for INO1 expression.  However, directed analysis of INO1 expression (Northern 
analysis) in rkr1Δ strains grown in minimal medium did not detect changes in INO1 expression 
compared to wild type strains.  I currently do not understand the observed difference between the 
phenotype and INO1 expression studies.  A possible explanation could be that this gene can be 
affected by cell density at the time of induction. Further understanding of Rkr1’s role in 
chromatin function should help to elucidate an explanation for this phenotype.   
6.2.5 How can we explain the genetic interactions between RKR1 and transcription 
factors? 
6.2.5.1 Why are rkr1Δ spt10Δ strains inviable? 
Additional evidence linking RKR1 to chromatin modification is its synthetic lethal 
relationship with SPT10. Spt10 regulates the transcription of many genes in yeast, particularly 
histone genes, and is important for histone H3 K56 acetylation at histone gene promoters in vivo 
(DOLLARD et al. 1994; HESS et al. 2004; XU et al. 2005).  However, a recent report indicates that 
Spt10 is not required for global histone H3 K56 acetylation (SCHNEIDER et al. 2006b).  Here, I 
show that Rkr1 does not affect histone gene expression nor does it regulate a process that 
overlaps with histone H3 K56 acetylation, supporting the idea that Spt10 has functions 
independent of histone H3 K56 acetylation. 
Strains lacking SPT10 are synthetically lethal with the loss of the histone chaperones 
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including CAF1 and the HIR genes, suggesting that Spt10 functions in parallel with histone 
incorporation into chromatin (D. Hess and F. Winston, personal communication).  The synthetic 
lethality between RKR1 and SPT10 suggests that Rkr1 could be important for histone deposition 
into chromatin.  Strains lacking Spt10 have reduced histone levels (DOLLARD et al. 1994; 
ERIKSSON et al. 2005; HESS et al. 2004), but our work has shown that rkr1Δ strains express the 
histone genes at levels that are similar to those observed in wild type strains.  If Rkr1 is 
important for incorporation of histones into chromatin, the inviability of a rkr1Δ spt10Δ strain 
could be explained by a synergistic effect on chromatin formation, where low levels of histone 
proteins (spt10Δ) are poorly incorporated into chromatin (rkr1Δ), resulting in disruption of 
chromatin structure that is too severe to sustain viability.  However, chromatin 
immunoprecipitation analysis shows that rkr1Δ strains have wild type levels of histones H3 and 
H4 incorporated at telomere-proximal locations, suggesting that Rkr1 may not be required for 
histone incorporation in this region.  Genetic analysis using strains lacking RKR1 and strains 
containing mutations in histone chaperone genes could be used to determine if Rkr1 is connected 
to histone incorporation into chromatin.   
6.2.5.2 Why are rkr1Δ srb5Δ strains inviable? 
Strains lacking RKR1 and SRB5 are inviable (Chapter 2).  Srb5 is a subunit of the 
Mediator coactivator complex.  While I do not understand the basis for this genetic interaction, it 
implies that Rkr1 is important for proper transcription initiation.  Strains lacking RTF1 that 
contain a point mutation in SRB5 (srb5-77) are also inviable, but rtf1Δ srb5Δ strains are not 
(COSTA 2001).  Subsequent analysis showed that the rtf1Δ srb5-77 genetic interaction was 
specific; RTF1 did not genetically interact with other Mediator subunits.  Strains that contain the 
srb5-77 mutation are sensitive to 6 azauracil (COSTA 2001), suggesting that these strains have 
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transcription elongation defects.  Genetic analysis using rkr1Δ srb5-77 double mutant strains has 
yet to be performed.  A genetic interaction with srb5-77 would implicate Rkr1 in the regulation 
of transcription.   
Mediator is composed of three modules, known as head, middle and tail domains 
(GUGLIELMI et al. 2004).  The head and middle domains are important for physical interactions 
with RNA Pol II (DAVIS et al. 2002).  The tail domain has been shown to physically interact with 
activators (HAN et al. 1999; PARK et al. 2000).  Srb5 is part of the head domain (GUGLIELMI et 
al. 2004).  Genetic analysis can be used to determine if other domains/activities of Mediator are 
required for viability in the absence of Rkr1.  
6.2.5.3 Why do rkr1Δ ctk1Δ strains grow poorly? 
Genetic analyses uncovered an interaction between RKR1 and CTK1, which encodes a 
CTD kinase.  Specifically rkr1Δ ctk1Δ strains grow poorly on rich medium.  Currently a 
mechanism to explain this observation is unknown.  Perhaps Rkr1 and Ctk1 are both required for 
optimal expression of a subset of essential genes in yeast.  Interestingly, Ctk1 is required for Set2 
recruitment to an actively transcribed gene (KROGAN et al. 2003b), suggesting that the sickness 
of rkr1Δ ctk1Δ strains may be due to combined effects of the loss of the unknown Rkr1-
dependent chromatin function and decreased H3 K36 methylation levels.  We have yet to 
determine if Rkr1 is important for H3 K36 tri-methylation.  However, no genetic interactions are 
observed in rkr1Δ set2Δ strains (Chapter 2), suggesting that Rkr1 does not function in parallel 
with histone H3 K36 methylation.  Further genetic analysis using strains that lack RKR1 and 
other CTD kinases and the CTD phosphatases could help uncover the cause of the poor growth 
of rkr1Δ ctk1Δ strains.   
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6.3 RKR1 IS A NUCLEAR, RING DOMAIN CONTAINING PROTEIN 
6.3.1 Rkr1 contains a functionally important RING domain 
Database analyses show that the only identifiable domain or motif in Rkr1 is a RING domain at 
the extreme carboxy terminus of the protein (Chapter 3).  Mutational analysis shows that the 
RING domain is required for Rkr1 function in vivo.  Although the mechanism that links Rkr1 to 
chromatin is unknown, the presence of a RING domain suggests that Rkr1 may post-
translationally modify transcription factors or chromatin components to alter their activity or 
stability.   
In most RING domains, the cysteine and histidine residues are arranged in either a 
C3HC4 or C3H2C3 sequence (PICKART 2001).  The C4HC3 pattern of the Rkr1 RING domain 
appears to be less common (DODD et al. 2004; HASSINK et al. 2005).  However, the solution 
structure of the C4HC3 RING domain of the Kaposi's sarcoma-associated herpesvirus K3 protein 
has been solved (DODD et al. 2004).  Chemical mutagenesis and two-hybrid analysis showed that 
this non-canonical RING domain interacts with ubiquitin conjugating enzymes on the same face 
of the RING domain as classical RING domains (DODD et al. 2004). 
RING domains bear sequence and structural similarity to another protein interaction 
domain, the plant homeodomain (PHD) finger (BIENZ 2006).  Interestingly, PHD fingers have 
recently been shown to interact with methylated lysine residues on histones (SIMS and REINBERG 
2006).  However, amino acids outside of the eight critical cysteine and histidine residues indicate 
that Rkr1 contains a RING domain and not a PHD finger.  The RING domain of Rkr1 contains a 
tryptophan four residues after the cysteine in the sixth position of the Cys/His sequence, and this 
amino acid is highly conserved among RING domain proteins (DODD et al. 2004).  In contrast, 
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PHD fingers contain an invariant tryptophan two positions amino-terminal to the seventh 
cysteine, a residue not found in Rkr1 (AASLAND et al. 1995). 
6.3.2 The RING domain of Rkr1 possesses ubiquitin ligase activity 
RING domain containing proteins often are ubiquitin-protein ligases that define substrate 
specificity within the ubiquitylation pathway.  In vitro experiments using purified E1 and E2 
components of the ubiquitylation machinery combined with purified GST fusions to the RING 
domain of Rkr1 show that GST-Rkr1 can promote polyubiquitylation of itself, indicating that 
Rkr1 is most likely a ubiquitin ligase in vivo.   
 I currently do not know the E2(s) with which Rkr1 functions in vivo, but several 
experiments could determine which ubiquitylation pathway utilizes Rkr1.  Directed yeast two-
hybrid experiments with Gal4-DNA binding domain fusions to Rkr1 and Gal4 activation domain 
fusions to the E2s should detect specific but transient interactions.  Also, directed double mutant 
analysis using rtf1Δ strains that contain mutations in the genes that encode the 11 ubiquitin E2s 
in yeast should yield the E2 that functions with Rkr1.  I would expect that an rtf1Δ strain that 
lacks the gene encoding an E2 would be inviable if a specific E2 functions with Rkr1.  In vitro 
experiments using purified E2 from yeast could confirm the results of the genetic analysis.   
6.3.2.1 What type(s) of ubiquitylation does Rkr1 catalyze? 
 Rkr1 may catalyze mono- or polyubiquitylation of substrates in vivo.  The results of the 
in vitro assay suggest that the RING domain of Rkr1 can catalyze protein polyubiquitylation, 
however the amino-terminal portion may be important for regulating ligase function in vivo.  If 
Rkr1 catalyzes polyubiquitylation, it would be interesting to determine which type(s) of ubiquitin 
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chains are formed.  Ubiquitin can be conjugated to itself to form polyubiquitin chains linked at 
one of six lysine residues within the ubiquitin protein sequence.  Linkages at lysines 48 and 63 
appear to be the most common types found in vivo, both leading to proteasomal destruction of 
the conjugated substrates.  Purified ubiquitin proteins that are mutated at the individual lysine 
residues could be used in in vitro ubiquitylation reactions.  Loss of signal in reactions that 
contain ubiquitin with a particular lysine substitution would suggest that Rkr1 catalyzes that type 
of polyubiquitylation.   
6.3.2.2 What are the targets of Rkr1’s ubiquitin ligase activity? 
 Finding targets of this activity is a very difficult process because any protein that interacts 
with Rkr1 in vivo is probably polyubiquitylated and targeted for destruction by the proteasome.  
We have established a collaboration with Richard Gardner’s lab at the University of Washington 
to use a biochemical approach to identify Rkr1 substrates.  These experiments involve using 
mass spectroscopic analysis to identify increased protein levels in rkr1Δ strains compared to wild 
type strains.  The proteins found at higher levels are potential substrates for the ubiquitin ligase.   
I propose that the conserved amino-terminal region serves as a substrate recognition 
module within Rkr1.  If this is true, then the proteins identified to interact in our yeast two-
hybrid screen (Chapter 4) may be substrates of Rkr1’s ubiquitin ligase activity.  Further 
experiments (described in section 6.4.1) will be needed to determine is these proteins are indeed 
ubiquitylated in a Rkr1-dependent manner.  This can be done by expressing untagged or HIS-
tagged ubiquitin in strains expressing tagged version of a protein of interest.  We can purify all 
ubiquitylated proteins with a nickel column, and then perform immunoblot analysis to detect our 
protein of interest in the ubiquitin-enriched proteins.   
 The amino terminus of Rkr1 is conserved in eukaryotes.  Mutational analysis of this 
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region of the protein could provide insight into the function of this region in vivo.  It would be 
interesting to determine if expression of an amino-terminally truncated Rkr1 in yeast could 
complement the lethality of a rkr1Δ rtf1Δ strain or lead to dominant negative effects in a wild 
type strain.  Complementation would suggest that the amino terminus of Rkr1 provides little or 
no functional specificity to Rkr1 in vivo.  Dominant negative effects would suggest that the 
amino terminus of Rkr1 is important for regulating substrate specificity. 
6.3.2.3 Could Rkr1 act as a ligase for ubiquitin-like modifications? 
From data obtained through genetic analysis and my in vitro experiments, I propose that 
the RING domain of Rkr1 is required for the ubiquitylation of one or more nuclear proteins.  
Protein sumoylation, a ubiquitin-like modification, is also facilitated by RING domain-
containing proteins (HAY 2005).  While it remains possible that Rkr1 could act as a SUMO-
protein ligase in vivo, our lab has obtained genetic and biochemical data that do not support this 
idea.  For example, we do not see any genetic interactions in strains containing mutations in 
RTF1 and UBC9, the gene encoding the sole SUMO-conjugating enzyme in yeast.  Rkr1 does 
not physically interact with SUMO (tested by directed yeast two-hybrid screen), arguing against 
a role for Rkr1 as a SUMO ligase.  Moreover, Cheng et al. recently reported that SUMO-protein 
ligases, such as Siz1, Siz2 and Zip3, have a unique variant RING sequence, C3HCHC2 (CHENG 
et al. 2006). 
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6.4 RKR1 PHYSICALLY INTERACTS WITH PROTEINS INVOLVED IN 
UBIQUITYLATION, TRANSCRIPTION AND CHROMATIN FUNCTION 
The amino terminus of Rkr1 physically interacts with 20 proteins in a yeast two-hybrid screen 
(Chapter 4).  These proteins fall into several functional classes, including transcription and 
chromatin related factors, and the ubiquitin related factor, Dsk2.  These physical interactions 
further support a model in which Rkr1 functions in parallel with Rtf1 using its ubiquitin ligase 
activity to affect chromatin function and transcription.  Future experiments will be aimed at 
confirming these physical interactions with full-length Rkr1.   
 Biochemical purification of Rkr1 suggests that Rkr1 is not part of a stably associated 
complex in vivo.  This observation supports a model in which the proteins that were shown to 
interact with Rkr1 in the yeast two-hybrid screen are most likely targets of its ubiquitin ligase 
activity.  
6.4.1 Are any of the proteins that interact with Rkr1 targets of its ubiquitin ligase 
activity? 
Many experiments can be performed to determine if the proteins that interact with the amino 
terminus of Rkr1 are ubiquitylation substrates.  Cycloheximide chase experiments can be used to 
determine if these proteins are degraded at faster rates in wild type strains compared to rkr1Δ 
strains.  Preliminary experiments using Gzf3 and Rsc8 suggest that Rkr1 is not important for the 
degradation of these proteins in rich medium.  However, Rkr1 may be important for the 
degradation of these proteins only when cells are stressed.  Alternatively, Rkr1 may be important 
for the degradation of only mutant versions of these proteins, which comprise a small fraction of 
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the total protein in the cell.  Cycloheximide chase experiments using strains that are grown in 
minimal medium or strains that are expressing mutant versions of these proteins may clarify 
Rkr1’s function in vivo.   
6.4.2 Physical connections between Rkr1 and the proteasome support a role for Rkr1 in 
ubiquitylation in vivo. 
Rkr1 physically interacts with Dsk2 (Chapter 4), a protein that contacts polyubiquitylated 
proteins and targets them to the proteasome for destruction (HARTMANN-PETERSEN and GORDON 
2004).  Further characterization is necessary to determine if a functional Rkr1 RING domain is 
required for this interaction.  This interaction supports a functional role for Rkr1 in protein 
ubiquitylation in vivo.   
 Rkr1 has been shown to physically interact with the 19S proteasome in the absence of 
ATP (VERMA et al. 2000).  This interaction also supports a role for Rkr1 in protein 
ubiquitylation in vivo.  However, this interaction has not been confirmed in our lab.  
Coimmunoprecipitation experiments could confirm the stability of this interaction.  The 19S 
proteasome has been shown to associate with actively transcribed genes, and to be required for 
connecting histone H2B ubiquitylation with histone H3 K4 and K79 methylation.  Chromatin 
immunoprecipitation experiments could be used to investigate whether Rkr1 is required for the 
association with the 19S proteasome with chromatin.  However, this model is improbable 
because histone H3 K4 and K79 methylation occur at wild type levels in rkr1Δ strains (Chapter 
2), although Rkr1 could recruit the proteasome to chromatin by mediating the ubiquitylation of 
other chromatin-associated proteins.     
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6.5 RKR1 IS IMPORTANT FOR THE PROPER EXPRESSION OF A SUBSET OF 
GENES IN YEAST 
Microarray analysis (see Chapter 5) shows that Rkr1 is required for the proper expression of a 
subset of genes in yeast.  Specifically, 50 genes are up-regulated more than 1.75 fold and 25 
genes are down-regulated more than 1.75 fold in a rkr1Δ strain.  These genes fall into many 
functional classes, and are found throughout the genome, suggesting that Rkr1 does not have 
strong effects on transcription in vivo.   
6.5.1 How does Rkr1 affect gene expression in yeast? 
This study provides the basis for many future experiments that can clarify Rkr1’s role in 
transcription.  At this point, I can envision two models for why some genes are mis-regulated in 
rkr1Δ strains.  The first model is that Rkr1 is required for proper chromatin architecture in yeast.  
Defects in gene expression may be detected if Rkr1 is important for establishing or maintaining 
proper chromatin structure within promoters.  Defects in this process could lead to access or 
occlusion of transcription factor binding sites that are important for the proper expression of 
downstream genes.  This model is supported by evidence that Rkr1 is important for telomeric 
silencing, a process that is influenced by genome wide defects in either chromatin modification 
or chromatin structure.  However, preliminary MNase digestion experiments suggest that strains 
lacking RKR1 do not have detectable changes in global chromatin structure compared to 
chromatin from a wild type strain (K. Klucevsek, M. Braun, and K. Arndt, unpublished 
obervations).  This suggests that Rkr1 may not affect gene expression through global chromatin 
structure.  However, Rkr1 physically interacts with Rsc8, a component of the RSC chromatin 
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remodeling complex, and genetically interacts with another chromatin remodeler, Chd1.  These 
interactions suggest that Rkr1 may affect gene expression by influencing the activity of a 
chromatin remodeling complex.  Support for this model also comes from the genetic interaction 
with SPT10.  Strains lacking SPT10 have reduced histone levels, and also have global changes in 
chromatin structure (DOLLARD et al. 1994; HESS et al. 2004; NATSOULIS et al. 1994).  This 
genetic interaction may suggest that Rkr1 is important for regulating the insertion of histones 
into chromatin, which would have a downstream effect on gene expression.  Investigating Rkr1’s 
role in chromatin structure by repeating the global MNase assays could help us to understand if 
Rkr1 plays a role in chromatin structure.  We could also direct these studies to look at chromatin 
architecture at specific genes by combining MNase digestions and Southern analysis.   
The second model for Rkr1’s role in gene expression proposes that Rkr1 is important for 
recruitment and/or activity of the transcription factors that regulate the expression of the genes 
that were identified by microarray analysis.  This model is supported by overlap in the yeast two-
hybrid and microarray datasets.  Gzf3 and Dal82, which physically interact with Rkr1 in a yeast 
two-hybrid screen, regulate the expression of nitrogen responsive genes in yeast (ELBERRY et al. 
1993; SOUSSI-BOUDEKOU et al. 1997).  Most of the genes regulated by these proteins were 
downregulated in strains lacking RKR1 (Chapter 5).  ChIP experiments could be used to 
determine if these proteins are properly recruited to their target genes in strains lacking RKR1.  
At this point, I cannot favor either model, simply due to a lack of information.  These models 
need not be mutually exclusive either.  Rkr1 may directly affect the recruitment of transcription 
factors by influencing chromatin remodeling activities at gene promoters.    
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6.5.2 Is Rkr1 directly involved in regulating any of the genes identified by microarray? 
I have tried to determine if Rkr1 localizes to activated genes, including INO1 and GAL1/10 by 
ChIP analysis.  These genes can be induced by the removal of inositol from the medium or 
addition of galactose to the medium, respectively.  I was unable to detect Rkr1 localization at 
these genes, either at the promoter or within the open reading frame (data not shown).  These 
results suggest that Rkr1 may not be associated with all genes in yeast, or that Rkr1 may be 
present at very low levels on chromatin.  Work from the laboratory of Dr. Michael Grunstein 
show that the association of the histone deacetylase Rpd3 with chromatin was only detected after 
crosslinking proteins to proteins with dimethyl adipimidate (DMA) and then crosslinking 
proteins to DNA with formaldehyde (KURDISTANI and GRUNSTEIN 2003).  It is definitely 
possible for a protein to associate with chromatin and not be detected by conventional 
formaldehyde ChIP analysis.  We could perform ChIP experiments using the highly sensitive 
method described above to determine if Rkr1 associated with chromatin at genes identified by 
microarray analysis, or use other methods that do not rely on assaying specific loci.   
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6.6 OVERALL MODEL FOR RKR1 ACTIVITY 
In summary, my results indicate the existence of a new nuclear protein ubiquitylation pathway 
that is functionally connected to chromatin and transcription.  Based on the findings described 
above, I hypothesize that the ubiquitin-protein ligase activity of Rkr1 operates in parallel with 
Rtf1 and several histone modifications to regulate a common, essential process.  Rkr1’s 
ubiquitylation activity may be important for establishing a chromatin structure that is needed for 
highly efficient transcription.  Alternatively, Rkr1 may be important for the proper recruitment 
and/or activity of transcription activators or repressors.  Although the best-characterized 
functions for Rtf1 relate to transcription, my data do not exclude the possibility that the synthetic 
lethal relationship between Rtf1 and Rkr1 is due to their involvement in other essential 
processes, which remain to be identified.  Future experiments will aim to expose the in vivo 
target(s) of Rkr1’s ubiquitin-protein ligase activity and explain how the target(s) relates to 
chromatin structure or function.  Finally, because Rkr1 is a conserved protein, further studies in 
yeast should illuminate the role of homologous proteins in humans and other eukaryotes. 
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APPENDIX A 
HIGH COPY SUPPRESSORS OF RKR1-RTF1 SYNTHETIC LETHALITY 
Proteins expressed at elevated levels can suppress growth defects of null mutant strains if the over-
expressed proteins can restore the function of the pathway controlled by the mutant protein.  To obtain 
high-copy number suppressors of rtf1Δ/rkr1Δ synthetic lethality, MBY186 (rkr1Δ::kanMX4, 
rtf1Δ::ARG4, leu2Δ1, ura3-52, trp1Δ63, arg4-12, [pKA61 = RTF1/URA3/CEN/ARS]) was transformed 
with a high-copy number, LEU2-marked library that contained 9-12 kb inserts of genomic DNA 
fragments.  Approximately 13,500 colonies were screened to ensure that ≥99% of the genome would be 
covered in the library.  Transformants were selected on SC-Leu dropout medium.  Transformants were 
replica printed to YPG, SC-Ura-Leu, SC-Ura-Leu+5FOA, and SC-Ura to determine which colonies could 
lose pKA61 and survive with the high-copy plasmid.  One hundred and thirty one 5FOA resistant 
colonies were patched to SC-Leu and replica printed to confirm resistance.  All colonies were 5FOA 
resistant upon re-printing.  LEU2-marked plasmids were recovered from transformants using the Smash 
and Grab method (HOFFMAN and WINSTON 1987) on cultures grown in SC-Leu medium.  Plasmids were 
re-transformed into MBY186 to confirm the suppression phenotype.  Forty eight plasmids confirmed 
5FOA resistance upon re-transformation.  PCR confirmed that 12 of these inserts contained RKR1 and 9 
contained RTF1.  DNA sequencing showed that there were 6 unique plasmids that conferred 5FOA 
resistance to MBY186 (Table 19).  The number of times each insert was obtained is listed in Table 19.  
 266 
 
Table 19.  High-Copy-Number suppressors of rtf1Δ/rkr1Δ synthetic lethality. 
Insert # # Isolates Gene name Gene description 
1 7 LSM4 mRNA processing factor; if nuclear, part of 
snRNP; if cytoplasmic, important for mRNA 
decay 
2 3 MRPL3 Mitochondrial ribosomal protein (large subunit) 
  CSI1 Subunit of Cop9 signalsome; required for 
deneddylation or removal of ubiquitin-like Rub1 
from Cdc53 (cullin); involved in adapting to 
pheromone signaling 
  PEX12 Contains a C3HC4 type RING domain; 
peroxisomal membrane protein 
  YMR027w Uncharacterized; Increased expression reduces 
Ty transposition 
  TAP42 Tor signaling pathway component; associates 
physically with Sit4 and PP2A 
  FAR8 Pheromone response 
3 1 YNL224c Uncharacterized; Physically interacts with Prp43 
(RNA helicase in spliceosome) 
  CNM67 Spindle pole body component 
  YNL226w Uncharacterized; Physically interacts with Nip7 
(nucleolar protein) 
  JJJ1 J-domain containing protein; Physically 
associates with the ribosome 
  YNL228w Uncharacterized; physically interacts with Eds1 
(unknown function) 
  URE2 Nitrogen catabolite repression regulator; inhibits 
GLN3 expression 
4 9 GPD1 NAD-dependentglycerol-3-phosphate 
dehydrogenase; required for glycerol 
biosynthesis 
  DIA3 Unknown function; “digs into agar”; involved in 
invasive and pseudohyphal growth 
5 2 TPO1 Polyamine transporter; membrane protein 
  ISA1 Mitochondrial matrix protein involved in the 
biogenesis of iron-sulfur clusters used as 
cofactors of many proteins 
  HSP104 Heat shock protein; works to refold misfolded 
and aggregated proteins; cytoplasmic and 
nuclear localization 
6 7 AIR1 Contains a C3HC4 type RING-domain; nuclear 
protein; Physically interacts with Hmt1 (arginine 
methyltransferase) to regulate the methylation of 
Npl3 (mRNA processing and export factor) 
  THS1 Threonyl-tRNA synthetase 
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